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Abstract
The minimal human alpha-thrombin binding aptamer, d(GGTTGGTGTGGTTGG), has
previously been successfully identified from a DNA library of randomized hairpin loop, m=15,
with the High Throughput Screening of Aptamers (HTSA) technique, later termed Acyclic
Identification of Aptamers (AIA). AIA eliminated the need for multiple cycles of in vitro
evolution typically used for aptamer discovery by employing libraries with an overrepresentation of all possible sequences and high throughput sequencing. Although the method
was successful at identifying the thrombin binding aptamer, improvements to partitioning and
sample preparation inconsistencies encountered during replication attempts were necessary in
order to maximize its value. Subsequent revisions and variations of the protocol improved and
streamlined the work-flow such that the thrombin binding aptamer (TBA) and multiple variants
were identified as high affinity sequences using the ligation based m=15 DNA hairpin loop
library mentioned above. The revised AIA protocol was also successful for identifying TBA and
multiple variants in a nuclease resistant, modified 2’-OMe RNA/DNA chimera library. Sample
throughput was increased with the introduction of indexed adapters containing sequence
“barcodes” that facilitate multiplexing during high throughput sequencing. To eliminate the
constraints of the hairpin loop library structure, a library based on direct amplification, the
“adapter” library was designed. The m=15 DNA and m=15 2’-OMe RNA/DNA chimera adapter
libraries were unsuccessful at identifying TBA from the library pool, likely due to interference
from the flanking adapter regions required for PCR amplification. A secondary PCR product
identified during sample work-up was also characterized. This prompted a significant interest in
creating the ability to accurately assess whether or not a sample should be sequenced prior to
consuming valuable resources. To accomplish this, the capture of a minimally flanked library

(pACAC-m15-CACA) with full length adapters and no requirement for amplification was
optimized. The library provides greater flexibility in secondary structure formation and was
shown to successfully identify TBA from an over-represented library pool. Amplification-free
AIA introduced the unique ability to predict relative maximum sequence frequencies based on
the quantity of recovered library, initial degree of over-representation, and anticipated data
output. The ability to predict whether or not a sequence could be counted above background was
used to assess whether that sample would be sequenced, ultimately saving time and money. To
expand the applicability of the tailed libraries and amplification free protocol, a novel
partitioning method that eliminated the requirement for protein immobilization was developed.
Reversible formaldehyde cross-linking in conjunction with Electrophoretic Mobility Shift Assay
was used to successfully identify TBA above background in proof of concept experiments using
amplification free sample preparation. The ability to perform AIA partitioning in solution
provides greater flexibility in target selection, including mixtures of proteins. The method also
effectively reduces the aptamer off-rate to zero by covalently linking high and moderate affinity
sequences to the protein target during selection, an advantage over protein immobilization for
partitioning where loss of some DNA from a reversibly bound complex is inevitable. The sample
preparation techniques that evolved over the course of this work offer superior control and
predictability in the outcome of high throughput sequencing data. This was aided by absolute
quantification with qPCR CopyCountTM software that effectively improved library
quantification, distribution of indices, and cluster quality, which is crucial for maximization of
data output on Illumina sequencing platforms. Consistent, high quality data eliminates the
potential for costly resequencing. Future experiments will capitalize on the breadth of
improvements to the AIA method described in this work.
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Chapter 1: Introduction

Aptamers are functional single-stranded oligonucleotides capable of folding into threedimensional structures that bind their targets with high specificity.[1] These structures provide
binding locations specific to molecular targets, including metal ions, chemicals, small molecules,
proteins, cell surfaces, and parasites,[1] with applications as biosensors,[1-10] therapeutic
agents[1, 11-18], and diagnostic tools.[1, 19-25] Aptamers closely mimic the activity of
antibodies and can have similarly high affinities for their targets.[1, 20, 26-28] There are
potential applications in all fields currently dominated by antibodies. There are many advantages
to utilizing aptamers; unlike antibodies, aptamers are identified in a process that does not involve
live tissue, so conditions can be manipulated to suit the target environment.[28] The use of toxic
substances or those that elicit a negative immune response is not restricted during the discovery,
isolation, and generation of aptamers.[28] Aptamers can be produced at 1-10% of the cost of
antibodies using scalable solid-phase DNA or RNA synthesis, a favorable characteristic for
commercial applications. Additionally, incorporating modified oligonucleotides, including 2’fluoro RNA[29], 2’-O-Methyl RNA[30] and L-oligonucleotides[31, 32] limits degradation in
vivo due to substrate specificity of nucleases. With such a broad range of applications and
benefits, the development of a fast, efficient, and widely applicable aptamer discovery protocol is
highly desirable. The Acyclic Identification of Aptamers (AIA) method was designed and
implemented with those goals in mind and was used successfully to rapidly screen and identify
aptamers in a single round of selection.[33] The goal of this work was to improve upon AIA by
utilizing varied oligonucleotide library structures and screening techniques, with the intent of
streamlining the approach as a universal aptamer discovery method.

1

The Origin of Aptamers
Many short RNA molecules are known to have functional roles in vivo. Viral RNAs were of
early interest to those studying functional RNAs, as they bind their targets with high affinity and
specificity.[34] In human immunodeficiency virus (HIV), a short mRNA named the transactivation response element (TAR) binds the viral Tat protein to promote viral replication.[35,
36] Additionally, RNA stem loop 3 (SL3), which is absent in spliced mRNA encoded by the HIV
provirus, interacts with the HIV nucleocapsid protein 7 (NcP7) and plays a vital role in viral
packaging.[37] The function of an adenovirus mRNA transcript termed virus-associated RNA
(VA RNA) that inhibits translation was also extensively studied.[38] The continued study of
these naturally occurring functional RNAs led to the development of a method to discover
functional nucleic acids artificially. The Systematic Evolution of Ligands by Exponential
Enrichment (SELEX) technique, also known as in vitro selection, was independently developed
by two separate groups led by Larry Gold and Jack Szotstak.[39, 40] The method utilizes
oligonucleotide libraries, typically of length 30-80 nucleotides, and capitalizes on the ability of
single-stranded oligos to fold into varied secondary structures. These stable conformations
include hairpins, internal loops and bulges, multi-branched loops, pseudoknots and Gquadruplexes which create highly specific binding sites for their targets (Figure 1.1).[41] These
highly specific oligonucleotides are called aptamers, a term credited to Andrew Ellington, who
worked alongside Szostak. The term comes from the Latin “aptus” meaning “to fit.”[40]

2

The SELEX Protocol
Library Design

SELEX has been the standard method for aptamer discovery since its development in 1990. The
method begins with a randomized RNA or DNA library of a specific length, m, and the notion
that a fraction of these sequences will fold in such a way to yield a binding site specific to the
target of interest. The goal is to isolate and identify these sequences through multiple rounds of
selection, purification, and amplification. There are four main considerations when selecting a
library for SELEX, (1) the chemistry of the library, (2) library length, (3) type of randomization
and (4) length and composition of fixed regions. Both DNA and RNA libraries are used in
SELEX, each with distinct advantages and disadvantages. DNA libraries are very stable in
nuclease-free environments, while RNA libraries are susceptible to hydrolysis due to the 2’hydroxyl group of the pentose sugar. However, the 2’-hydroxyl group increases the hydrogen
bonding potential of RNA, giving it a broader range of secondary and/or tertiary structure
formations than a DNA molecule of the same sequence. This may increase the likelihood of
discovering an aptamer, as the secondary and/or tertiary structure is critical to creating a binding
site for the target. Modified nucleic acids may also be used to provide nuclease resistance, such
as 2’-fluoro RNA, 2’-amino RNA, and 2’-O-Methyl RNA. The chemistry and application of
these modifications will be discussed in the next section.

The length of the DNA or RNA library used in SELEX is highly varied. If there is no known
nucleic acid binding activity for the chosen target, multiple library lengths may need to be
explored, as there are benefits to both short and long libraries. For traditional SELEX
experiments, library lengths of 30 to 60 nucleotides are most common.
3

These shorter libraries allow for structural motifs to be easily identified and aligned in sequence
data.[42] Libraries as short as 22 and 26 nucleotides have been used to successfully identify an
aptamer for isoleucine.[43, 44] Additionally, libraries of 25 nucleotides have been used
successfully to identify aptamers for arginine [45] and proteins [46-48]. However, longer
libraries may be necessary as they allow for greater structural complexity. In the case of naturally
occurring 76-mer tRNA molecules, a library of 80 nucleotides would have a much higher
success rate at identifying any tRNA mimics than a shorter library.[42] Longer libraries of 120
[49-53] and 228 [54] nucleotides have been used to successfully identify aptamers. It is possible
to identify shorter motifs within long libraries; however, the folding of the motif may be
influenced by the context of the remaining library sequence. Truncation of the library to the
shorter motif may improve or deplete the function.

Additionally, because shorter motifs

naturally occur at a higher frequency within the library, selection of these shorter motifs may
dominate over a sparsely represented longer binding motif.[55] Conversely, the selection of
shorter binding motifs within a long library may be inhibited by the folding of the remaining
library sequence.

The diversity of a library used in a SELEX experiment, and consequently the diversity of any
shorter n-mer, is limited by both the library length and quantity of library used. DNA libraries
are synthesized by solid-phase synthesis, thus the frequency of any unique sequence is ultimately
limited by the library length and synthesis scale. Table 1.1 outlines the combinatorial
considerations to be made when selecting a library. The number of possible sequences for a
library of length, m, is 4m. The number of possible sequences increases exponentially as library
length increases and the number of unique sequences occurring in a library pool is dependent on
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the synthesis scale. For a typical synthesis scale of 1 µmole, approximately 6.02x1017 library
molecules will be synthesized. In order for every possible sequence to be present at least one
time and assuming a 100% yield, the library can be no longer than 28 nucleotides. Additionally,
only a fraction of the 1 µmole synthesis would be used during a partitioning step. For these
reasons, the libraries used in SELEX are always sparsely sampled. In fact, most sequences will
not be present at all and any present sequences will occur only once. For example, a 40-mer
library contains approximately 1.2x1030 possible sequences. A 1 µmole scale synthesis is capable
of producing only 5.0x10-5 % of these sequences. In other words, only 1 in every 2.0x106 unique
sequences is synthesized. A common argument for choosing a longer library in SELEX is the
notion that all possible shorter n-mers will exist within the longer library.[42] For example, all
possible 30-mers will exist within a 40-mer library. This is true when considering the entire
1.2x1030 unique sequences in a 40-mer library, however, the entire population cannot be used in
a SELEX experiment. If a 100 pmol aliquot of a 40-mer library is used during selection,
approximately 6.0x1013 molecules are used.

A 30-mer library contains 1.15x1018 unique

sequences. It is impossible for all of the 30-mers to be present in the 100 pmol aliquot. For much
shorter n-mers, the presence of all possible sequences is dependent on the n-mer length and
quantity of library. Additionally, the secondary or tertiary structure of the 30-mer will be
influenced by the remaining library sequence, which may cause it to behave differently than the
same sequence from a 30-mer library. Even if a given 30-mer is present multiple times within the
aliquot of 40-mer library, the remaining randomized region will not be identical. This is
complicated further by the fact that an identical 1 nmol aliquot of 40-mer library cannot be
replicated due to the sparsely represented nature.

5

The degree and type of randomization in a library can also be varied. In addition to complete
randomization, libraries with partial or segmental randomization have been used. Segmental
randomization involves complete randomization of a short region or regions within a known
aptamer sequence. This method can aid in the discovery of higher affinity binding sequences
while illustrating the role of specific nucleotides within the aptamer sequence.[42]

Partial

randomization, also known as doping, involves the introduction of point mutations into a known
sequence. Doping at one or more locations within a selected sequence and reselecting against the
target may aid in the identification of critical nucleotides and their role in target binding.[42, 56]

Due to the sparsely represented nature of SELEX libraries, multiple rounds of selection,
purification, and amplification are required in order to isolate any high affinity sequences from
the starting library pool. To facilitate amplification, SELEX libraries are flanked by fixed, noncomplementary primer regions. For RNA libraries, the library is synthesized as DNA and the 5’primer region is used to facilitate RNA transcription, given it contains a T7 RNA polymerase
promoter sequence. Following selection, RT-PCR regenerates and amplifies the DNA library and
the cycle can be repeated. The composition of the flanking regions, often called primer or
priming regions, should be designed carefully. Ideally, the sequences will be non-complementary
and lack any significant secondary structure. The corresponding primers used for amplification
should anneal with high efficiency, have suitable melting temperatures, and not form primer
dimers.[42] Efficient and specific amplification of the library molecules is critical for
regenerating a library used in SELEX.

6

In Vitro Selection
The SELEX method, as illustrated in Figure 1.2, includes multiple cycles of selection,
purification, and amplification. If a DNA library is desired, an aliquot of the synthesized library
is typically enriched by PCR amplification in order to create multiple copies of each unique
sequence in the starting pool. A commonly used method for regeneration of single stranded DNA
is the use of a modified primer, such as 5’-biotinylated primer, followed by separation on
streptavidin beads.[54, 57-59] The strands may also be separated by electrophoresis.[60] If an
RNA library is desired, the DNA library is simply transcribed into RNA; the DNA library may
or may not be amplified prior to this step.[40, 61]

During the selection step, the target is usually immobilized in order to separate bound from unbound library molecules. This is typically achieved using affinity chromatography methods,
including nitrocellulose filters, or modified sepharose or magnetic beads.[62, 63] The conditions
for the selection step, including target/library concentrations, buffer composition, temperature,
and incubation time all affect the selection stringency. The ionic strength of the buffer is an
important consideration, as the shielding effect of solvent ions will naturally influence
electrostatic interactions between negatively charged DNA and a target with charged regions.
Also, solvent cations stabilize oligonucleotide secondary structures.[64, 65] Unbound library
molecules are removed by washing with multiple rounds of selection buffer. Bound library
molecules are typically collected following elution with a chemical denaturant, such as
Guanidine HCl or Urea.[20, 66] Phenol may be used to co-elute protein and library directly from
an affinity matrix[67] or to extract the library from complexes co-eluted by another method.
Alternatively, competing ligands may be used to elute protein-library complexes[57] and
7

adjusting ionic strength has been successfully used to elute the library. [46] Ethanol precipitation
is most commonly employed to purify and concentrate the eluted or extracted library.

Following selection, the library pool may now contain sequences with affinity for the target,
along with some percentage of nonspecific binding sequences. The purified library is amplified
in order to create multiple copies of the surviving sequences for use in the next cycle of
selection. RNA libraries are subjected to reverse-transcription PCR and subsequent transcription
to regenerate the single-stranded RNA library. Single-stranded DNA is regenerated as mentioned
previously. As the cycle of selection, purification, and amplification is repeated, typically 5-15
times, the frequency increases for any high affinity sequences originally present in the library
pool, or ones that evolved through the amplification process. In order to identify these sequences,
SELEX traditionally employs Sanger sequencing of a few dozen to a few hundred cloned
sequences. The SELEX method is a labor intensive and time consuming process with minimal
data out. Many efforts to improve the method have been published, including the AIA method
from which this work was developed.

Improving the SELEX Method
Modified SELEX
The goal of many modified SELEX methods is to simultaneously improve selection efficiency
while reducing labor and time demands. One such method, Capillary Electrophoresis SELEX
(CE-SELEX), has successfully identified aptamers while reducing the number of selection
cycles. The method utilizes the electrophoretic mobility shift of target-library complexes to
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separate them from unbound library and target. Carryover of nonspecific library molecules is
significantly reduced in the method, allowing the number of necessary selection cycles to be
reduced. The CE-SELEX method has successfully identified aptamers in as few as 1 or 2
selection rounds in a matter of days,[68-75] compared to weeks to months for traditional
SELEX. One potential drawback of CE-SELEX is the poor separation of small target molecules
from target-library complexes, especially when the target is smaller than the individual library
members.[76] The method is also limited by the type of target; the target must shift the
electrophoretic mobility of the bound oligonucleotide and the application does not work for
whole cells.[77] Additional methods aimed at reducing the number of selection rounds include
Non-SELEX, M-SELEX, and I-SELEX. Non-SELEX utilizes multiple rounds of capillary
electrophoresis but forgoes any amplification steps.[78-80] M-SELEX, or microfluidic SELEX,
utilizes chip-based microfluidics and magnetic beads to achieve efficient separation of target
bound libraries via magnetic force in combination with high pressure wash steps.[81-84] ISELEX, or inertial microfluidic SELEX, utilizes curvilinear microfluidic channels to capitalize
on the effect of centrifugal acceleration on hydrodynamic forces. Smaller particles travel to the
outer wall of the channel, while larger particles travel toward the inner wall. Target bound
oligonucleotides are collected while unbound oligonucleotides are diverted to a separate outlet.
The method was applied to whole cell SELEX and successfully identified aptamers for surface
proteins of malaria parasite-infected red blood cells.[85]

Automating the SELEX process with robotic workstations was also explored. The goal of
automated SELEX was to streamline workflow without necessarily reducing the number of
selection cycles. The first SELEX workstation included a pipetting robot, thermocycler, and
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magnetic bead separator.[86] Several modifications and improvements to the workstation
allowed it to perform as many as 12 rounds of selection in only 42 hours.[87] Several aptamers
were discovered using automated SELEX,[86, 88-91] and the workstation was even used to
perform in vitro transcription and translation of the protein target.[92] Semi-automated SELEX
utilizing robotic magnetic separation and solid-phase emulsion-PCR has also been successful at
identifying aptamers, with 12 selection cycles completed in only 10 days.[93]

An alternative selection method to the traditional affinity chromatography or bead-based
methods is the Electrophoretic Mobility Shift Assay (EMSA). Similarly to CE-SELEX, EMSASELEX capitalizes on the electrophoretic shift of target bound oligonucleotides. Unbound
oligonucleotides travel through the gel faster than target bound oligonucleotides. The method
offers the distinct advantage of visualizing the ratio of bound to unbound library, provided
autoradiography is utilized when working in minute concentrations. The stringency of selection
can then be visualized over a range of selection cycles; the ratio of shifted library increases as the
number of selection cycles increases. It can be assumed that high affinity sequences have been
selected when the ratio does not increase with additional cycles. The stringency of selection can
also be increased simply by decreasing the amount of protein, thus increasing competition for
binding sites.[94] The conditions of EMSA-SELEX are limited due to compatibility with gel
electrophoresis. Sample volume constraints affect library and target concentration, ultimately
limiting the diversity of long SELEX libraries.[77] However, EMSA as a partitioning method
was successful at identifying aptamers for Roaz, a rat zinc finger protein, after 9 rounds of
selection.[95] In addition to PAGE-EMSA,[95, 96] agarose-EMSA has been used successfully
for in vitro selection[97].
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Capture-SELEX offers yet another unique method of selection. Traditional SELEX is not well
suited for the selection of many small organic molecules, as it requires their immobilization to a
solid support. Capture-SELEX was designed to immobilize the oligonucleotide library instead of
the target during selection. The library was synthesized with a “docking sequence” that is
complementary to an immobilized oligonucleotide on a magnetic bead surface. The small
molecule target is allowed to bind to the immobilized library in solution; any sequences that
show affinity for the target undergo a conformational change for binding, causing them to be
released from the beads. The high affinity sequences are then collected from the supernatant. It is
possible for some sequences to undergoing a conformational charge that does not include the
docking sequence, in which case those sequences are not released from the beads. Aptamers for
kanamycin-C were identified after 13 rounds of Capture-SELEX.[98] The method was also used
in conjunction with Surface Plasmon Resonance to identify aptamers for tobramycin, an
aminoglycoside antibiotic.[99]

Modified Libraries
The composition and functionality of SELEX libraries has been modified is various ways in
order to improve selection efficiency, including the introduction of modified nucleotides for
enhanced capture, modified nucleic acids offering increased nuclease resistance, or reducing or
eliminating fixed flanking regions. Introducing modified nucleotides capable of covalently crosslinking with proteins has been shown to improve selection efficiency. PhotoSELEX, or
photochemical SELEX, utilizes photocross-linking of modified oligonucleotides to the aromatic
or sulfur-bearing amino acid residues of the protein target. UV-induced covalent bonds between
a 5-bromouracil substituted DNA library and recombinant human basic fibroblast growth factor
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resulted in the selection of high affinity aptamer sequences.[100] Photocross-linking of a 5’iodouracil substituted RNA library was used in a dual selection method to identify sequences
with high affinity for Rev, a protein from HIV-1.[101] In an effort to improve capture efficiency
by reducing the off-rates of aptamer sequences, SomaLogic, Inc. developed SOMAmers (Slow
Off-Rate Modified Aptamers). These nucleotides capitalize on the notion that aptamers may
exhibit protein-like properties if they contain functional groups similar to amino acid side
chains.[102] With only four possible nucleotides, the diversity of a DNA or RNA library
depends almost entirely on the length and sequence complexity of the library. Expanding the
chemical diversity of the oligonucleotide side chains to include 5’-benzyl, 5’-naphthyl, 5’tryptamino and 5’-isobutyl groups increases the binding potential of the library.[20, 103]

Introducing nuclease resistance is a popular modification to the SELEX protocol. Retaining high
affinity sequences throughout the selection process is critical for efficient aptamer discovery.
While DNA libraries are easy to work with in vitro and are relatively stable, RNA libraries are
much more susceptible to hydrolysis by small amounts of contaminating nucleases. However,
both DNA and RNA aptamers are susceptible to hydrolysis in vivo, where the presence of
nucleases cannot be controlled, thus limiting their applications.

One of the first methods for introducing nuclease resistance was the use of L-nucleotides in place
of the naturally occurring D-nucleotides.[31] Libraries synthesized with L-nucleotides, also
known as spiegelmers, are not recognized by nucleases due to substrate specificity. In order to
select L-aptamers, the D-nucleotide library is partitioned against a mirror image protein
containing D-amino acids. Once the D-aptamer sequence is identified, the L-aptamer is
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synthesized. The L-aptamers have high affinity for the naturally occurring proteins containing Lamino acids, while remaining nuclease resistant. Several spiegelmers for various small protein
targets have been identified [31, 32, 104-106] and applications in therapeutics are promising due
to their bio-stability and immunologic passivity.[107, 108] A limitation of the method, of course,
is that a mirror image protein cannot be expressed in cells; however the chemical synthesis of
many interesting bio-active peptide targets from D-amino acids is simple and economically
feasible.

Chemically modified nucleotides such as 2’-fluoro, 2’-amino, and 2’-O-methyl (2’-OMe) also
offer nuclease resistance in addition to preventing hydrolysis of RNAs, although incorporation of
these modified nucleic acids into the SELEX protocol has its challenges. The structures of these
three types of modifications are shown in Figure 1.3. Modified nucleotides may be used both
during the selection process as modified libraries and post-SELEX as modified aptamers. After
identifying an aptamer by SELEX, a nuclease resistant variant containing modified nucleotides
can be chemically synthesized. The type and degree of modification are important considerations
for in vivo applications. 2’-fluoro and 2’-amino modifiers are more costly than 2’-OMe modifiers
and pose a greater safety concern. Both 2’-fluoro and 2’-amino nucleotides are not naturally
occurring within the human body[30, 41, 109] and they could potentially be incorporated into
host DNA with unknown toxicological effects.[110] The introduction of synthetic 2’-OMe
nucleotides into biological systems is not a safety concern. The nucleotides exist in the human
body as a result of posttranscriptional modification of ribosomal RNA,[111] yet 2’-OMe
nucleoside triphosphates are not accepted by human DNA polymerase as substrates.[30, 109,
110] This unique property of 2’-OMe RNA nucleotides eliminates the safety concerns of using
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2’-OMe RNA aptamers in therapeutic applications. The effects of 2’F, 2’NH2, and 2’-OMe
nucleotides on aptamer secondary structure must also be considered. Modifications to an aptamer
sequence found through SELEX may disrupt the secondary structure, the binding properties
and/or inhibitory or catalytic function of the aptamer.[112, 113] In some instances, function is
altered to varying degrees depending on which nucleotides are substituted.[113] Partial
substitution often allows for retention of binding/function while imparting some degree of
nuclease resistance. [113-115]

The issue of altering aptamer structure and/or function by incorporating modified nucleotides can
be avoided by utilizing modified libraries during the selection process. In SELEX, the modified
library must be generated enzymatically prior to each selection cycle. This poses a challenge
because T7 RNA polymerase and DNA polymerase incorporate modified nucleotides with very
poor efficiency. A modified library prepared by chemical synthesis can be read efficiently by
reverse transcriptase, leaving only the amplification of modified DNA and/or regeneration of
modified RNA as the challenge. Efforts to develop mutant T7 RNA polymerases that are capable
of incorporating 2’-modified nucleotides have had success with incorporating 2’F and 2’NH2
nucleotides while retaining the ability to incorporate 2’-deoxy nucleotides.[116, 117] The
incorporation of 2’-OMe nucleotides was very inefficient, although enhanced with the
introduction of a double mutant T7 polymerase.[117, 118] Burmeister et al. were able to
carefully optimize transcription conditions utilizing the double mutant T7 RNA polymerase
enough to discover aptamers for vascular endothelial growth factor, interleukin 23, and thrombin
with high specificity and nuclease resistance.[30, 109] The use of 2’F libraries in SELEX has
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seen greater success than 2’NH2 and 2’-OMe, specifically for libraries comprised of a mixture of
2’-fluoro-pyrimidine and standard purine nucleotides.[119-123]

Altering the structure of the library, specifically the length of the fixed flanking regions, has
potential for improving selection efficiency in SELEX. In most applications the two fixed
regions required for amplification and regeneration of the library, and cloning for Sanger
sequencing are about 20 nucleotides each. This contributes significantly to the overall length of
the library. In many instances, the combined fixed regions are longer than the actual library. This
brings possibilities for nonspecific binding to the target, inclusion of parts of the fixed region in
folding the core binding domains of selected aptamers, and interference between highly abundant
fixed sequences with low to moderate affinity and the desirable high affinity sequences that are
present in low abundance. Reducing or eliminating the primer regions (complementary to the
PCR primers) reduces interactions between the PCR primers and the library region, as well as
between the fixed sequences and the target during partitioning.[124-126] Although it has been
argued that the fixed regions do not significantly contribute to or reduce binding potential of the
library,[127] primer sequences do often contribute to an aptamer’s binding sequence.[128]
Additionally, genomic SELEX may benefit significantly from minimal primer or primer free
libraries, as fixed regions often account for the majority of selected sequences.[129] A 2009
review discusses various methods for reducing the fixed-sequence regions of libraries for
aptamer selection, including minimal primer and primer-free SELEX.[125] Minimal primer
SELEX utilizes two nucleotide flanking regions on the 5’ and 3’-termini of the library, and
primer free SELEX utilizes 0 or 2 nucleotides on the 3’-terminus only. The minimal primer
method was developed with an m=27 DNA library with fixed primer regions on each side (18
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and 19 nucleotides). The 64-mer was PCR amplified to yield the dsDNA product. Restriction
enzyme digestion with Nt.BstNBI/NotI generated the library with two nucleotide flanking
regions on the 5’ and 3’-termini. The digested product was analyzed on denaturing PAGE and
the library was extracted and purified. Following partitioning against a melanoma cell line,
surviving library molecules were recovered and new primer regions ligated. The library was PCR
amplified again to yield the dsDNA library fit for a second round of digestion and
partitioning.[124] The primer free method works similarly, with varied restriction enzymes to
cleave the library at different locations. Eliminating interference from flanking regions with
minimal primer and primer free SELEX may improve selection efficiency. Carryover of
nonspecific binding sequences would be reduced and any high affinity sequences in the library
pool will be constrained minimally.

Aptamer Applications
As a result of the many variations of SELEX, aptamers for over 3000 targets have been
discovered. Applications in biosensors, diagnostics and therapeutics have been explored for a
number of these aptamers. Most notable is the first aptamer-based drug, Macugen, which was
approved by the U.S. Food and Drug Administration in 2004 for the treatment of age-related
macular degeneration.[12, 130] The drug was developed from a 27-mer RNA aptamer for antivascular endothelial growth factor (VEGF). The aptamer was discovered from a 2’-fluoropyrimidine modified RNA library and the final aptamer was substituted with 2’-O-methylpurines to further improve the aptamers functionality in vivo, and was further modified with a
terminal polyethylene glycol (PEG).[120] Elevated VEGF contributes to macular degeneration
by inducing angiogenesis and increasing vascular permeability and inflammation. The
16

PEGylated aptamer effectively inhibits VEGF, slowing the progression of the disease.[130]
Aptamer therapeutics that have reached Phase III clinical trials include Revolixys (or
pegnivacogin), an anticoagulation system utilizing an aptamer for factor IXa[103, 123, 131-133]
and Fovista, a drug utilizing an aptamer for anti-platelet-derived growth factor-B for the
treatment of age-related macular degeneration.[103, 134] Other aptamer therapeutics include, but
are not limited to, an aptamer inhibitor of von Willebrand factor which plays an important role in
platelet coagulation,[135-138] and an aptamer inhibitor of nucleolin which was shown to have
anti-proliferative effects on advanced carcinomas.[139]

Aptamers have great potential as diagnostic tools, with applications including biosensing,
imaging, and disease cell and biomarker discovery (see the beginning of this introduction for
references). Aptamers are highly specific to the targets, offering a high level of confidence for
their use as diagnostics. One such aptamer for theophylline binds with 10,000 times greater
affinity than it does for caffeine, a molecule that differs by only a single methyl group.[140]
Aptamers have been shown also to bind with high sensitivity; aptamer-modified quantum dots
were shown to detect a mere 7 zeptomoles of C-reactive protein in 150µl of spiked human serum
using surface plasmon resonance imaging.[141] An aptamer for tenascin-C, an extracellular
matrix protein upregulated by a number of cancers, has been used to successfully image tumor
cells utilizing

99m

Tc radiolabeled nucleotides.[60, 142] In addition to differentiating between

healthy and cancer cells, one study demonstrated that it is possible to differentiate between
various cancer stages. 44 potential biomarkers were selected from 813 total proteins measured;
from these, a panel of 12 blood proteins were identified and used to distinguish between stages IIII of non-small cell lung cancer.[143] The biomarkers were identified using SOMAscan
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technology, a highly selective, multiplexed assay that quantifies proteins by quantifying
SOMAmers following selection in solution. In recent publications this technology was capable
of measuring 1,129 proteins and has been used to discover biomarkers for many other diseases,
including mesothelioma,[144] Alzheimer’s[145] and chronic kidney disease.[20] Although
aptamers offer great potential as diagnostics, clinical or other market applications are still
extremely limited compared to the prevalent use of antibodies. With applications as antitoxins,
antivenins, as well as bacterial, viral and cancer treatments, the continued study of aptamer
discovery and functionality is highly significant. [146]

While modified bases offer attractive features from a chemical point of view, there are other
important issues, especially for aptamer therapeutics. Solid-phase DNA synthesis is such a large
business that the monomers are cheap enough that DNA has a substantial cost advantage over all
other formulations. This advantage makes it likely that an effective DNA aptamer would be
preferred over all of the other possibilities for applications where a great deal of material could
be needed, for instance to replace monoclonal antibodies and other “biologicals” in
pharmaceutical applications. Monomer precursors for current generation SOMAmers are not
even commercially available and will never come close to the economies of scale for simple
therapeutics based on DNA or even RNA aptamers. Another issue for aptamer therapeutics is
clearance – a biological half-life should be neither too long nor too short. Terminal modification
of DNA aptamers along with nanoparticle delivery schemes should give half-lives in the range of
hours, which is a typical time-scale for many current drugs. On the other hand, few natural
mechanisms exist to degrade spiegelmers and other unusual modified nucleic acids, which could
lead to toxicity, off-target effects, and regulatory challenges.
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Acyclic Identification of Aptamers
Continued efforts to increase selection efficiency, reduce time and labor demands, and produce
stable, functional aptamers will likely spur increased interest in aptamer based technologies from
an industry currently dominated by antibodies. One such effort is the Acyclic Identification of
Aptamers (AIA), previously named High Throughput Screening of Aptamers (HTSA), originally
developed by the Borer lab.[33] The method addresses the bottleneck of multiple cycles of in
vitro evolution. AIA utilizes libraries with an over-representation of all possible sequences and
was used to successfully identify the thrombin binding aptamer (TBA) after a single round of
selection and subsequent high throughput sequencing. A schematic representation of the AIA
method can be found in Figure 1.4. High throughput sequencing (HTS) has been an increasingly
popular addition to the SELEX protocol,[83, 99, 147] offering millions of sequence reads in
comparison to hundreds from traditional Sanger sequencing. Sanger sequencing requires that the
library pool converges to a relatively small number of sequences in order to identify them in the
limited sequence space. When HTS is used intermittently throughout the selection process, the
breadth of sequence data may allow for fewer cycles because the evolution and frequency of
aptamer candidates can be monitored. In combination with HTS, the AIA approach offers a fast,
efficient and high throughput method for aptamer discovery. A comparison highlighting the time
and labor commitment of AIA versus traditional SELEX can be found in Figure 1.5.

Synopsis of Chapters
The work presented in this thesis builds upon the original AIA method by improving sample
preparation techniques, introducing a 2’-OMe RNA/DNA chimera library, exploring a variety of
library structures that exhibit over-representation of sequences, and implementing a novel
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partitioning method with broad applications. In Chapter 2, experiments were aimed at
consistently replicating the results of the original, published AIA results, a necessary precursor to
optimize and expand the AIA method. Additionally, experiments aimed at observing the effects
of target to library ratio on selection efficiency were explored. Inconsistencies in sample
preparation and partitioning efficiency were encountered that produced lower than expected
frequencies for the canonical thrombin binding aptamer and poor data quality. In chapter 3, a
series of troubleshooting experiments and procedural modifications achieved consistency in
sample preparation. The improved AIA method successfully identified the canonical thrombin
binding aptamer at sufficient frequency above background with improved high throughput
sequencing data quality. To illustrate the applicability of 2’-OMe libraries in AIA, a 2’-OMe
RNA/DNA chimera library was also used to successfully identify the 2’-OMe RNA analog of the
canonical thrombin binding aptamer at high frequency above background. Attempts to adapt the
partitioning method to discover novel aptamers for four epigenetic protein targets using hairpin
loop libraries of various lengths was not successful. Although the hairpin loop library structure
used in these experiments was ideal for selecting the canonical thrombin binding aptamer, it was
possible that the hairpin structure was inhibiting aptamer discovery for these protein targets. A
requirement for the success of AIA is applicability to a broad range of protein targets and this
prompted the introduction of a different library structure that eliminated the hairpin loop
conformation. Index adapters were also introduced in this chapter; sequence “barcodes” built
into the adapter constructs used in ligating the partitioned library allowed for multiplexing
multiple experiments during high throughput sequencing, ultimately increasing sample
throughput.
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In chapter 4, methods for capture, amplification and sequencing of the “adapter library” were
optimized. In addition to eliminating the hairpin loop structure, the adapter library did not require
ligation and was captured by PCR amplification. The goal of capturing the library with
amplification was to reduce sample loss and shorten the AIA protocol further. However, during
methods development, it was found that the variable quantities of library recovered during
partitioning complicated the amplification methods. After the initial exponential phase of
amplification, a secondary product that appeared larger during gel electrophoresis was formed.
This product was identified as heteroduplex DNA and it was found that sequencing heteroduplex
DNA resulted in the correct sequencing cassette but with reduced data quality. DNA and 2’-OMe
RNA/DNA chimera adapter libraries were screened against thrombin to gauge their functionality
in AIA. Neither library was successful at identifying TBA from the library pool. It is possible
that the adapter constructs that flanked the variable region were interfering with aptamer
selection. To remedy this, methods to capture un-flanked and minimally flanked libraries that
would allow complete or nearly complete freedom in secondary structure formation were
explored as described in chapter 5. Although the m=15 adapter library failed to identify TBA
from the starting pool of library, many of the techniques mastered in this chapter allowed
significant progress to be made in chapters 5 and 6 with increased confidence during sample
preparation. The experiments also prompted a significant interest in creating the ability to
accurately assess whether or not a sample was of sufficient quantity and quality for productive
high throughput sequencing prior to consuming valuable resources. This was successfully
accomplished in chapter 5.
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Chapter 5 outlines experiments aimed at capturing un-flanked libraries with various versions of
ligation. Efficient capture of un-flanked libraries was not achieved which prompted the
introduction of a minimally flanked library. The library is flanked by two, four-base noncomplementary tails that do not constrain the variable region to a hairpin loop, but can be
captured by ligation similarly to the hairpin loop library. A benefit to revisiting the ligationbased capture approach is the ability to eliminate the amplification step required with the adapter
libraries. Ligating full length adapters to the “tailed” library and proceeding directly to
sequencing shortened the AIA protocol and eliminated a potential source of error. Without
amplification, sequence data would accurately represent the selected library sequences with zero
amplification bias from sample preparation. Amplification free AIA introduced the unique ability
to predict relative maximum sequence frequencies based the quantity of recovered library, initial
degree of over-representation and anticipated data cluster density. The ability to predict whether
or not a sequence could be counted above background was used to assess whether that sample
would be sequenced, ultimately saving time and money. Once capture efficiency was optimized
and an experiment produced the desired quantity of recovered library, the m=15 DNA tailed
library was shown to successfully identify the canonical thrombin binding aptamer above
background with frequencies similar to the prior expectations. To expand the applicability of the
tailed libraries and amplification free protocol, a novel partitioning method that eliminated the
requirement of protein immobilization was developed.

In chapter 6, reversible formaldehyde cross-linking in conjunction with electrophoretic mobility
shift assay was developed as a partitioning method. Reversible formaldehyde cross-linking
produces covalent links between protein-bound library molecules in solution. In combination
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with EMSA under denaturing conditions, this method allows for the separation of high and
moderate affinity sequences from low affinity and nonspecific sequences. This method was used
to successfully identify the thrombin binding aptamer above background in proof of concept
experiments using amplification free sample preparation. The ability to perform AIA partitioning
in solution provides greater flexibility in target selection, including mixtures of proteins. These
experiments also confirmed the ability to predict maximum sequence frequencies based on the
quantity of recovered library and initial level of over-representation. Additionally, the quality of
sequencing data was improved with the introduction of qPCR CopyCountTM software. qPCR
CopyCountTM eliminates the requirement of a standard curve, which reduces cost and labor
demands. It was found that qPCR CopyCountTM provided a more accurate determination of
library quantity than the gold-standard KAPA Library Quantification kit; this is crucial for
maximization of data output on Illumina sequencing platforms. Consistent, high quality data
eliminates the potential for costly resequencing.

The sample preparation techniques that evolved over the course of this work offer superior
control and predictability in the outcome of high throughput sequencing data. Chapter 7 outlines
future goals for this work including (1) optimization of the ForteBio Octet RED96 interaction
analysis system as a partitioning method. (2) Experiments exploring the application of the
principles and techniques of AIA to a minimal primer method, that would incorporate moderate
cycling and aggressive mutagenesis, look especially promising for the discovery of novel
aptamers. (3) Application of the improved AIA methodology to additional protein targets to
discover novel aptamers with DNA, 2’-OMe and 2’F libraries. (4) Transition of the GAIIx
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sequencing platform to perform post-sequencing protein binding studies as a secondary
screening method for aptamer characterization.
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Figure 1.1 Common aptamer conformations
(a) Hairpin loop, (b) multi-branched loop, (c) internal loop/internal bulge, (d) pseudoknot. Gquadruplex structure can be seen in Figure 2.1.
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Figure 1.2 SELEX method outline

Schematic representation of the SELEX method with a synthetic DNA library. The outline is
similar for RNA libraries, with added T7 Transcription prior to partitioning and Reverse
Transcription prior to PCR amplification. (Adapted from the figure by Dr. Philip Borer.)
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Figure 1.3 2’ Modified nucleotides
Chemical structures of abbreviated 2’OH, 2’O-Methyl, 2’-Fluoro and 2’-Amino ribonucleotides
where B = A, G, C or U.
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Figure 1.4 AIA method outline
Schematic representation of the AIA method with a synthetic 39-mer hairpin loop DNA library
against human α-thrombin immoblized on Concanvilin-A beads. Experimental details are
elaborated in Chapter 2. (Figure by Dr. Philip Borer.)
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Figure 1.5 SELEX versus AIA

Comparison of SELEX versus AIA workflows. AIA eliminates cycling which drastically reduces
time and labor demands. A single experiment is reduced from weeks to days. Sequencing on the
Illumina GAIIx requires 2-4 days, while sequencing time for the Illumina MiSeq is significantly
reduced to 1-2 days. (Figure by Dr. Mark McPike.)
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Table 1.1 Combinatorial considerations for 100 pmol of library
m

Pm

Np

tm

1
3
5
7
9
11
13
15
16
17
18
19
20
21
22
23
24
25
30
60
120

4
64
1,024
16,384
262,144
4.20E+06
6.70E+07
1.10E+09
4.30E+09
1.70E+10
6.90E+10
2.70E+11
1.10E+12
4.40E+12
1.80E+13
7.00E+13
2.80E+14
1.10E+15
1.20E+18
1.30E+36
1.80E+72

1.50E+13
9.40E+11
5.90E+10
3.70E+09
2.30E+08
1.40E+07
9.00E+05
56,066
14,016
3,504
876
219
55
13.7
3.4
0.9
0.2
0.1
5.00E-05
4.60E-23
3.30E-59

1.50E+06
9.40E+04
5.90E+03
3.70E+02
2.30E+01
1.40E+00
9.00E-02
5.50E-03
1.40E-03
3.50E-04
8.70E-05
2.20E-05
5.50E-06
1.40E-06
3.30E-07
8.60E-08
2.10E-08
5.50E-09
5.00E-12
4.60E-30
3.30E-66

Combinatorial considerations for 100 pmol of DNA library of variable length, m. Calculations
assume precise DNA synthesis with A, T, G, and C occurring at 25% each for each position in
the sequence. The number of unique sequences of length, m, is Pm = 4m. The average quantity
of each unique sequence is Np = 6.0x1013/Pm, where there is a total of 6.0x1013 library
molecules in the 100 pmol pool. The average number of times a particular sequence will
appear if 6.0x106 clusters are sequenced, is tm, where tm=6.0x106/Pm (See Chapter 2 for details
on Illumina clustering).
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Chapter 2: Acyclic Identification of Aptamers

Chapter Summary
The HTSA method (High Throughput Screening of Aptamers) described by Dr. Gillian
Kupakuwana[148] and later termed AIA (Acyclic Identification of Aptamers)[33] made marked
improvements to the traditional aptamer discovery method known as SELEX. AIA eliminated
the timely process of cyclic evolution by employing over-represented libraries and deep
sequencing. Dr. Kupakuwana successfully identified the minimal human α-thrombin binding
aptamer (TBA), originally discovered by Bock et al using the SELEX technique[57], with the
HTSA/AIA method.[33] “Canonical” TBA is a fifteen residue DNA molecule formed of two
stacked G-quartets connected by three T-rich loops, dGGTTGGTGTGGTTGG.[149] A 39-mer
DNA library containing a constant stem to the variable m=15 region was designed with the intent
of selecting for TBA. The conserved complementary eight base-pair stem and four base noncomplementary tails presented the library region in a hairpin loop and allowed for capture of the
library via ligation.

From a 100 pmol aliquot of this m=15 DNA library containing

approximately 56,000 copies of any unique sequence, TBA was successfully selected above
background following partitioning against thrombin.[33, 148] This chapter outlines experiments
aimed to reproduce Dr. Kupakuwana’s data consistently, a necessary precursor to optimize and
expand the AIA method. Additionally, experiments to explore the effects of protein to library
ratio and library length on identifying high affinity sequences are detailed.
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Library Design and Target Selection
The 39-mer DNA library was designed by Dr. Mark McPike and James Crill II (Borer Lab) and
was synthesized by Integrated DNA Technologies, Coralville, IA. The m=15 variable region is
flanked by a conserved stem and tails: complementary eight base-pair stem and four base noncomplementary tails, dACACGCGCATGC-m15-GCATGCGCCACA (Figure 2.1). The eight
base-pair stem presents the variable region in a hairpin formation, while the non-complementary
tails serve as sticky ends to capture the library with adapters for ligation. The hairpin structure
and m=15 length were deliberate design choices, as the 15-mer TBA’s structural motif is two
stacked quartets, which is presented similarly to a hairpin (Figure 2.1). During synthesis, hand
mixing of the four possible nucleotides ensures that the variable m=15 region contains each base
at equal probability, 25%. The incorporation rate of the four bases during DNA synthesis can
vary due to efficiency of incorporation, and this varies for all synthesizers. If unaccounted for,
this can create libraries with skewed ratios of the four nucleotides. It may also alter the profile of
the library pool and may limit the complexity of the library due to sequence specific effects.[150]

The human α-thrombin binding aptamer has been well characterized by both NMR and X-ray
crystallography, [65, 149, 151-154] which made human α-thrombin an ideal target for the
development of HTSA and continued use in improving AIA protocols. Human α-thrombin is a
serine protease that converts fibrinogen into active fibrin and is involved in the coagulation
cascade in blood.[155] There is no known physiological binding between thrombin and nucleic
acids, however, TBA inhibits the activity of thrombin when bound. With potential for anticlotting therapy, the structural properties of the thrombin-binding aptamer are important and
have been studied extensively. The 15-mer aptamer was used in a Phase I clinical trial by
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Archemix Corporation and Nuvelo, Inc. in 2005 as an anti-coagulation agent for coronary artery
bypass graft surgery. The pure form of TBA did not enter Phase II due to a high dosage
requirement,[156] however, a modified 26-mer aptamer for thrombin was discovered and is
currently undergoing a Phase II clinical trial.[157] The nature of thrombin-TBA binding and the
correct conformation of TBA have been reconciled by comparing both NMR and X-ray
crystallography data (Figure 2.2). It has been well established that the thrombin-binding aptamer
forms a three dimensional structure of two stacked guanine quartets in solution. The guanine
quartets are connected by two T-T loops on one end, and by a T-G-T loop on the opposite end.
The orientation of these loops differs between the NMR and X-ray crystal structures of the
thrombin-binding aptamer. Although the 5’-syn-anti-3’-orientation of the guanine residues along
the edges of the quartets is conserved in both the NMR and X-ray crystal structures, the
orientation of the two TT and TGT loops and directionality of the guanine bases differs.[154]
The NMR structure determined by Macaya et al. has the two TT loops crossing the two narrow
grooves and the TGT loop crossing a wide groove.[153] Conversely, the X-ray crystal structure
indicates that the two TT loops cross the two wide grooves and the TGT loop crosses the narrow
groove. These two arrangements are non-superimposable. In order to reconcile the differences
between the NMR and X-ray structures and determine the most likely structural orientation of
the thrombin-binding aptamer, Kelly et al. re-examined the crystallographic data to determine if
it was consistent with the NMR solution structure.[154] They compared eight different
directional and structural orientations of the NMR model to the X-ray crystal structure, which
was based on the D4 symmetry of the guanine quartets. Given their criteria including strand
directionality, the number of close contacts between the aptamer and thrombin, and steric clashes
in the crystalline environment, the optimally oriented structure was found to be consistent with
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the directionality of the NMR solution structure. This specific orientation consists of the two TT
loops across the narrow grooves and the TGT loop across the wide groove. Thrombin in complex
with an aptamer of this orientation results in the two TT loops in close proximity to the
fibrinogen recognition site (exosite I) of thrombin, a specific anion binding exosite that is distinct
from the catalytic site. Additional crystollagraphic evidence from Russo et al. confirms this
orientation.[65]

Reconciliation of the correct thrombin-TBA binding orientation sheds new light on the
conclusions made from the earliest AIA results. The first six bases of TBA, GGTTGG were
99% conserved for the top 108 TBA sequence variants (54,140 total counts). The middle TGT
loop saw moderate variability, while G8, G10, G14 and G15 saw the largest variability.
Although affinity decreased with a substitution in the TGT loop, the sequences were still
recovered during partitioning. Variation in the two TT loops was minimal, with ≥99.00%
conservation, indicating that fewer sequences with substitutions in these loops were recovered
during partitioning. This is consistent with the reconciled binding nature of TBA; substitutions
within the two TT loops may cause binding affinity to drop so drastically that these sequences
would not survive partitioning. The binding affinity of TBA for thrombin was estimated by Dr.
Kupakuwana via Surface Plasmon Resonance (SPR). The estimated Kd of 12 nM is similar to
previously determined affinities.[33] The human α-thrombin used in the proceeding experiments
was purchased from Hematologic Technologies, Essex Junction, VT. The quality and purity of
this product was analyzed by Dr. Kupakuwana via MALDI TOF as >90% pure with minimal
degradation products.[33]
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Replicating Aptamer Selection for Thrombin
The ratio of 60:1, protein: library used by Bock et al. [57] was used in the original AIA protocol.
A partitioning procedure with agarose-Concanavilin-A beads was used in order to screen the
m=15 DNA library against glycosylated human α-thrombin. The DNA library was applied to
thrombin immobilized on Con-A beads. After several wash cycles, the protein-DNA complexes
were eluted. Phenol extraction and ethanol precipitation resulted in a partitioned DNA library
containing sequences with an affinity for human α-thrombin. An outline of the AIA method can
be found in Figure 1.4.

Partitioning of the DNA library was performed using agarose-Concanavilin-A beads
(Glycoprotein Isolation Kit, Pierce Biotechnology) at room temperature. The Con-A beads
contained in spin columns were pre-equilibrated in partitioning buffer (20 mM Tris-HCl, 140
mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) by three wash cycles. The buffer was
removed by centrifugation at 1,500 rpm for 1 minute. A 100 pmol aliquot of the DNA library in
750 µl partitioning buffer was applied to 500 µl of pre-equilibrated Con-A beads. Following a 20
minute incubation with end-over-end rotation at 25 rpm, the DNA was recovered by
centrifugation. Nonspecific binding resulted in the negative selection of the DNA library. The
negatively selected DNA library was then applied to 1 ml of pre-equilibrated Con-A beads with
6 nmol of immobilized thrombin. Following a 30 minute incubation with end-over-end rotation
at 25 rpm, the unbound DNA was removed by centrifugation. Three wash cycles (5 minutes,
rotation at 25 rpm) with 750 µl partitioning buffer ensured thorough removal of unbound DNA.
Thrombin-DNA complexes were eluted from the Con-A beads with 750 µl elution buffer (α-
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methyl mannoside, Glycoprotein Isolation Kit, Pierce Biotechnology) during a 5 minute
incubation with rotation at 25 rpm and collected by centrifugation.

Phenol extraction and ethanol precipitation
Phenol extraction was used to recover the partitioned DNA libraries. An equal volume of Trisbuffered, pH 8.0, 0.1mM EDTA, 50% phenol, 48% chloroform, 2% isoamyl alcohol (Sigma
Aldrich) was added to the eluted protein-DNA mixture and vortexed for 30 seconds.
Centrifugation at 13,000 rpm for 5 minutes resulted in an aqueous top layer (containing the
library) and an organic bottom layer. The aqueous layer contains the anionic DNA while the
denatured protein is contained in an intermediate layer. The aqueous layer was removed and the
library was subsequently extracted twice with equal volumes of 100% chloroform. The library
was then purified by ethanol precipitation. One tenth the volume of 3M sodium acetate and three
times the volume of cold ethanol and were added to the library and mixed briefly. Following a 30
minute incubation at -80°C, centrifugation at 13,000 rpm for 30 minutes resulted in a library
pellet. After decanting the liquid, the pellet was washed with 1 ml 70% ethanol. Centrifugation at
13,000 rpm for 20 minutes resulted in a library pellet. The pellet was air dried at room
temperature in a Speed-Vac and then resuspended in dH2O.

Modifying the library for sequencing
The procedure for modifying the library for sequencing is outlined in Figure 2.3. The DNA
library was ligated with sequencing adapters and their complements, compatible with the
Illumina SR (Single Read) Format. Adapter 1, Adapter 1 Complement, Adapter 2, and Adapter
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2 Complement (See Appendix 2 for sequences) at 50 µM were added in 10 µl volumes to the 20
µl library. The mixtures were incubated at 90°C for 3 minutes. After cooling to room
temperature, 7 µl of 10X ligation buffer (300 mM Tris-HCl, 100 mM MgCl2, 100 mM
Dithiothreitol, 10 mM ATP, pH 7.8), (Promega), 2 µl dH2O and 1 µl T4 DNA ligase (50%
glycerol stock, 3 u/µl), (Promega) were added. Incubation at 25°C for 30 minutes completed the
ligation. The ligated library was purified with a QIAquick PCR Purification Kit (Qiagen) to
reduce the volume from 70 µl to 30 µl, more suitable for gel electrophoresis in a single well. The
kit also removes protein; however, this is not a requirement for gel electrophoresis. The product
was visualized on a 2% TBE agarose gel alongside a 50 bp DNA ladder. (See Figure 3.3 in the
next chapter for illustration of the product size.) The product is 105 nucleotides long with 66 of
those being base-paired with Adapter Complements and runs between the 100 and 150 bp ladder
bands. The product band was excised and purified with a MiniElute Gel Extraction Kit (Qiagen),
resulting in pure ligated DNA library. PCR amplification with Forward and Reverse Primers
(See Appendix 2 for sequences) extends the 5’-length of the ligated product to allow for
annealing to the immobilized complement of the Illumina flow cell, while simultaneously filling
in the complement to the variable region. The 10 µl purified adapter ligated library was
combined with 1 µl each of the Forward and Reverse Primers at 10 µM (IDT, Coralville, IA), 1
µl of 250 µM dNTPs (Stratagene), 2 µl 10X Pfu Turbo Polymerase buffer (200 mM Tris-HCl, 20
mM MgSO4, 100 mM KCL, 100 mM (NH4)2SO4, 1% TritonX-100, 1 mg/ml nuclease free BSA,
pH 8.8), (Stratagene), 4 µl dH2O, and 1 µL Pfu Turbo polymerase (50% glycerol), (Stratagene).
The 20 µl reaction mixture was amplified with the following conditions:
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Denaturation
PCR Amplification (18 cycles)

Final Extension

94°C
94°C
61°C
72°C
72°C

2 min.
1 min.
1 min.
1 min.
10 min.

The final 130 bp product was size checked on a 2% TBE agarose gel alongside a 50 bp DNA
ladder (See Figure 3.4 for illustration of product size).

Sanger sequencing
The partitioned, ligated, and modified DNA libraries were screened using Sanger sequencing
prior to sequencing on the Illumina GA to ensure the presence of the correct ligated and modified
DNA sequences: the sequencing cassette. PCR of a small aliquot of the sample using a 5’phosphorylated Forward and Reverse Primers (IDT) adds a 5’-phosphate to the library, allowing
ligation into a plasmid. Using a CloneSmart HCKan cloning kit (Lucigen), 100 ng of the 5’phosphorylated

DNA

library

(determined

by

quantification

with

the

NanoDrop

Spectrophotometer) was ligated into a pSmart-HCKan vector at room temperature for 30
minutes. Ligation was terminated at 70°C for 15 minutes, cooled to room temperature for 15
seconds, then to 4°C for 15 seconds in a thermocycler. To 25 µl Lucigen E. Cloni 10G
electrocompetent cells, 2 µl of the ligated pSmart-HCKan vector was added. The mixture was
carefully transferred to a pre-chilled electroporation cuvette. Electroporation in an Eppendorf
Model 2510 pulser at 1800V and addition of 975 µl CloneSmart Recovery Media (11.8 g Bactotryptone, 23.6 g yeast extract, 9.4g anhydrous K2HPO4, 2.2g anhydrous KH2PO4, 0.4% glycerol
in 1L dH2O) completed the transformation. After incubated for 1 hour at 37°C with shaking at
250 rpm in 5 ml falcon culture tubes, 40 µl was plated on a kanamycin (100 µg/µl) agar plate.
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Overnight incubation produced a high colony density, and 8 individual colonies were picked and
inoculated in 5 ml Superbroth (32g tryptone, 20g yeast extract, 5g NaCl, 5ml 1.0M NaOH in 1L
dH2O) with kanamycin (50 µg/ml). After overnight incubation at 37°C with shaking at 150 rpm,
cells were collected with centrifugation at 1000 rpm for 10 minutes. The plasmids were extracted
and purified with a QIAprep Spin Miniprep Kit (Qiagen), and then Sanger sequenced using the
CloneSmart SL1 Primer (See Appendix 2) at the Core Facility for DNA Sequencing at SUNY
Upstate Medical University, Syracuse, New York. Data is viewed using Chromas Lite software
(Figure 2.4), (Technelysium Ptt, Ltd., South Brisbane, QLD, Australia).

Quantitative PCR
After the correct sequencing cassette was identified via Sanger sequencing, an additional quality
control method was implemented in order to maximize data quality. The precise quantity of
amplifiable DNA was determined with the KAPA Library Quantification Kit on the BioRad
iCycler. The KAPA kit was specifically designed to reproducibly and accurately determine
sample concentration for sequencing on Illumina platforms. The KAPA kit is capable of
amplifying single or double stranded products containing the Illumina P5 and/or P7 motifs (See
Appendix 2 for sequences). The accurate quantification of a library is crucial for maximization
of data output on Illumina sequencing platforms. If the amount of amplifiable library is
overestimated, the result is lower than expected cluster density. If the amount of amplifiable
library is underestimated, the result is crowded clusters and poor resolution. Any non-library
DNA that is not flanked by the adapter motifs is irrelevant as it will not be amplified.
Quantification by UV absorption is not a reliable method because it accounts for all DNA
species as well as other contaminants that absorb UV similarly, such as residual ethanol. The
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KAPA kit requires the use of six standard solutions and the acquisition of a standard curve. The
quantification of unknowns is inferred based on this curve.[158]

The concentration of the sample was estimated on the BioTek Synergy 3 Microplate reader and
diluted to 20 nM. The sample is diluted further to 1:1000 in library dilution buffer (10 mM TrisHCl, pH 8.0, 0.05% Tween 20). The dynamic range of the assay extends from 20 pM to 0.0002
pM via the six DNA standards. At 20 pM, the 1:1000 dilution is at the upper limit of the standard
curve; however, concentrations were typically overestimated by UV absorption and diluting to
the upper limit of the curve ensured that data points would fall within the range of the standard
curve. The library and DNA standards were prepared in triplicate as follows: 12 µl KAPA SYBR
FAST qPCR Master Mix containing Primer Premix, 4 µl dH2O and 4 µL diluted library or DNA
standard. qPCR cycling was as follows: (1) 5 minutes at 95 °C and (2) 35 cycles of 30 seconds at
95°C and 45 seconds at 60°C. The average concentration (pM) of the triplicate data points is
adjusted to compensate for the size of the DNA standards and the 1:1000 dilution:
Avg. Conc. (pM) x [452 bp/library length] x 1000 = Conc. of library stock (pM)
There is no need to account for the 4 µl volume of the library used in the 20 µl reaction because
the volume is the same for the library and standards. If one of the triplicate data points is an
outlier, it is discarded. If more than one is an outlier, the data cannot be considered reliable and
the assay must be repeated. If the quantity of amplifiable DNA was sufficient (5-20 nM) and
Sanger sequencing data was agreeable, the sample was considered for sequencing.
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Partitioning at Other Protein: Library Ratios
The m=15 DNA library was also partitioned at ratios of 30:1 (3 nmol thrombin: 100 pmol
library), 15:1 (3 nmol thrombin: 500 pmol library) and 3:1 (3 nmol thrombin: 1 nmol library),
using 500 µl Con-A beads for partitioning and 250 µl beads for negative selection. These
experiments were aimed at increasing the selection pressure for high affinity sequences while
providing benchmark data for optimizing the minimal ratio that provides usable AIA counts. By
decreasing the quantity of thrombin relative to the quantity of library, the competition to occupy
binding sites naturally increases. If all of the high affinity binding sequences occupy binding
sites on the protein target, any excess protein increases the likelihood of carryover of nonspecific
binding sequences. In order to identify high affinity binding sequences, they must be counted
above background; a high carryover of nonspecific sequences decreases the ratio of captured
high affinity sequences to background, which would be reflected in the data. Dr. Kupakuwana
explored this hypothesis with 6:1 (600 pmol thrombin: 100 pmol library) and 1:1 (100 pmol
thrombin: 100 pmol library) ratio experiments. Although she observed TBA at 28,389 counts out
of a total 5,719,989 counts (frequency of 0.496 %) for the 6:1 experiment, she only observed 642
counts of TBA out of a total 7,788,985 counts (frequency of 0.008%) for the 1:1 experiment. The
original 60:1 experiment produced 48,671 counts of TBA out of a total 1,728,220 counts
(frequency of 2.3 %).[148] Here, “count” refers to the number of times a specific sequence
occurs as a “good read,” which is defined in the next section. These results do not reflect the
hypothesis that a decreased ratio of protein: library increases selection pressure. In fact, they
demonstrate that the selection pressure is decreased. The aforementioned additional experiments
were aimed at probing this hypothesis further.

41

Additionally, m=16 and m=19 DNA libraries were partitioned against thrombin in 60:1 ratio
experiments (6 nmol thrombin: 100 pmol library). The number of TBA molecules in each of
these pools decreased from ~56,000 for an m=15 library to ~14,000 and ~219, respectively.
However, due to their increased length, any 15-mer may occur within these libraries at multiple
positions within the variable region. As suggested by Marshall and Ellington,[42] complete
sampling of a library of length, m, may not be necessary, as the library would be completely
represented, if not over-represented for all n-mers of length <m. Given that the m=16 and m=19
libraries are over-represented at 100 pmol, any 15-mer sequence would also be over-represented.
These experiments were aimed at exploring the capabilities of under-represented libraries for
identifying the known 15-mer, TBA, in the context of longer variable regions.

High Throughput Sequencing
Sequencing of the experiments in this chapter was performed on our in-house Illumina Genome
Analyzer IIx (GAIIx). All Illumina sequencing platforms require immobilization of the library
sequences to the surface of a proprietary glass flow cell. The GAIIx utilizes an eight lane
microfluidic flow cell which allows the user to input 8 different sample solutions for sequencing.
On the flow cell, surface bound templates complementary to the prepared libraries allow for
capture of the library sequences as they flow through the microfluidic channel (lane). These
immobilized oligonucleotides are referred to as the “primer lawn” (See Appendix 2 for
sequences). Following NaOH denaturation, the library molecules are captured by a
complementary sequence on the primer lawn. An extension step generates the full length,
double-stranded product. The original library molecule is washed away following a NaOH
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denaturation. The complement to the original library molecule is now covalently linked to the
flow cell surface. Next, the strand “bridges” to anneal to its complement on the primer lawn and
the double stranded product is generated. This bridge amplification of the captured library
sequences creates millions of colonies, each containing up to 1,000 copies of the original
sequence, known as clusters. The clustering process is performed on the free standing Cluster
Station. The clustered flow cell is transferred to the GAIIx where it is sequenced by Sequencing
by Synthesis (SBS) technology.

The dye-terminating chemistry utilizes four fluorescently-

labeled nucleotides. After the initial annealing of the sequencing primer, single fluorescent
dNTPs are incorporated during each cycle. High resolution imaging through four filters captures
fluorescence emission to determine the specific location of base incorporation that corresponds
to individual clusters. The fluorescent dye is then enzymatically cleaved to allow for
incorporation of the next base. Prior to sequencing, a diol linker within the P5 flow cell oligo is
cleaved with periodate, leaving only the strands connected to the flow cell at their 5’-ends.[159]
This allows for the sequencing primer to anneal to the immobilized strand such that SBS occurs
from the top, down. This ensures that the fluorescence emission is observed at the same distance
from the flow cell for each cycle of base incorporation. The number of base incorporations is
user defined to reflect the length of the library or any sequence portion of interest. The
experiments in this chapter utilized a 36 base, Single Read (SR) kit. The workflow is outlined in
Figure 2.5.

Data analysis
Sequence data is reported in FASTQ format, a text file that identifies each sequence and the
corresponding quality scores. The FASTQ file identifies all 36 base incorporations, meaning
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additional processing is required in order to analyze the internal region. To accomplish this, a
Perl script was created by Dr. Huitao Sheng of Dr. Chluhuri’s bioinformatics group at Syracuse
University (See Appendix 2). The Perl script has since been annotated and modified by Dr.
Damian Allis as our data analysis needs changed over time, as seen in future chapters. The Perl
script identifies and qualifies the constant tail and stem regions independently of the variable
region. The quality of the tail and stem regions identifies sequences as “good”, “candidate” or
“bad” reads. Candidate reads contain ≤2 mismatches or a single gap or insertion within the eight
nucleotides from the 5’-end of the variable region, or the five nucleotides from the 3’-end. Of
these sequences, those containing a variable region of exactly 15 nucleotides (or any user defined
number) are good reads. Sequences that did not meet the criteria of candidate reads are
considered bad reads. The stringency of the qualifiers for candidate and good reads, as well as
the length of the head and tail under scrutiny are user defined and may be changed to suit a
specific experiment. These three files are searchable text files and the full length sequences are
reported. After the Perl script has parsed the full length sequences, the occurrence of each
“good” read is tallied to generate the “n-mer count” file which reports only the user specified
variable region and the frequency of each sequence. The nmer count data can be reformatted into
FASTA format using an additional Perl script for use in sequence alignment or drawing
phylogenic trees (See Appendix 2). ClustalX2 allows for sequence alignment of up to 1000
sequences while TreeView plots the alignments to create phylogenetic trees.
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Results and Discussion
Of the four initial AIA experiments (60:1, 30:1, 15:1, and 3:1 ratio) aimed at duplicating and
expanding the original AIA results, the 60:1 experiment was disqualified for sequencing due to
poor qPCR results. This sample also failed to produce the correct sequencing cassette as
determined by Sanger sequencing. The remaining three samples were sequenced on the Illumina
GAIIx. The raw data files were parsed based on the last eight bases of the head (dGCGCATGC)
and the first five bases of the tail (dGCATG). The top twenty sequences for the published 60:1
AIA experiment are reported in Table 2.1, which shows the canonical TBA 15-mer,
GGTTGGTGTGGTTGG, at highest abundance. The top twenty sequences from this work are
reported in Tables 2.2-2.4 for comparison. Dr. Kupakuwana identified two major motifs:
sequences similar to TBA and a carbohydrate binding sequence. Motif Ia has TBA variants with
mainly TG substitutions, for which the decreasing counts going down Table 2.1 correlate with
the decreasing DNA-thrombin binding constant as determined by SPR. Motif Ib contains weaker
binding TBA variants which adds TC and/or GA substitutions. The carbohydrate binding
aptamer (Carb1) weakly binds the glycan component of thrombin, which is a post-translational
modification,[160] and binds glucose with a KD of ~1.4 µM, which is found in the Con-A
storage buffer. A third sequence of note, a systematic artifact, is termed the “jump” sequence.
The jump sequence “skips over” the m=15 variable region and a portion of the tail to include a
section of Adapter 2 in the reported sequence. This systematic artifact was hypothesized to
originate during PCR amplification of the ligated library. Sequence similarity between Adapter 2
and the tail region allows the Perl script to identify these sequences as “good” reads and is
illustrated in Figure 2.7. Multiple variations on this “jump” behavior are seen in the candidate
and bad reads files as well. This sequence and its variants can be excluded from sequence
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alignments and further data analysis by confirming the “jump” behavior by looking at the 15-mer
in context within the good reads file.

Table 2.5 compares pertinent statistical data from the three AIA experiments in comparison with
the original 60:1 AIA experiment. Acyclic selection does not allow the library pool to converge
into a small number of sequences; therefore, selection efficiency is determined by the presence
of specific sequences above the background or noise threshold. When considering the success of
an AIA experiment, it is critical to look at the frequency of a sequence in addition to the count.
The count represents the number of times a specific sequence occurs, however, the total number
of sequences per experiment varies. High throughput sequencing provides an enormous sequence
space and as such, there can be a large variation in the quantity of data. Thus, the frequency of a
sequence is a more accurate determination of selection efficiency. It is also useful to compare
sequence frequency with respect to good reads and total reads. The overall percentage of good
reads is indicative of sample quality. An AIA experiment can have any combination of high/low
selection efficiency and good/poor data quality. An ideal result is a high percentage of good
reads which contain high frequency aptamer candidates with a low background. In the remainder
of this dissertation, the “frequency” for a sequence or a set of sequences is taken with respect to
the total of good reads.

The counts of TBA for the 30:1, 15:1 and 3:1 experiments were 10, 78, and 56, respectively. The
frequency of TBA for the three experiments and the original 60:1 experiment with respect to
good reads and total reads is reported in Table 2.5. As mentioned, the frequency of TBA for the
original 60:1 experiment was 2.37 %. The frequencies of TBA for the 30:1, 15:1 and 3:1
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experiments are 0.00012 %, 0.00094 % and 0.00067 %, respectively. Although the frequency
increases for the 15:1 experiment compared to the 30:1, it does not increase for the 3:1 compared
to the 15:1. Overall, the frequencies are very much lower than the original 60:1 experiment.
There is also a lack of TBA variants within the three experiments. This can be visualized by
comparing phylogenetic tree diagrams showing similarity as the result of sequence alignment
(Figure 2.6). Unlike the many TBA variants found in the original 60:1 experiment data, only the
consensus TBA sequence is found in the three AIA experiments.

It is imperative to compare the frequency rather than counts when the starting quantity of library
differs, as with the 30:1, 15:1 and 3:1 ratio experiments (100 pmol, 500 pmol, 1 nmol of library,
respectively), because the library is over-represented to different extents. If the starting count per
unique sequence is considered solely, the frequency of TBA would be expected to increase 5fold for the 15:1 experiment and 10-fold for the 3:1 experiment compared to the 30:1
experiment. Although the frequency increases 8-fold for the 15:1 experiment, it only increases
~5-fold for the 3:1 experiment.

In combination with a hypothesized increase in selection

pressure due to the relative decrease in protein, frequency is expected to diminish further. The
new data display an overall low frequency and lack of a clear trend in frequency with respect to
the protein: library ratio. More sequencing runs might allow testing the hypothesis that a
decreased ratio of protein: library increases selection pressure, but a sequencing kit for each run
on the GAIIx cost about $8,000, so we decided not to pursue this further until the overall lower
than expected frequency of TBA was addressed. The samples also produced lower than expected
frequencies for the carbohydrate binding sequence.
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The small number of sequences above background in these experiments suggests an issue with
the partitioning method; at a 100 pmol scale with approximately 56,000 starting copies of each
sequence, counts for high affinity sequences were expected to be higher. There are at least three
possible explanations for the low frequencies: (1) the partitioning was not stringent enough,
meaning large quantities of non-specific sequence were carried over. This would prevent any
high affinity sequences from appearing significantly above background. (2) It is also possible
that too-stringent washing could elute bound TBA and its weaker binding relatives as well as the
desired removal of non-specifically bound DNA. Using the value of Kd = 12 nM reported by
Kupakuwana, et al.,[33] for the TBA-Thrombin complex and assuming a diffusion controlled
on-rate, kon = 1×107 typical for the interaction of fairly large molecules in aqueous solution, the
definition that Kd = kon/koff can be used to predict that koff = 0.12 sec-1, and the lifetime of the
complex  = 1/koff = 8 sec. Lifetimes for more weakly bound variants of TBA can be lower by
orders of magnitude. Of course, the on-rate may be slower for a bead-bound complex and the
on/off processes may be more complex kinetically than assumed in this simple model. However,
it does emphasize that loss of some DNA from a reversibly bound complex is inevitable using
immobilization for partitioning. This is part of the rationale for adopting the covalent
formaldehyde crosslinking approach for partitioning described in Chapter 6. Although the
present work closely emulated the Kupukuwana protocols for washing the bead-bound library,
the possibility remains that there were differences. (3) During a negative selection step, it was
observed that the beads were absorbing much of the library. If the overall pool of library is
decreased significantly, fewer copies of each sequence are present, making it difficult to select
high affinity binders above the background. This background binding varied considerably from
lot-to-lot of agarose Concanavalin-A beads and was explored in the next chapter.
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The jump sequence and/or variants of it are present in all three experiments. The counts are
similar to TBA and Carb1 but do not dominate the good reads. Also, a large percentage of the
total reads were qualified as good reads, indicating that there is not an issue with the quality of
data from the sequencer. For the experiments with m=16 and m=19 libraries, the m=16
experiment was disqualified for sequencing due to poor qPCR results. This sample also failed to
produce the correct sequencing cassette as determined by Sanger sequencing. The m=19 sample
was sequenced on the Illumina GAIIx. The top twenty sequences are reported in Appendix 2.
The sequences that occur above background are exclusively jump sequence variants. Any nonjump sequences occur at counts of two or one, rendering that data unusable for determining any
high affinity sequences. The poor data quality could be attributed to unsuccessful partitioning
and/or flawed sample preparation. It is possible that the m=19 library did not bind to thrombin
with any specificity, which would produce very little correctly ligated product for amplification.
This could allow jump sequences to dominate during amplification. The library’s hairpin loop
structure allows the m=15 variable region to form the desired G-quadruplex structure with ease,
however, the added bases in the m=16 and m=19 libraries may prevent this. However,
inconsistent sample preparation for the m=15 library, 60:1 experiment aimed at duplicating the
original 60:1 experiment indicates that the failure of the m=16 and m=19 libraries is also due in
part to flawed sample preparation.

Although the three experiments summarized in Tables 2.2 – 2.5 identified TBA and the Carb1
sequences above background, frequencies are much lower compared to the original 60:1
experiment. The unexpectedly low sequence counts for the variable ratio experiments led to
several troubleshooting experiments that are detailed in the next chapter. Additionally, steps to
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improve sample preparation aimed at eliminating the jump sequence and reliably producing the
correct sequencing cassette were employed.
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Figure 2.1 Hairpin loop library structure and thrombin binding aptamer
(a) Structure of the m=15 hairpin loop DNA library. Four base non-complementary tails and 8
base complementary stem regions shown in blue. Variable region loop, m, shown in red. The
constant region at the 5’-end of the variable loop is termed the “head.” The constant region at the
3’-end of the variable loop is termed the “tail.” (b) Structure of the canonical G-quadruplex
thrombin binding aptamer in the structural context of the library. Head and tail regions
designated by black lines. The stacked eight stacked G’s form a quadruplex structure, shown in
blue. The two TT and single TGT loops are shown in red. (Figure by Dr. Philip Borer.)

51

Figure 2.2 Two proposed interactions of the thrombin binding aptamer and thrombin as
determined by X-Ray crystallography and NMR
(a) Thrombin binding aptamer (blue/red) in complex with the anionic exosite I of thrombin, the
fibrinogen exosite. The T7 of the TGT loop is shown within the hydrophobic pocket formed by
Ile24, His71, Ile79 and Tyr117 (green) near the fibrinogen binding site. Hydrogen bonding and
ionic interactions of the TGT loop with thrombin are based on the original X-ray model from
Padmanabhan, et al in 1993.[151] Protein Data Bank ID Number 1HAP. (b) Thrombin binding
aptamer (blue/red) in complex with the fibrinogen exosite. T12 of the TT loop is shown in the
hydrophobic pocket formed by Ile24, His71, Ile79 and Tyr 117 (green), placing the TT loop in
close proximity to the fibrinogen binding exosite. This interaction is based on the most optimally
oriented NMR model.[65, 152, 154] Protein Data Bank ID Number 1HAO.
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Figure 2.3 Preparing the library for sequencing in AIA
The partitioned DNA library is ligated with Adapter 1 and Adapter 2 following annealing of the
head and tail regions with overhangs on Adapter 1 Complement and Adapter 2 Complement
(Splint and Splint 2). PCR amplification adds a 5’-extension of 25 bases (A), which contains the
P5 sequence necessary for annealing to the Illumina flow cell. PCR amplification simultaneously
fills in the gap across from the variable region, m. During sequencing on the Illumina platform,
the sequencing primer anneals complementary to a portion of Adapter 1 Complement.
Sequencing by Synthesis across the bottom strand begins at the 3’-end of the 39-mer library
insert and continues for a user defined number of base incorporations (B). The reported sequence
is the top strand, which corresponds to the original library sequence. (Figure by Dr. Philip
Borer.)
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Figure 2.4 Sanger sequencing sample data
Screenshot of successful Sanger sequencing of an m=15 DNA hairpin loop library ligated with
Adapter 1 and Adapter 2. The 39mer library sequence is underlined. The correct Adapter 1 and
Adapter 2 sequences flank the library (See Appendix 2 for sequences).
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Figure 2.5 Overview of Illumina sequencing
(a) Preparation of library for sequencing (image shows blunt end adapter ligation only). (b)
Single-stranded library fragments anneal randomly to the flow cell surface, complement strand is
generated. NaOH denaturation and washing leaves only the single-stranded, newly generated
complement strands attached to the flow cell. (c) PCR reagents are added to initiate bridge
amplification (d) One cycle of bridge amplification. (e) NaOH denaturation leaves only the
single-stranded templates attached to the flow cell. (f) Cyclic bridge amplification generates
millions of clusters with up to 1,000 copies each. (g) Following cleavage of fragments attached
at the 3’-end, the sequencing primer is annealed and the first sequencing cycle begins by adding
a mixture of the four fluorescently labeled nucleotides. (h) (Left) Bird’s eye view of four
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clusters. Emission fluorescence identifies the first base incorporation. (Right) Repetition of the
sequencing cycles determines the sequence of each fragment. Figure adapted from [159].
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Figure 2.6 Phylogeny trees of original 60:1 and new 30:1 AIA for thrombin

(a) Original 60:1 experiment for thrombin. Phylogenic tree of sequences occurring at least 7
times (top 150 sequences). TBA and variants (motif Ia) in blue. Carbohydrate binding sequence
variants in red. Adapted from [148] (b) 30:1 experiment for thrombin, phylogenic tree of top 100
sequences. TBA in blue, carbohydrate binding sequence in red. Little correlation is seen between
sequences.
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Figure 2.7 The jump sequence
(a) Snapshot of the 39-mer library (bases 59-90) ligated to Adapter 1 and Adapter 2 (shown 5’ to
3’). The Perl script recognizes the two underlined sections as the head and tail. The reported 15mer is identified in red.
(b) Snapshot of the most common jump sequence, a systematic artifact of library preparation.
The lowered section, including the entire randomized region and 11 of 12 tail bases, is jumped
over. The Perl script recognizes the correct head, but recognizes a portion of Adapter 2 as the tail
(underlined). The portion of Adapter 2 that is 15 bases downstream from the jumped section
differs from the original tail by a single mismatch, allowing the sequence to be reported as a
good read. The reported 15-mer is consequently the last base of the tail and the first 14 bases of
Adapter 2. Variation on the exact number of bases “jumped” and insertions/deletions can alter
the sequence of the reported 15-mer, however, all jump sequences qualified as good reads are
recognized due to sequence similarity between the tail and Adapter 2.
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Table 2.1 Top 15 aequences, original 60:1
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
GGTTGGTGTGGTTGG 46444
gctatcatcgcaacg
29405
GGTTGGTGTGGTTTG 2451
gctatcatcgccacg
1040
AGATCGGAAGAGCTC
710
gctatcatcgcaccg
678
GGTTGGTGTTGTTGG
647
GGTTGGTGTGGTTGT
591
GGTTGGTTTGGTTGG
419
gctctcatcgcaacg
354
GGCTGGTGTGGTTGG
255
gctatcatcgcaacc
220
GGTTGGTGTGTTTGG
215
gctatcctcgcaacg
199
GGTTGGCGTGGTTGG
195
gctatcatcgcaacg
160
GGTTGGTGTTGTTTG
159
gctatcatcccaacg
153
GGTTGGTGTGGCTGG
125
GGTTTGTGTGGTTGG
124

Identifier
TBA (Thb1)
Carb1
Ia
II
Jump
Ia
Ia
Ia
Ia
II
Ib
II
Ia
II
Ib
II
Ia
II
Ib
Ia

Top twenty sequences from the 60:1, thrombin: m=15 DNA partitioning experiment of Dr.
Kupakuwana.[148] A total of 1,959,748 good reads out of a total 2,231,235 reads. A total of
1,728,220 unique sequences occur in the good reads file. The canonical TBA sequence (rank = 1) is
the parent of motif, Ia, where mainly TG substitutions occur, and the lower ranking motif Ib,
which has TC and/or GA substitutions; these motifs are shown in upper case with the variant
base underlined. A novel carbohydrate binding sequence and its relatives were identified as motif
II, where the highest ranking sequence is referred to as Carb1 (sequences are shown in lower case
with variations from Carb1 underlined). The background threshold was identified as 4 counts. 296
unique sequences occur above background. A PCR artifact is labeled as “Jump;” see text for
explanation.
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Table 2.2 Top 15 sequences, 30:1
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
CGGATGCATTTATTC
195
GCCACAGATCGGAAG
40
TAGTGCATGCGCCAC
10
GGTTGGTGTGGTTGG
10
TTCCGATCTACACGC
8
AGATCGGAAGAGCTC
5
gctatcatcgcaacg
5
ATAGCGTTCTATCGA
4
TGACAGGAGAGAAAT
4
TTTATCTTCGGTGCG
4
CATTGTATGAGTTTT
4
AACAGAGGCTATAAA
4
AGTCAGTACTTCGGA
4
ATTCGAATCTGCACA
4
TATTGCTTTTCAGGT
3
TGTTAAGGTTAACCT
3
ATCCGGTAGTCACTC
3
GAAGCTTAGTGAACG
3
ATCGGGCGGTTACGC
3
ATATGAGAGGGCTTA
3

Identifier
Jump*
TBA
Jump
Carb1

Top twenty sequences from the 30:1, thrombin: m=15 DNA partitioning. A total of 8,721,035
good reads out of a total 8,984,277 reads. A total of 8,639,971 unique sequences occur in the
good reads file. The background threshold was identified as 3 counts. Only 7 unique sequences
occur above background.
*Jump sequence variant.
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Table 2.3 Top 15 sequences, 15:1
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
GGTTGGTGTGGTTGG
78
CGGATGCATTTATTC
49
TAGTGCATGCGCCAC
34
gctatcatcgcaacg
25
GCCACAGATCGGAAG
24
AGGTGTGGAGCCATT
15
CAGCTACGGAATGAC
8
AATGTTGGATAATGG
6
CGCGCCAGGTTAAAC
5
CTCGTACTGGTATTC
5
TGCAAGTCAAAGAGG
5
TGAACTGGGGAAGAT
4
GCTTTCGAGTAAACG
4
ACCGTATTGAATTCA
4
AGCAATGTATTCTAG
4
GGCACCGTGGTATAA
4
AGTAAATTCCACTGG
4
TGCATGGCCTGACCT
4
GCTATCGGGTCCTTG
4
CTTAGGTCACGCGCA
4

Identifier
TBA

Carb1
Jump*

Top twenty sequences from the 15:1, thrombin: m=15 DNA partitioning. A total of 8,481,474
good reads out of a total 9,168,389 reads. A total of 8,267,894 unique sequences occur in the
good reads file. The background threshold was identified as 4 counts. Only 11 unique sequences
occur above background.
*Jump sequence variant.
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Table 2.4 Top 15 sequences, 3:1
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
CGGATGCATTTATTC
111
GGTTGGTGTGGTTGG
56
GCCACAGATCGGAAG
31
gctatcatcgcaacg
17
CAGCTACGGAATGAC
12
AGGTGTGGAGCCATT
10
TTCCGATCTACACGC
9
TAGTGCATGCGCCAC
8
AATGGTCTAACAGAG
5
AGTCAGTACTTCGGA
5
AGATCGGAAGAGCTC
5
TGGGCAGTTTACGGC
4
ATGACTTTGTCAAGC
4
TAGCGATCTATATAG
4
AAGCCAATTATGCCG
4
GGTGTTAATGGAGGA
4
CTCAGGATGTAGAAA
4
TGACAGTTCAAGTCT
4
TTCAGTTTGGCACTT
4
GGCCGGGCTGTCAGG
4

Identifier
TBA
Jump*
Carb1

Top twenty sequences from the 15:1, thrombin: m=15 DNA partitioning. A total of 8,484,318
good reads out of a total 8,785,571 reads. A total of 8,322,934 unique sequences occur in the
good reads file. The background threshold was identified as 4 counts. Only 11 unique sequences
occur above background.
*Jump sequence variant.
Table 2.5 Statistical sequencing data for original 60:1 and variable ratio AIA experiments
30:1 AIA

15:1 AIA

3:1 AIA

Quantity of Protein
Quantity of Library
Starting Copies per Sequence

Original
60:1 AIA
6 nmol
100 pmol
56,000

3 nmol
100 pmol
56,000

3 nmol
200 pmol
112,000

3 nmol
1 nmol
560,000

Total Reads

2,142,146

8,984,277

9,168,389

8,785,571

Experiment
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Total Good Reads
Total Unique Sequences
% Unique Sequences Occurring Once

1,959,748
1,728,220
88.2 %

8,721,035
8,639,971
99.1 %

8,481,474
8,267,894
97.4 %

8,484,318
8,322,934
98.1 %

Background/Noise Threshold
Sequences Above Background

4
296

3
14

4
11

4
11

TBAa
Frequency of TBA per Good Readsb
Frequency of TBA per Total Readsc
TBA Variants Above Background

1_46,444
2.37 %
2.17 %
100+

4_10
0.00012 %
0.00011 %
0

1_78
0.00094 %
0.00085 %
0

1_56
0.00067 %
0.00064 %
0

Carb1 Sequencea
Carb1 Variants Above Background

1_29,405
50+

7_5
0

4_25
0

4_17
0

Statistical analysis of sequencing data for the original 60:1 experiment and 30:1, 15:1 and 3:1
AIA experiments, m=15 DNA library partitioned against thrombin. (a) For canonical TBA, the
rank (left) and count (right) are separated by an underscore. (b) Counts of TBA divided by the
total good reads. (c) Counts of TBA divided by the total reads.
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Chapter 3: AIA Improvements and Application of a 2’-OMe
RNA/DNA Chimera Library

Chapter Summary
The first section of this chapter focuses on improvements to the AIA method. Issues related to
consistency in sample preparation and partitioning efficiency were encountered while aiming to
reproduce the original AIA results. Many experiments failed the qPCR and Sanger sequencing
quality control tests and were not sequenced. For the three experiments with m=15 hairpin loop
library against thrombin that were sequenced, the target sequence (TBA) was found at lower than
expected counts. The frequency of these counts within the entire collected data was also much
lower than anticipated. Additionally, variants of TBA were not found within the data. To address
these issues, a number of control experiments were sequenced and experimental changes were
implemented. The m=19 hairpin loop library against thrombin experiment produced a high
percentage of jump sequences, indicating substantially poor data quality. The experimental
changes were aimed at improving the consistency of sample work-up, including establishing
protocols to ensure quality qPCR data as well as minimizing or eliminating the jump sequence
artifacts. For the first control experiment, an unpartitioned aliquot of the m=15 DNA library was
sequenced. The purpose was to visualize how ligation and PCR affect sequence frequency,
specifically the jump sequence, and to identify possible PCR champions. Second, aliquots of the
m=15 DNA library negatively selected against Con-A beads from two manufacturers, Pierce
Biotechnology and GE Healthcare Life Sciences, were sequenced in order to visualize the effect
of negative selection on sequence frequency. Third, the m=15 DNA library was partitioned
against thrombin without the negative selection step using Con-A beads from both Pierce
64

Biotechnology and GE Healthcare. The purpose was to visualize the effects of negative selection
on partitioning efficiency.

The first procedural modification was aimed at eliminating the jump sequence. It was
hypothesized that gel purifying the final product prior to sequencing may eliminate the jump
sequence. The m=15 DNA library was partitioned against thrombin immobilized on Con-A
beads from both Pierce Biotechnology and GE Healthcare in duplicate; the first sample in each
set was prepared following the standard protocol while the second sample was purified on
agarose gels following PCR. The second procedural modification included two changes to the
adapter formats; (1) a 12 base portion of Adapter 2 was altered to eliminate sequence similarity
between the fragment and a portion of Adapter 1, and (2) introduction of a multiplexing Adapter
1. The goal of altering the 12 base portion of Adapter 2 was to eliminate the potential for binding
between Adapter 1 and Adapter 2 that could reduce ligation efficiency. The goal of introducing a
multiplexing Adapter 1 was to increase the number of samples that can be clustered per lane of
the Illumina flow cell while utilizing the Single Read Illumina format. The third set of changes
includes improvements to the ligation scheme; (1) a lower concentration of adapters and (2)
overnight incubation at 16°C which resulted in a cleaner gel product. Superior gel purification
techniques were also introduced, including (1) a positive ligation control to serve as a size
marker for lower concentration samples and (2) use of disposable gel excision tips to reduce
cross contamination while excising gel bands. Finally, details including the length of library to
protein binding time and use of negative selection were explored.

65

The second section of this chapter focuses on the introduction of a 2’-OMe RNA/DNA chimera
library. RNA aptamers are often preferred over DNA aptamers due to their presumably more
versatile secondary structures and wide range of possible modifications. However, standard RNA
is susceptible to nuclease degradation and hydrolysis. Modified nucleotides such as 2’-OMe
RNA offer increased nuclease resistance and their application in the AIA method is
straightforward. The acyclic method eliminates the requirement to regenerate 2’-OMe RNA, a
major obstacle in using 2’-OMe RNA in SELEX. Additionally, screening directly with a 2’-OMe
RNA as opposed to a post-SELEX 2’-OMe modification eliminates the potential for altered
aptamer structure or function. The 2’-OMe RNA/DNA chimera library was designed such that
the non-complementary tails and constant stem regions consist of DNA nucleotides and the
variable region consists of 2’-OMe RNA nucleotides. This format allows for a simple DNA
ligation strategy while retaining the ability to screen for 2’-OMe RNA aptamers. The library was
screened against human α-thrombin using several of the procedural modifications mentioned in
first section of this chapter.

The third section of this chapter briefly discusses AIA for four Epigenetic protein targets:
WDR5, RbBP5, Ash2L and DPY-30. WDR5 (tryptophan-aspartate repeat protein-5), RbBP5
(retinoblastoma-binding

protein-5), Ash2L

(absent-small-homeotic-2-like), and

DPY-30

(Dumpy-30) compose the sub-complex, WRAD, that combines with MLL1 (mixed lineage
leukemia protein-1) to form a H3K4 (histone H3 lysine 4) methyltransferase core complex in
eukaryotes.[161] The epigenetic maintenance of transcriptionally active states of chromatin in
eukaryotes is dependent on the conversion from mono- to dimethylation of H3K4, although the
mechanism is not well characterized.[162] When MLL1 is in complex with WRAD, a 600-fold
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increase in dimethylation was observed compared to MLL1 alone.[163] The interaction of MLL1
with WRAD is critical for many biological processes, including development, hematemesis,
postnatal neurogenesis and tissue homeostasis.[162] Improved understanding of the mechanism
of the MLL1 core complex would aid in understanding the role of mixed lineage leukemia
proteins in human development disorders.[162] Identifying aptamers for the molecular surfaces
of the four sub-units may aid in the development of potential therapeutics. A variety of DNA and
2’-OMe RNA/DNA chimera libraries of length m=15, m=17, m=18, m=19, m=20, m=21 and
m=22 were screened against the four targets.

Part 1: Control Experiments and Implementing Procedural Modifications
Control Experiments
Although the initial AIA experiments identified TBA and the Carb1 sequences above
background, frequencies were much lower compared to the original 60:1 AIA experiment. The
unexpectedly low sequence counts for the variable ratio experiments in combination with the
qPCR and Sanger sequencing failures for numerous experiments prompted an examination of the
AIA protocol. The first troubleshooting experiment was to create a “baseline” to compare
subsequent experiments to. A 100 pmol aliquot of the m=15 library was ligated and PCR
amplified as described in chapter 2. The sample passed both the Sanger sequencing and qPCR
quality control tests and was sequenced on the Illumina GAIIx. The top 20 sequences are listed
in Table 3.1.
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The second series of troubleshooting experiments was aimed at evaluating the performance of
Con-A beads as the protein immobilization method of choice. After monitoring a negative
selection step with Con-A beads from Pierce Biotechnology (scaled up to quantities of DNA that
could be detected by UV absorption on a Nanodrop spectrophotometer, ~2.0 pmol in 2µl), it was
found that the beads were binding most of the DNA library (flow-through was not quantifiable).
Although the quantities of library used during aptamer screening are too small to be quantified
via UV absorption, it was assumed that only a fraction of the original 100 pmol library would be
applied to the immobilized thrombin given this information. This would result in a significantly
smaller pool of library with lower initial counts per unique sequence. It would be more difficult
to isolate high affinity sequences from the background in under-represented libraries, and this
result is counterproductive to the goals of AIA. Dr. Kupakuwana had previously experienced
similar problems with the Con-A beads, but they were remedied by purchasing new beads. This
was not the case for several different lots of Pierce Biotechnology Con-A beads that were tested.
Con-A beads from GE Healthcare Life Sciences were tested in a similar manner and absorbed
~10% of 0.005 µmoles of DNA in 500 µl buffer. This is a more favorable quantity of recovered
DNA, however, it could not be determined if the ratio applies for 100 pmol.

Aliquots of the m=15 DNA library (100 pmol) negatively selected against Con-A beads from the
two manufacturers, Pierce Biotechnology and GE Healthcare Life Sciences, were sequenced in
order to visualize the effect of negative selection on sequence frequency. Following the negative
selection step, the library was phenol extracted, ethanol precipitated, ligated and PCR amplified
as described in chapter 2. The top twenty sequences for the Pierce Biotechnology beads
experiment are listed in Table 3.2. Data from the experiment with GE Healthcare beads could
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not be reliably analyzed due to a sequencing error. For the third set of control experiments, 10
pmol aliquots of the m=15 DNA library were partitioned against thrombin immobilized on ConA beads from the two manufacturers, without the negative selection step. The sample was
prepared by binding, phenol extraction, ethanol precipitation, ligation and PCR amplification as
described in chapter 2. Data for these two experiments could not be reliably analyzed due to a
sequencing error and is therefore not shown.

Results and discussion
Of the five control experiments that were sequenced, only data from the unpartitioned m=15
DNA library and negatively selected m=15 DNA library against Con-A beads from the two
manufacturers was of sufficient quality to be parsed and compiled using the Perl script. The raw
data files were parsed based on the last eight bases of the head (dGCGCATGC) and the first five
bases of the tail (dGCATG). A comparison of the highest frequency sequences from the three
experiments reveals two sequences that recur in all three files, dCATGGCCAGAGTATA and
dAACAGGACCCCATTC. These two sequences occur 3-4 times above background in Table
3.1 and at least 50 times above background in Table 3.2. These sequences have no clear
significance and could be contaminants in the original library or sequences that are preferentially
amplified during PCR. The three experiments were sequenced on the same GAIIx flow cell and
could also be contaminants from sample preparation or qPCR. An Aptamatrix, Inc. customer
sample was also run on the same flow cell; however, this was eliminated as a source of
contamination because these two sequences occur within the correct complete head and tail
regions of the library structure. With the exception of these two sequences and two jump
sequence variants occurring 13 and 8 times in Table 3.1, the unique sequences occurring in the
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data are evenly distributed. Considering the large sequence space of 11,953,616 good reads, this
indicates that the library is not skewed in any visible manner. Analysis of the data in Table 3.2
for the negatively selected library against Pierce Biotechnology Con-A beads reveals that
negative selection skews the library pool. It was hypothesized that negative selection would
eliminate sequences with a high affinity for Concanavalin-A, while the remainder of the library
pool would be equally represented. At a length of m=15, the library contains approximately 1.07
billion unique sequences; eliminating a small fraction of these sequences would not be visible
within the experimental sequence space of 11.6 million total reads. The data shows high counts
for many sequences, with 42 unique sequences occurring above the background threshold of
seven counts. This, in combination with the variability of Con-A beads for absorbing the library
during negative selection, led to the decision to eliminate the negative selection step from the
AIA protocol. While this would be a problem for traditional SELEX because negative selection
must be repeated in each round to prevent substrate-binders from dominating the evolving pool,
it is a minor problem in a single round of selection in AIA.

Implementing Procedural Modifications
Gel purification of the final product

The first procedural modification was aimed at eliminating the jump sequence in order to
maximize data output. For every jump artifact that is sequenced, one library sequence is not,
reducing the quantity of usable data. Although jump sequence variants can be identified and
ignored during data analysis, eliminating them would improve data quality. Purifying the final
PCR product via agarose gel electrophoresis allows for only the correct size product to be
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applied to the flow cell. If the jump sequence artifacts are a byproduct of PCR amplification and
run at a different length than the correct products on the gel, they would be eliminated in the
final purification step. Also, gel purification eliminates excess primers or primer dimers, which
can contribute to loss of data. By design, the forward and reverse primers contain the P5 and P7
sequences required for annealing to the flow cell (see end of Appendix 2 for sequences). Excess
primers occupy valuable space on the oligo lawn, yet fail bridge amplification, therefore
reducing the number of possible clusters.

The m=15 DNA library was partitioned against thrombin immobilized on Con-A beads from
both Pierce Biotechnology and GE Healthcare in duplicate; the first sample in each set was
prepared following the protocol as described in chapter 2 while the second sample was agarose
gel purified following PCR. A 60:1 ratio of protein: library (6 nmol thrombin: 100 pmol library)
was used for these experiments. The experiments were performed in parallel with the control
experiments; therefore, the negative selection step was still performed. In both cases, the
partitioning using the Pierce Con-A beads failed Sanger sequencing and qPCR analysis, again
indicating an issue with the quality and consistency of the Con-A beads from this manufacturer.
The non-gel purified and gel purified samples using the GE Con-A beads were sequenced on two
different flow cells on the GAIIx. The top twenty sequences and additional run statistics are
provided in Tables 3.3 and 3.4.

Although the two experiments were performed under identical partitioning conditions, the
frequency of TBA per total good reads is 0.18% (no gel purification) versus 0.0012% (gel
purification). Also of note is the drastic difference in frequency of the jump sequence between
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experiments. In the non-gel purified sample, jump sequence variants dominate the high counts
and a relatively small percentage of total reads were qualified as good reads (5.1%). For the gel
purified sample, fewer jump sequence variants are found above background and a higher
percentage of reads were qualified as good reads (33.6%). This indicates that the gel purified
sample produced higher quality data, even though it was a less stringent partitioning. The
difference in TBA frequency is most likely due to variations in the performance of Con-A beads,
while the quality of the data is likely due to the final gel purification. Although gel purification
did not eliminate the jump sequence, its frequency was greatly reduced and the overall data
quality was improved. The next goal was to improve the ligation and purification of the ligated
sample in order to improve data quality.

Ligation scheme improvements
The second procedural modification included two changes to the adapter formats; (1) a 12 base
portion of Adapter 2 was altered to eliminate sequence similarity between the fragment and a
portion of Adapter 1, and (2) introduction of a multiplexing Adapter 1. The Adapter 1 and
Adapter 2 sequences used in AIA were based on Illumina’s SR adapter structure. In the Illumina
model for library preparation, Adapter 1 and Adapter 2 contain a 12 nucleotide complementary
region that allows the two strands to anneal and form a “forked adapter.” This complex is ligated
to both ends of the library via a 3’-T overhang and PCR amplification with appropriate primers
fills in the “forked” regions. The ligation scheme used in AIA utilizes four Adapter constructs in
order to anneal to the head and tail regions of the library, rather than a single base overhang.
Adapter 1 anneals to Adapter 1 Complement and Adapter 2 anneals to Adapter 2 Complement.
For this reason, eliminating the “forked adapter” is essential for efficient ligation. By altering this
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12 base portion of Adapter 2, the complementarity with Adapter 1 is eliminated, ensuring only
Adapter1/Adapter1 Complement and Adapter2/Adapter2 Complement complexes are formed.
The changes are outlined in Figure 3.1 and sequences are listed in Appendix 3. Another change
made to the adapter format was the introduction of an indexed Adapter 1. A 6 base index was
added to the 3’-end of Adapter 1 (with the appropriate complement added to the 5’-end of
Adapter 1 Complement) in order to multiplex several samples in a single flow cell lane. The goal
was to increase the number of samples that can be clustered per lane of the Illumina flow cell
while still utilizing the Single Read Illumina format. The data contains the 6 base index followed
by the head, library and tail, respectively. A Perl script then parses the data from each lane based
on the indices in the raw data (complete Perl script is available from Dr. Damian Allis, Syracuse
University, upon request). Each indexed data file is then parsed with the original Perl script to
qualify each sequence as a good, candidate or bad read. The location of the indices is outlined in
Figure 3.2 and a complete list of indices can be found in Table 3.4.

The third set of procedural modifications includes improvements to the ligation scheme; (1) a
lower volume and concentration of adapters and (2) overnight incubation at 16°C. Superior gel
purification techniques were also introduced, including (1) a positive control for ligation to serve
as a size marker for lower concentration samples and (2) use of disposable gel excision tips to
reduce cross contamination while excising gel bands. The large volume and large quantity of
adapters used in the ligation step was cause for concern. At 70 µl, the ligation product required
concentration using the QIAquick PCR Purification Kit (Qiagen) in order to load the entire
sample in a single electrophoresis well. Eliminating this step by reducing the reaction volume
eliminated a potential source of sample loss. In combination with the reduced volume, the
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concentration of adapters was also reduced. The ligation efficiency and subsequent PCR
amplification of the gel purified products for a set of control partitioning analyses was analyzed
for three different reaction conditions: (1) 70 µl volume, original 0.5 nmol of each adapter, (2)
varied volume, 3:1 ratio of adapter: library (determined via UV absorption) and (3) 20 µl
volume, 0.01 nmol of each adapter. Even after purification with the QIAquick PCR Purification
Kit, condition (1) produces overblown adapter bands on the gel, making resolution difficult. For
condition (2), quantifying the library is not accurate at the low concentrations that result from
partitioning and introduces an opportunity for product loss. It was found that condition (3)
produced the cleanest resolution of ligation products via gel electrophoresis and in turn, a larger
quantity of the correct PCR product. Figure 3.3 compares the ligation product of conditions (1)
and (3) on separate agarose gels. It was found that 0.01 nmol of each adapter per reaction was
sufficient for ligation of 1.0 pmol of m=15 DNA library and resulted in a much cleaner gel
product than a ligation with 0.5 nmol of each adapter. These conditions are sufficient to ligate the
small quantity of library recovered following a partitioning. Additionally, the ligation
temperature and time was changed from room temperature for 30 minutes, to overnight at 16°C
as recommended by Promega. In order to ensure that the correct ligated product is gel extracted
with minimal contamination, the use of a disposable gel excision tip was introduced. Previously,
the region of interest was cut from the gel using a razor blade. Some flexibility was allowed in
collecting the correct band due to the nature of working with a razor blade, especially if the
product band was not visible due to low concentration. The gel excision tips (GeneCatcher)
allow for a 4.0 mm by 1.0 mm gel slice to be collected. With a gel slice of this size, the exact
location of the product band must be known. A positive control of 1-10 pmol library ligated with
adapters was included on each gel to ensure that a ligation product was visible. The location of
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sample bands was extrapolated using the location of the control. The gel tips also minimize the
risk of cross contamination and the indexed Adapter 1 allowed possible contaminants from the
positive control size marker to be differentiated from the samples following sequencing.

Applying Procedural Modifications to Variable Ratio Partitioning
The previous 60:1 protein: library ratio requires a large quantity of protein (6 nmol on a 100
pmol DNA library scale). Reducing the amount of protein needed increases cost efficiency and
conserves materials. Gold et al. demonstrated a successful aptamer selection procedure using
<100 pmol of various protein targets,[20] at least 60 times less than the AIA procedure, giving
confidence that the AIA protocol could be successful in the 20-100 pmol protein range. At a 100
pmol scale, the over-represented m=15 DNA library contains approximately 56,000 copies of
each possible sequence (Table 1.1). In a 1:1, 100 pmol thrombin: 100 pmol library screen, the
ratio of protein to each unique sequence is 1:56,000. Compared to a screen with 1:10 protein:
library ratio with 1 nmol library (100 pmol thrombin), the ratio of protein to each unique
sequence decreases to 1:560,000. The same effect occurs when the protein quantity is decreased
and the library quantity remains constant. It is hypothesized that this decreased ratio would
produce a lower quantity of recovered library, and that with more library per protein, a larger,
scaled percentage of binding sequences should be higher affinity sequences.

Additionally,

skewing the ratio from excess protein relative to library toward excess library relative to protein
introduces inter-aptamer competition for target binding site. With excess library relative to
protein there is no effectice inter-aptamer competition. This may influence the distribution and
frequency of aptamer hits. This hypothesis was tested in previous AIA experiments as discussed
in chapter 2; however, results were inconsistent. The hypothesis was tested again utilizing the
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improvements in sample preparation mentioned in this chapter and a smaller quantity of protein
to conserve materials.

Partitioning the m=15 DNA library
The m=15 DNA library was partitioned at ratios of 1:1 (100 pmol thrombin: 100 pmol library),
1:10 (100 pmol thrombin: 1 nmol library) and 1:100 (100 pmol thrombin: 10 nmol library) with
no negative selection. Partitioning of the DNA library was performed using agaroseConcanavilin-A beads from GE Healthcare Life Sciences at room temperature. The Con-A
beads contained in spin columns were pre-equilibrated in partitioning buffer (20 mM Tris-HCl,
140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) by three wash cycles. A 100
pmol aliquot of glycosylated human α-thrombin (Haematologic Technologies) in 750 µl
partitioning buffer was immobilized on 100 µl of pre-equilibrated Con-A beads during a 30
minute incubation with end-over-end rotation at 25 rpm. The DNA library in 750 µl partitioning
buffer was then applied to the immobilized thrombin. Following an overnight incubation at 4⁰C
with end-over-end rotation at 25 rpm, the unbound DNA was removed by centrifugation. Three
wash cycles (5 minutes, rotation at 25 rpm) with 750 µl partitioning buffer removed unbound
DNA. Thrombin-DNA complexes were eluted from the Con-A beads with 200 µl elution buffer
(α-methyl mannoside, Glycoprotein Isolation Kit, Pierce Biotechnology) during a 5 minute
incubation with rotation at 25 rpm and collected by centrifugation.

Phenol extraction and ethanol precipitation
Phenol extraction was used to recover the partitioned DNA libraries. An equal volume of Trisbuffered, pH 8.0, 0.1mM EDTA, 50% phenol, 48% chloroform, 2% isoamyl alcohol (Sigma
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Aldrich) was added and vortexed for 30 seconds. Centrifugation at 13,000 rpm for 5 minutes
resulted in an aqueous top layer (containing the library) and organic bottom layer. The aqueous
layer was removed and the library subsequently extracted twice with equal volumes 100%
chloroform. The library was then purified by ethanol precipitation. One tenth the volume (20 µl)
of 3M sodium acetate and three times the volume (600 µl) of cold ethanol and were added to the
library and mixed briefly. Following an overnight incubation at 20°C, centrifugation at 13,000
rpm in an AccuSpin Micro 17R microcentrifuge (Fisher Scientific) for 30 minutes resulted in a
library pellet. After decanting the liquid, the pellet was washed with 1 ml 70% ethanol and
pelleted by centrifugation at 13,000 rpm for 20 minutes. Increased precipitation time at -20°C
rather than -80°C was implemented in order to improve recovery. The pellet was dried in a
SpeedVac and resuspended in 10 µl dH2O.

Modifying the library for sequencing
The DNA library was ligated with the modified sequencing adapters and their complements
using the improved ligation conditions and Indexed Adapter 1. Adapter 1, Adapter 1
Complement, Adapter 2, and Adapter 2 Complement (IDT) at 10 µM were added in 1 µl
volumes to the library. The index on Adapter 1 is dictated by the number of samples prepared
and the number of samples desired per Illumina flow cell lane. The 1:1, 1:10 and 1:100 samples
were ligated with Indices 1, 3 and 2, respectively. The mixtures were incubated at 90°C for 3
minutes. After cooling to room temperature, 2 µl of 10X ligation buffer (300mM Tris-HCl (pH
7.8), 100mM MgCl2, 100mM DTT and 10mM ATP; Promega), 3 µl dH2O and 1 µl T4 DNA
ligase (10mM Tris-HCl (pH 7.4), 50mM KCl, 1mM DTT, 0.1mM EDTA and 50% glycerol;
Promega) were added. Incubation of the 20 µl reaction overnight at 16°C completed the ligation.
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The product was visualized on a 2% TBE agarose gel alongside a 25 bp DNA ladder. The
product is 105 nucleotides long with 66 of those being base paired with Adapter Complements
and runs between the 100 and 125 bp ladder bands. The product band was excised with a 4.0 mm
by 1.0 mm disposable gel excision tip (GeneCatcher) and purified with the MiniElute Gel
Extraction Kit (Qiagen), resulting in a pure, ligated DNA library. PCR amplification with
Forward and modified Reverse Primers (See Appendix 3) extends the 5’-length of the ligated
product to allow for annealing to the immobilized complement of the Illumina flow cell, while
simultaneously filling in the complement to the variable region. The 10 µl purified adapter
ligated library was combined with 1 µl each of the Forward and modified Reverse Primers at 10
µM (IDT, Coralville, IA), 1 µl of 100 µM dNTPs (Agilent), 2 µl 10X Paq5000 Hotstart DNA
polymerase buffer (proprietary to Agilent), 4 µl dH2O, and 1 µL Paq5000 Hotstart DNA
polymerase (Agilent). The 20 µl reaction mixture was amplified with the following conditions:
Denaturation
PCR Amplification (18 cycles)

Final Extension

94°C
94°C
61°C
72°C
72°C

2 min.
30 sec.
30 sec.
30 sec.
5 min.

The final product was purified on a 2% TBE agarose gel alongside a 25 bp DNA ladder. The
~130 base pair band was excised with a disposable gel excision tip and extracted with the
MiniElute Gel Extraction Kit (Qiagen). The purified library was resuspended in 10 µl dH2O.

Control experiments
During the experiment, a control ligation was used as a size marker in the event that the ligated
experimental sample had a concentration too low to be visualized. A 10.0 or 1.0 pmol aliquot of
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the m=15 DNA library was ligated under identical conditions. The product was gel purified
alongside the experimental samples and PCR amplified. This product was run alongside the
amplified experimental samples to serve as a ~130 bp marker and is illustrated in Figure 3.4.

Sanger sequencing
The AIA protocol previously utilized Sanger sequencing prior to sequencing on the GAIIx to
ensure the presence of the sequencing cassette: the correctly ligated and modified DNA
sequences. This step was time consuming and if a sample failed the Sanger sequencing analysis,
it always failed qPCR analysis. This step was ultimately removed from the protocol in favor of
only using qPCR analysis.

Quantitative PCR and high throughput sequencing
The precise quantity of amplifiable DNA was determined with the KAPA Library Quantification
kit on the BioRad iCycler as described in chapter 2. The concentration of the samples was
estimated on the BioTek Synergy 3 Microplate reader and diluted to 20 nM. The quantity of
amplifiable DNA in the 20 nM dilution for the three variable ratio experiments (1:1, 1:10 and
1:100 thrombin: library) was determined as 0.6 nM, 4.8 nM and 5.6 nM, respectively. The
samples were multiplexed alongside samples from AptaMatrix, Inc. and sequenced on the
GAIIx. The 1:1 and 1:100 samples were sequenced on a different lane than the 1:10 sample.
Sequencing data was parsed with the Perl script; the last 8 bases of the head and first 5 bases of
the tail were used to qualify the data.
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Results
Sequencing results for the 1:100 DNA library screen were not viable due to an error in
multiplexing. It was determined that a sample from AptaMatrix, Inc. was incorrectly indexed,
resulting in a library of the same length and index as the 1:100 experiment in that lane. The top
20 counts and other run statistics for the 1:1 and 1:10 thrombin: library experiments are
presented in Tables 3.6 and 3.7. A comparison of run statistics is presented in Table 3.9. TBA
was the highest ranked non-jump related sequence for both experiments and several TBA
variants exist above background. The background was estimated based on the presence of
“signal,” or TBA-like sequences, in comparison to unrelated sequences of the same frequency.
For the 1:1 experiment, TBA was the highest counted sequence at 977. With a background count
of 3, TBA appears at approximately 325 times background. For the 1:10 experiment, TBA was
the highest counted sequence at 5,506, ranking above the jump sequence. With a background of
3, TBA appears at approximately 1,800 times background. Dr. Kupakuwana observed TBA at
approximately 10,000 times background; however, the new results are still excellent. The
frequency of TBA in the good reads for the 1:1 and 1:10 experiments is 0.06% and 0.18%,
respectively, while Dr. Kupakuwana observed TBA at 2.37%. This is a dramatic improvement
from the very low frequencies observed in chapter 2. Both the 1:1 and 10:1 data sets contain
dozens of TBA variants, and the highest counted sequences are dominated by these variants.
The data from these two experiments reflects the ratios of protein: library, as the frequency of
TBA and TBA variants increased as the number of starting copies of each sequence increased
during partitioning. The top 50 sequences of each experiment were aligned with ClustalX2 and
the phylogeny output is shown in Figure 3.5. A distinct cluster of TBA like sequences is seen in
each tree, indicating that partitioning was efficient.
80

Neither CarbI nor related sequences were found in either experiment summarized in Figure 3.5.
Although CarbI was found in the Table 2.2, it is at a low count and there are no variants. The
absence of CarbI may be a result of switching to Con-A beads from GE Healthcare rather than
Pierce Biotechnology. The Pierce Biotechnology storage solution contains glucose, which was
identified as a target for CarbI with a Kd of ~1.4 µM.[33] The GE storage solution does not
contain glucose which leaves only thrombin as the binding target for CarbI. The CarbI sequence
does appear above background for the 60:1 partitioning with GE beads in Table 3.3. Just as the
counts for TBA vary from experiment to experiment, the behavior should be expected for CarbI.
It is likely the case that CarbI was recovered in this experiment as a result of weak binding to
glycosylation sites on thrombin. The absence of CarbI in the later experiments was not
investigated further, as it only has weak affinity for the glycan content of thrombin and does not
have any effect on the clotting activity.

The data quality of the two experiments was excellent, with a total of 95.9% and 96.4 % of the
total reads qualified as good reads by analyzing the last 8 bases of the head and first 5 bases of
the tail. Also promising is the minimal number of jump sequence variants. Only one jump
sequence variant is found above background in the 1:1 experiment at 15 counts. No jump
sequence variants are found above background in the 1:10 experiment. This indicates that the
overall quality of the sample was high. This can be attributed to improved sample preparation
and gel purification of the final product. The jump sequence in the new AIA experiments varies
from that in the previous experiments (sequence can be found in Table 2.1) due to the sequence
change in Adapter 2; however, the location of the jump sequence within the ligated library has
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not changed and it is still qualified as a good read based on similarity between the tail and
Adapter 2.

Overall, the modifications made to the AIA protocol produced sequence data with a low
percentage of jump artifacts and a high percentage of good reads. The partitioning successfully
identified TBA and several TBA variants as high affinity sequences well above background.
Additionally, the frequency of TBA increased as the selection pressure and number of starting
copies of TBA was simultaneously increased.

Part II: 2’-OMe/DNA Chimera Library
While DNA libraries and aptamers are easy to work with in vitro and are relatively stable, RNA
libraries and aptamers are more susceptible to degradation by nucleases and spontaneous
hydrolysis. However, both DNA and RNA aptamers are susceptible to hydrolysis in vivo, where
the presence of nucleases cannot be controlled. Modified nucleotides such as 2’-OMe RNA offer
increased nuclease resistance and their application in the AIA method is straightforward. The
acyclic method eliminates the requirement to regenerate 2’-OMe RNA, a major obstacle in using
2’-OMe RNA in SELEX. Additionally, screening directly with a 2’-OMe RNA as opposed to a
post-SELEX 2’-OMe modification eliminates the potential for altered aptamer structure or
function. For these reasons, we chose to investigate the use of 2’-OMe RNA libraries in the AIA
method. The 2’-OMe RNA/DNA chimera library was designed such that the non-complementary
tails and constant stem regions consist of DNA nucleotides and the variable region consists of 2’OMe RNA nucleotides. This format allows for a simple DNA ligation strategy while retaining
82

the ability to screen for 2’-OMe RNA aptamers. The m=15 2’-OMe RNA/DNA chimera library
was synthesized in-house by Dr. Deborah Kerwood on the ABI 394 synthesizer.

The library was screened against human α-thrombin using the improved AIA protocol, similarly
to the variable ratio experiments described in this chapter. The m=15 2’-OMe RNA/DNA
chimera library was partitioned at ratios of 1:10 (100 pmol thrombin: 1 nmol library) and 1:5 (20
pmol thrombin: 100 pmol library). Following ligation, the 2’-OMe RNA/DNA chimera library
was RT-PCR amplified using the SuperScript III One-Step RT-PCR System with Platinum Taq
DNA polymerase (Invitrogen). The library was amplified using the following conditions: 25 µl
2X Master mix, 10 µl library, 1 µl 10 µM Forward Primer, 1 µl 10 µM Reverse Primer, 2 µl
SuperScript III RT/Platinum Taq Mix.
cDNA Synthesis
Denaturation
PCR Amplification (18 cycles)

Final Extension

50 °C
94°C
94°C
61°C
68°C
68°C

15 min.
2 min.
15 sec.
30 sec.
1 min.
5 min.

The forward PCR Primer (IDT) contains an extension sequence that produced a 5’-overhang for
annealing to the immobilized complement of the Illumina flow cell. The volume of the PCR and
RT-PCR products were reduced to 10 µl with the QIAquick PCR Purification Kit (Qiagen) prior
to gel purification. A 10 pmol aliquot of the m=15 2’-OMe RNA/DNA chimera library was
ligated and RT-PCR amplified as a positive control alongside each partitioning experiment.
qPCR analysis determined the concentration of 20 nM dilution as 1.8 nM for the 1:5 experiment
and was sequenced on the Illumina GAIIx. The 1:10 experiment did not amplify well and the
qPCR data was unreliable, therefore it was not sequenced.
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Results and discussion
The top 20 sequences for the 1:5 m=15 2’-OMe RNA/DNA chimera library screen are reported
as DNA sequences as listed in Table 3.8. TBA is the highest ranked sequence at 58,781 counts
and the frequency of TBA as a percentage of good reads is 3.50%. A large number of TBA
variants are also present above background. The top 50 sequences were aligned with ClustalX2
and the phylogeny output is shown in Figure 3.6. The figure illustrates that only 10 of the top 50
sequences are non-TBA like. The background count was determined as 13, which places TBA
approximately 4,500 times above background. As compared to the variable ratio m=15 DNA
library partitioning in Tables 3.6 and 3.7, significantly more TBA variants are present in the 2’OMe RNA/DNA experiment and the counts for these variants drops off much slower. TBA
variants are found throughout the entire data set, with several occurring at counts of 1. These are
not considered above background, as they are dominated by unrelated sequences of the same
count. This is the case up to counts of 13. The increase in counts for TBA and TBA variants in
this 100 pmol starting pool compared to the 100 pmol starting pool of the 1:1 DNA experiment
may be due to the nature of short, single-stranded RNA, which may fold into more complex three
dimensional structures than DNA and lead to high affinity aptamers beyond the G-quadruplex
structure of TBA. However, the high selectivity for the TBA sequence is consistent with this
hairpin molecule folding into the quadruplex in the 2’-OMe-ribose context. Additionally, the
pattern of TBA variant sequences underlined in Table 3.8 (2’-OMe) is very different from that in
the DNA shown in Table 2.1 (DNA). The 2’-OMe variants from canonical TBA are more
tolerant of substitution in the central TGT sequence and T,G  C,A substitutions. These
differences suggest subtle differences in the details of how 2’-OMe-TBA binds to thrombin
compared to canonical DNA-TBA. The high frequency of TBA and large number of TBA
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variants occurring well above background indicate that the partitioning was highly selective.
CarbI and related sequences are not present in the data set, again due perhaps to the absence of
glucose in the storage buffer for Con-A beads.

In addition to exceptional selection efficiency, the experiment yielded high quality data.
Approximately 69.2% of the total reads were qualified as good reads, and of these only two
variants of the jump sequence are present above background, the most abundant at 54 counts.
The data quality can be attributed to improved sample preparation and gel purification of the
final product. A comparison of the 2’-OMe RNA/DNA chimera library screen, 1:1 and 1:10
screens, as well as the 30:1 screen from chapter 2 and the original 60:1 experiment from Dr.
Kupakuwana can be found in Table 3.9.

The application of an m=15 2’-OMe RNA/DNA chimera library in the AIA for thrombin
protocol yielded exceptional results. Although it is reported as DNA, the data represents 2’-OMe
RNA in the m=15 variable region. The 1:5 experiment produced TBA as the most abundant
sequence, a large number of TBA variants, and few jump sequences. This experiment
demonstrates that a 2’-OMe RNA library is well suited to the AIA method. Additionally, this
experiment demonstrated a successful partitioning utilizing only 20 pmol of thrombin, a quantity
significantly less than the 6 nmol used in the original AIA method. Additional experiments with
the m=15 DNA and m=15 2’-OMe RNA/DNA chimera library under identical conditions would
be required in order to directly compare the performance of the two libraries. These experiments,
along with additional variable ratio experiments that would be needed to confirm the findings of
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the 1:1 and 1:10 experiments, were not performed in favor of exploring the new library structure
described in chapter 4.

Part III: AIA for Epigenetic protein targets
The AIA protocol was adapted for four epigenetic protein targets, WDR5, RbBP5, Ash2L and
DPY-30, provided by Dr. Michael Cosgrove, SUNY Upstate Medical University, Syracuse, NY.
With the exception of the following, the modified AIA protocol described in this chapter was
followed. His-tag modified forms of the proteins were immobilized on Dynabeads His-Tag
Isolation and Pull down magnetic beads (Invitrogen). Protein variants without his-tags were
biotinylated with the ChromaLink Biotin Labeling Kit (SoluLink) and immobilized on NanoLink
Streptavidin magnetic beads (SoluLink). The binding capacity of the beads, (60 pmol/µl and 20
pmol/µl, respectively) was used in an effort to saturate the beads and eliminate the negative
selection step. The his-tagged proteins were stored in a TCEP buffer (20 mM Tris, pH 7.5, 300
mM NaCl, 1 µM ZnCl2, 1 mM TCEP) and were bound to beads equilibrated in this solution. The
immobilized protein was washed 3X with the TCEP buffer, washed a final time with SBIT buffer
(40 mM HEPES, pH 7.5, 125 mM NaCl, 5 mM KCl, 1 mM MgCl 2, 1 mMCaCl2, 0.05%
TWEEN-20)[20] and resuspended in SBIT buffer. The biotinylated proteins were buffer
exchanged during the biotinylation procedure and were stored in 1X PBS, which was used in
place of the TCEP buffer. Following an overnight partitioning of the library against the
immobilized protein with 0.5% BSA, the beads were washed 2X with SBIT buffer containing 0.1
mg/ml salmon sperm DNA (Invitrogen), and an additional 2X with SBIT buffer.[20] His-tagged
protein-library complexes were eluted with 2M Guanidine HCl in SBIT buffer for 30 minutes at
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room temperature. Biotinylated protein-library complexes were eluted with 8M Urea for 3
minutes at 94⁰C.

Although a multitude of protein target and library combinations were explored, only a fraction
were sequenced. The m=15, m=17, m=19 and m=21 2’-OMe RNA/DNA chimera library against
his-tagged RbBP5, his-tagged Ash2L and his-tagged DPY-30 as well as the m=17, m=19 and
m=22 DNA libraries against biotinylated RbBP5 were sequenced. The m=15 library was
screened with approximately 56,000 starting copies of each sequence. The m=17, m=19 and
m=21 and libraries were screened with approximately 10,000 starting copies of each sequence.
The m=22 library was screened with approximately 300 starting copies of each sequence. The
ratio of target: library for the 2’-OMe RNA/DNA chimera libraries was 1:10 with varied
quantities of protein to accommodate the copy numbers above. The ratio of target: library for the
DNA libraries was 1:3, 1:50, and 1:80 for the m=17, m=19 and m=22 libraries, respectively.
None of the experiments produced sequences above background, indicating that no high affinity
sequences were present in the starting pools and/or the partitioning was not stringent enough to
isolate them from the background. Additional experiments with varied partitioning conditions
may reveal whether or not the stringency could be increased in order to isolate any aptamer
candidates. However, these experiments were not performed in favor of exploring the new
library structure described in chapter 4.
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Figure 3.1 Illumina SR Adapters versus AIA Adapters
(Top) Illumina SR Adapter sequences, 12 base complementary regions highlighted in red. When
annealed, the Adapters form a forked structure with a single T overhang for ligation. The
Adapter complex ligates to both the 5’ and 3’-ends of the adenylated library. (Middle) AIA
Adapter 1 (Index 1) and Adapter 2 sequences, 12 base complementary regions highlighted in red.
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The complementary regions allow the Adapters to form the forked structure, which competes
with the desired Adapter1/Adapter 1 Complement and Adapter 2/Adapter 2 Complement
structures. (Bottom) AIA Adapter 1 (Index 1) and revised Adapter 2 sequences, original
complementary regions highlighted in red, revised bases highlighted in blue. In the revised
Adapter 2 sequence, 9 of the 12 complementary bases are altered, preventing the forked structure
shown. This eliminates competition with the desired Adapter1/Adapter 1 Complement and
Adapter 2/Adapter 2 Complement structures required for ligation of the library.





Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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Figure 3.2 Location of AIA Adapter 1 Index
Adapter 1 and Adapter 1 Complement annealed, with 12 base overhang required for ligation to
the library. The index required for multiplexing with the SR format is positioned at the 3’-end of
Adapter 1. The sequencing primer sits in front of the index. During data processing, the first 6
bases represent the index and are parsed independently of the head, library and tail. The index
files are then processed with the original Perl script. 



Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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Figure 3.3 Original versus modified ligation conditions
2% Agarose gels of ligated m=15 DNA hairpin loop libraries after partitioning. Black arrows
indicate location of excess Adapters. Red arrows indicate ligated product. (a) Lane 1: 50 bp
DNA ladder. Adapters at original concentration, total quantity is 0.5 nmol of each Adapter. This
gel demonstrates the difficulty in purifying the ligated product from excess Adapters if the gel is
not run for a sufficient time. The excess Adapter band is overblown and interferes with the
ligated product. (b) Lane 1: 50 bp DNA ladder. Adapters at original concentration, total quantity
is 0.5 nmol of each Adapter. This demonstrates separation of ligated product from excess
Adapters. Adapter bands are overblown and ligated product does not run in a clean band. (c)
Lane 1: 25 bp DNA ladder. Modified ligation conditions. Total quantity of Adapters is 0.01 nmol
each, 16°C overnight incubation. Lane 4 is a positive control, 10 pmol of library ligated. Note
the conversion of free Adapters to ligated product. Lanes 2 and 3 are partitioned samples, ligated
product bands are present but difficult to visualize without adjusting image contrast. Ligated
products are clearly separated from excess Adapters. Adapter bands are not overblown and
ligated product runs as a concise band.
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Figure 3.4 PCR product of ligated m=15 DNA hairpin loop library
2% Agarose gel of PCR amplified ligated m=15 DNA hairpin loop library. Lane 1: 25 bp DNA
ladder. Lane 2: Positive control, PCR product of gel purified 10 pmol ligated library. Lane 3:
PCR product of gel purified ligated partitioning sample. Arrow indicates the location of the
correct product bands.
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Figure 3.5. Phylogeny trees of the top 50 sequences for the 1:1 and 1:10 ratio experiments
Phylogeny trees created following sequence alignment with ClustalX. (A) Top 50 sequences, 1:1
thrombin: m=15 DNA library. TBA-like sequences circled in blue. (B) Top 50 sequences, 10:1
m=15 DNA library: thrombin. TBA-like sequences circled in blue.
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Figure 3.6 Phylogeny tree of the top 50 sequences for the 1:5 2’-OMe RNA/DNA chimera
library experiment
Phylogeny tree created following sequence alignment with ClustalX. Top 50 sequences, 1:5
thrombin: m=15 DNA library. TBA-like sequences circled in blue. Only 10 of the top 50
sequences are unrelated to TBA.
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Table 3.1 Top 20 sequences, m=15 DNA library
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
GCCACAGATCGGAAG
13
CATGGCCAGAGTATA
12
AACAGGACCCCATTC
10
ATGCGCCACAGATCG
8
ACTGCATGCGCCANN
4
GAGGGTACATCCGGG
4
CATAACGAAAGCACT
4
TGATCTTCGCACAAT
4
ATGTCCTTACACGGC
4
GGGTTGGTTGCACTA
3
AGTACAAGGCACGCA
3
GGTCTATAGCCCCTT
3
ATGGGTCTACTTGTT
3
CATGCTCAGTAAGAA
3
GGTTTGGCTTAGGGT
3
CTAATAGAGAAGTCA
3
GTAGACGGGTCATTG
3
ATCATCGCATAACAT
3
CGGCATATTGTTTCT
3
GACATGGCGCAGTAT
3

Identifier
Jump*

Jump*

Top twenty sequences from a 100 pmol aliquot of the unpartitioned m=15 DNA library. A total
of 11,953,616 good reads out of a total 12,940,575 reads. A total of 11,864,123 unique sequences
occur in the good reads file. The background threshold was identified as 3 counts. 9 unique
sequences occur above background.
*Jump sequence variant.

95

Table 3.2 Top 20 sequences, m=15 DNA library negatively selected against
Pierce Biotechnology Con-A beads
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
AACAGGACCCCATTC
460
ACGATGGGATAGGAA
391
CGGAAGAGCGGTTCA
280
CATGGCCAGAGTATA
260
CACATAGGATAACCT
186
CGCGCTACGGTGGTG
152
TCACGCTCCTACTCG
107
CCACATCATAACGAT
94
GTTCTAATAAGTCGC
89
CATGCGCCACAGATC
77
CATGCGCCACCGATC
52
ATGCGCCACAGATCG
35
CTAGCAGCTCATCAT
34
ACGTAGGGTCGCCGC
25
TTGCGGACGAGCCTA
24
AAGTAACGCTCAGGC
23
CCGTAGAGCATCCAA
23
GCTATCATCGCAACG
23
AGGCTTGACTCAGTT
21
CTGTCGGTCAGGGAT
16

Identifier

Jump*

Jump*
Jump*
Jump*

Top twenty sequences from a 100 pmol aliquot of the m=15 DNA library negatively selected
against Con-A beads from Pierce Biotechnology. A total of 7,281,704 good reads out of a total
11,672,270 reads. A total of 6,216,093 unique sequences occur in the good reads file. The
background threshold was identified as 7 counts. 42 unique sequences occur above background.
*Jump sequence variant.
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Table 3.3 Top 20 sequences, m=15 DNA library partitioned against thrombin, no gel
purification
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count Identifier
AGATCGGAAGAGCTC 119007 Jump*
GGTTGGTGTGGTTGG
2054
TBA
CGATCGGAAGAGCTC
1075 Jump*
AGATCGGANGAGCTC
1032 Jump*
AGATCGGAANAGCTC
910 Jump*
AGATCGGAAGGGCTC
667 Jump*
GTTAGCCATTAGTTT
654
AGATCGGAAGCGCTC
577 Jump*
AGATCGGAACAGCTC
386 Jump*
AGATCGGAGGAGCTC
380 Jump*
AGATCGGAAGAGATC
322 Jump*
AGATCGGAAGAGCTA
307 Jump*
GAGGGTCGAGGATTA
288
GCTATCATCGCAACG
285
Carb1
AAAGAGGCTAGCTTG
281
AGATCGGACGAGCTC
272 Jump*
CGGATGCATTTATTC
250
AGATAGGAAGAGCTC
246 Jump*
TATCGCTATAGAATG
223
AGATCGGATGAGCTC
222 Jump*

60:1, GE Con-A beads. A total of 1,135,020 good reads out of a total 22,145,341 reads. A total
of 597,402 unique sequences occur in the good reads file. The background threshold was
identified as 11 counts. 197 sequences occur above background. Several of the top hits are
variations of the jump sequence.
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Table 3.4 Top 20 sequences, m=15 DNA library partitioned against thrombin, gel
purification of final product
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count Identifier
AACAGGACCCCATTC
946
CATGGCCAGAGTATA
295
CCACATCATAACGAT
235
TTGCGGACGAGCCTA
214
GTTCTAATAAGTCGC
190
ACGATGGGATAGGAA
146
TCACGCTCCTACTCG
87
CACATAGGATAACCT
49
CCGTAGAGCATCCAA
44
AAGTAACGCTCAGGC
35
GGTTGGTGTGGTTGG
34
TBA
AAAGAGGCTAGCTTG
27
CGCGCTACGGTGGTG
24
TGTCTATGGGGACTT
23
CTCGACACAAGTTGA
21
TATCAGATCGGAAGA
16
CGCTCAAGTCAAATC
12
AGGAGTACACGCATG
12
ACCAGGACCCCATTC
11
TAGACAACACGTTAG
10

60:1, GE Con-A beads, gel purified PCR product. A total of 2,871,584 good reads out of a total
8,536,557 reads. A total of 5,683,961 unique sequences occur in the good reads file. The
background threshold was identified as 8 counts. 25 sequences occur above background.
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Table 3.5 List of Adapter 1 Indices
Index
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Sequence
ATCGTA
GATAGC
CGATCT
TCGCTA
TACGTC
AGTAGT
GCATGA
CTGCTG
TCAGTA
ATGAGC
GACTAT
CGTCCA
TCAGAG
ATGCGA
GACTCG
CGTATC

List of twelve Adapter 1 Indices used for multiplexing compatible with the Illumina SR flow cell
format.
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Table 3.6 Top 20 sequences, 1:1 thrombin: m=15 DNA library
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
GGTTGGTGTGGTTGG
AGTTGGTGTGGTTGG
TGTTGGTGTGGTTGG
AGACAGAGGTCAGTC
GGTTGGTATGGTTGG
GGTTGATGTGGTTGG
GGTTGGTGTGATTGG
GGTTGGTGAGGTTGG
GGTTGGTGTGGTTTG
GGTTGGTGGGGTTGG
GGTTGGTGCGGTTGG
GGTTGGGGTGGTTGG
GGTTGGTGTGGCTGG
AGTTGATGTGGTTGG
GATTGGTGTGGTTGG
GGTCGGTGTGGTTGG
GGTTGGTGTGGTTGA
GGTTAGTGTGGTTGG
GGTTGGTGTGGTTGT
GGTTGGTGTGGTTAG

Count Identifier
977
TBA
262
22
15 Jump*
13
11
10
9
9
9
8
8
7
7
6
6
6
6
6
6

1:1 thrombin: m=15 DNA library (100 pmol thrombin: 100 pmol library). A total of 1,520,709
good reads out of a total 1,568,269 reads. A total of 1,503,898 unique sequences occur in the
good reads file. The background threshold was identified as 3 counts. 31 sequences occur above
background. Several of the top hits are variations of TBA, with 26 variants above background.
*Jump sequence variant
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Table 3.7 Top 20 sequences, 1:10 thrombin: m=15 DNA library
Rank
Sequence
1
GGTTGGTGTGGTTGG
2
GGTTGGGGTGGTTGG
3
AGTTGGTGTGGTTGG
4
GGTTGGCGTGGTTGG
5
GGTTAGTGTGGTTGG
6
GGTTGGTGGGGTTGG
7
GGTTGGTGCGGTTGG
8
GGTTGGTGTGGTTAG
9
GGTTGGTGAGGTTGG
10
NNNTNCNNNNNGNAN
11
GGTCGGTGTGGTTGG
12
GGTTGGTGTGATTGG
13
GATTGGTGTGGTTGG
14
GGTTTGTGTGGTTGG
15
GGTTGGTGTGGTCGG
16
GGTTGGTATGGTTGG
17
GGTTGGTGTAGTTGG
18
GGTTGGTGTGGTTTG
19
NNNTNCTNNNNGNAA
20 NNNNNCNNNNNGNAN

Count Identifier
5506
TBA
57
33
32
27
26
22
22
21
18
16
16
14
13
13
13
13
12
12
11

1:10 thrombin: m=15 DNA library (100 pmol thrombin: 1 nmol library). A total of 3,015,490
good reads out of a total 3,127,147 reads. A total of 2,981,529 unique sequences occur in the
good reads file. The background threshold was identified as 3 counts. 104 sequences occur above
background. Several of the top hits are variations of TBA, with 38 variants above background.
*Jump sequence variant
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Table 3.8 Top 20 sequences, 1:5 thrombin: m=15 2’-OMe/DNA chimera library
Rank
Sequence
Count Identifier
1
GGTTGGTGTGGTTGG 58781
TBA
2
GTTTTGTTTGGTTGG
391
3
GGTTGGGGTGGTTGG
345
4
GGTTGGTGGGGTTGG
175
5
GGTTGGTGCGGTTGG
118
6
GGTTGGCGTGGTTGG
116
7
GGTTGGAGTGGTTGG
90
8
GGTTGGTGTGGCTGG
70
9
GGTTGGTGTGGTCGG
57
Jump*
10
AGACAGAGGTCAGTC
54
11
GGTTGGTGAGGTTGG
53
12
GGATGGTGTGGTTGG
39
13
GGTTGGTGTGGTTGA
38
14 GGTTGGGGGGGTTGG
37
15
GGCTGGTGTGGTTGG
33
16
GGTTGGTGTGGTTCG
32
17
GCTTGGTGTGGTTGG
31
18
GGTTGGTGTGGTTGC
31
19
GGTCGGTGTGGTTGG
30
20
GGTTGGTGTGGTTAG
30

1:5 thrombin: m=15 2’-OMe RNA/DNA chimera library (20 pmol thrombin: 100 pmol library).
Data is reported as DNA but represents the 2’-OMe RNA analog. A total of 1,681,274 good
reads out of a total 2,431,077 reads. A total of 66,934 unique sequences occur in the file. The
background threshold was identified as 13 counts. 160 sequences occur above background.
Several of the top hits are variations of TBA, with 42 variants above background; underlined
bases in variants differ from canonical TBA.
*Jump sequence variant.
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Table 3.9. Statistical sequence data for improved variable ratio and 2’-OMe RNA AIA
experiments
Original
60:1 AIA
6 nmol
100 pmol
56,000

1:1 AIA

1:10 AIA

1:5 2’-OMe

100 pmol
100 pmol
56,000

100 pmol
1 nmol
560,000

20 pmol
100 pmol
56,000

Total Reads
Total Good Reads
Total Unique Sequences
% Unique Sequences Occurring
Once

2,142,146
1,959,748
1,728,220
88.2 %

1,568,269
1,520,709
1,503,898
99%

3,127,147
3,015,490
2,981,529
99%

2,431,077
1,681,274
667,934
39%

Background/Noise Threshold
Sequences Above Background

4
296

3
31

3
104

13
60

TBAa
Frequency of TBA per Good Readsb
Frequency of TBA per Total Readsc
TBA Variants Above Background

1_46,444
2.37 %
2.17 %
100+

1_977
0.062 %
0.062 %
26

1_5,506
0.18 %
0.17 %
38

1_58,781
3.50 %
2.42 %
42

Carb1 Sequencea
Carb1 Variants Above Background

1_29,405
50+

N/A
N/A

N/A
N/A

N/A
N/A

Experiment
Quantity of Protein
Quantity of Library
Starting Copies per Sequence

Statistical data for the original 60:1 experiment, 1:1 and 1:10 variable ratio experiments and the
1:5 2’-OMe RNA/DNA chimera library experiments. (a) The rank (left) and count (right) are
separated by an underscore. (b) Counts of TBA divided by the total good reads. (c) Counts of
TBA divided by the total reads.
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Chapter 4: AIA with Adapter Libraries

Chapter Summary
The hairpin loop library design described in chapters 2 and 3 was used to successfully identify
the thrombin binding aptamer from pools of m=15 DNA and m=15 2’-OMe RNA/DNA chimera
libraries. Consistency in sample preparation and data quality were achieved with a number of
procedural modifications. However, the library design was unsuccessful at identifying any
aptamer sequences for the Epigenetic targets mentioned in chapter 3 from over-represented
libraries of varied lengths. It is possible that no aptamer candidates existed in the pools, however,
the limiting nature of the hairpin loop design may have been a factor. The library design
explored in this chapter eliminated the constraints of the hairpin loop structure. In place of the
eight base complementary stem and 4 base non-complementary tails, the variable regions was
flanked by portions of the Illumina TruSeq Adapter 1 and Adapter 2 constructs. This library
design is employed similarly to SELEX libraries with the Adapter regions serving as priming
regions in PCR. By eliminating the ligation step and proceeding directly to PCR amplification,
the AIA method becomes more efficient and even less time consuming. Additionally, retention
of sequences selected from libraries is improved. An unknown percentage of selected library
sequences is likely lost during ligation due to partial or failed ligations. It may also be possible to
“capture” the bound library molecules off of the immobilized protein target by PCR without
phenol extraction and ethanol precipitation, further simplifying the AIA protocol. This library
based on direct amplification is termed an “adapter library.” The work-up and experimental
details for both DNA and 2’-OMe RNA/DNA chimeric adapter libraries were determined in
simulated partitioning using dilute concentrations of library. Following the determination of
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optimal PCR amplification conditions, the libraries were screened against thrombin to gauge
their functionality in AIA. Although written in this order, several experiments were completed
simultaneously and therefore conclusions were made simultaneously. Some experiments may
seem redundant when presented in the order written, however, this manner allows for an
organized presentation of methods and results.

Library Design
The sequence arrangement for the adapter library design is illustrated in Figure 4.1. The variable
region of the adapter libraries ranges from m=15 to m=22 which allows for a sufficient number
of copies per sequence for a single round of partitioning. A 2’-OMe RNA/DNA chimera adapter
library was also designed, with a 2’-OMe RNA library region and DNA adapters, which is RTPCR amplified following partitioning similarly to the hairpin loop ligation library. The adapter
sequences that flank the library region are based on the Illumina TruSeq adapter format.
Illumina’s TruSeq technology is in improvement on the Single Read versus Paired End Read
versus Multiplex Paired End Read sequencing technologies. The three older technologies
employed unique adapter constructs that were not interchangeable. Single Read samples could
not be sequenced on Paired End Read flow cells and vice versa. The Single Read format
operated as described in chapter 2, with the immobilized oligo sequenced from the top down.
The Paired End Read format sequenced the oligo from the top, down, and then from the bottom,
up. The multiplexed Paired End format utilized an index within Adapter 2. With TruSeq
technology, Single Read, multiplexed Single Read, Paired End Read, or multiplexed Paired End
Read formats use the same adapter constructs and flow cell chemistry. This allows greater
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flexibility in planning and executing sequencing runs. The full length TruSeq adapter sequences
and modified primer sequences for use with the adapter libraries are listed in Appendix 4. In the
adapter libraries, the last 18 bases of TruSeq Adapter 1 flank the 5’-terminus of the variable
region. The first 28 bases of TruSeq Adapter 2 flank the 3’-terminus of the variable region, with
bases 2 through 9 modified to include an internal index. Indicated in green in Figure 4.1 is the
eight base internal index that was designed to identify individual libraries. During a multiplexed
sequencing run, libraries of different lengths, i.e. m=15 vs. m=21, can easily be separated during
data processing in the event of a multiplexing error due to the six base difference. When the
difference in length is smaller, i.e. m=15 vs. m=17, separating the data can be more difficult. A
sequence of length m=16 could be either an m=15 library with single base insertion or a m=17
library with single base deletion. Without the internal index, it would be impossible to identify
the origin of said 16-mer and the sequence would necessarily be discarded. Of greater
importance is the need to differentiate DNA and 2’-OMe RNA libraries of the same length, as
well as fixed sequences used as controls in a number of experiments. By assigning a different
index to each library or fixed sequence, contaminating sequences can be eliminated from the data
set.

Workflow Summary
The adapter libraries are modified for sequencing using a two-step amplification scheme. The
amplification scheme was designed as a two-step process in order to achieve a cleaner product.
The quantity of recovered library is typically too low to quantify via UV absorbance, therefore
the required number of amplification cycles is unknown. In SELEX, aliquots of recovered library
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are often amplified with varied cycle numbers to determine the optimum number of cycles for
preparative PCR without nonspecific products.[164] Although this practice reduces the amount
of library in the recovered pool, the cyclic enrichment of SELEX eliminates the concern over
losing a fraction of the library. In AIA, it is critical to retain the entire recovered library because
high affinity sequences cannot be enriched in subsequent selection cycles. Following the first
amplification step, the library can be accurately quantified and the concentration of template can
be controlled for the second round of amplification. This would allow for a predetermined
number of amplification cycles in order to produce a predictable quantity and quality of product.
The products of each amplification step are illustrated in Figure 4.2 and all primer sequences are
listed in Appendix 4. The first primers are termed CAP1 and CAP2 for “capture” primers, used
to capture the surviving library molecules following partitioning. During amplification, the CAP
primers fill in the gap across from the library region while adding minimal length to the product:
15 bases to the 5’-termini and 6 bases to the 3’-termini which provide priming locations of
similar melting temperature for the second round of PCR. The final product for an m=15 adapter
library is 82 base-pairs in length. Following gel purification of the CAP amplification adapter
library, a second round of amplification with Primer 1 (P1) and Primer 2 (P2) adds two important
features. Indicated in purple and orange in Figure 4.2 are regions complementary to
oligonucleotides on the Illumina flow cell for bridge amplification. Primer 2 also adds an
additional six base index termed the “Illumina index,” the underlined portion of Adapter 2 in
Figure 4.2. Each Primer 2 is termed for the appropriate index (Primer 2.1, Primer 2.2, etc.) and
the sequences are taken directly from the Illumina TruSeq Adapter indices. This index allows
multiple samples of the same library (with identical internal eight base index) to be sequenced on
the same flow cell lane. A complete list of P2 Illumina Indices is found in Table 4.2. It was
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originally thought that using full length primers to achieve the final 137 base-pair product in one
step would be difficult due to the comparably small complementary regions between the primers
and adapter library. It was later found that a one-step amplification scheme using the full length
primers functions well. However, it was not pursued due to the results mentioned in future
sections.

In addition to the implementation of the TruSeq adapter format, a new sequencing system was
used for the experiments in this chapter. The Illumina MiSeq Personal Sequencer is a bench top
next-generation sequencer with faster sample prep, sequencing, and data analysis times than the
Illumina GAIIx. Compared to the eight lane flow cell of the GAIIx, the single lane flow cell of
the MiSeq requires fewer samples to financially justify a sequencing run. This is beneficial when
developing a new library design because sequence data can be analyzed for a single lane
(typically 1-12 samples) before valuable materials are used in filling an entire GAIIx flow cell
(typically 7-64 samples). This was a major obstacle during troubleshooting and experimental
sample preparation in chapters 2 and 3. It was often the case that data from a single experiment
was needed in order to dictate changes made to the subsequent experiments. However,
sequencing a single sample on a GAIIx flow cell was not financially responsible. Sequencing
fewer samples at a time would allow capitalization on the findings of previous experiments in a
more efficient manner. Prior to sequencing on the MiSeq, we attempted to modify the GAIIx to
function similarly to a MiSeq. With the assistance of Dr. Borer and Dr. Mark McPike, we
attempted to adjust the microfluidics and reagent volumes of the GAIIx to run the eight lanes
independently of each other. We installed eight individual valves on both the cluster station and
GAIIX that allowed for reagents to be directed to any number and combination of lanes. We
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were successful in reprogramming the automated clustering and sequencing programs to deliver
appropriate reagent volumes depending on the number of lanes in use. Although we were able to
cluster and sequence the lanes independently from one another, data produced from GAIIx runs
with fewer than eight lanes was unusable. The pump assemblies and reagent chemistry were
designed for use with all eight lanes and performed very poorly when used otherwise, producing
very low cluster densities. The project was abandoned in favor of using the Illumina MiSeq at
SUNY Upstate’s Microarray core facility, run by Frank Middleton, Ph.D. and Karen Gentile. \

Prior to sequencing, the precise quantity of amplifiable DNA was determined with the KAPA
Library Quantification kit on a BioRad iCycler. A 20 nM dilution was made from the final gel
purified product and used for qPCR quantification. If a sufficient quantity of amplifiable DNA
(5-20 nM in 10 µl) was confirmed by qPCR, the samples qualified for sequencing. Depending
on the kit version, the Illumina MiSeq requires 10 µl of 2 nM sample DNA or 5 µl of 4nM DNA.
Depending on the number of samples per sequencing run and starting concentration, the volume
of each sample varies in order to achieve equal representation of multiplexed samples. During
sequencing, data is streamed in real-time to Illumina’s cloud-based data storage and analysis
platform called BaseSpace. The data is parsed by BaseSpace using the Illumina Index added in
the second round of PCR. The Perl script was used to parse the data further, both by Internal
Index and library length. The adapter library does not contain a “head” region to facilitate
parsing of the data, so qualifications were based only on the quality of the internal index found in
Adapter 2 and length of the variable region. A 10 base sequence was added to the raw data files
to function as the “head” in order for the Perl script to function properly, but had no impact on
the determination of good, candidate or bad reads. Multiplexed TruSeq Single Read and
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multiplexed TruSeq Paired End Read formats were used in data analysis in this chapter. Figure
4.3 illustrates the functionality of the Read 1 Primer, Read 2 Primer, and Index Read Primers.
The TruSeq Single Read format reads only in the 5’  3’ (termed Read 1) direction while the
TruSeq Paired End Read format reads in both the 5’  3’ direction (Read 1) and the 3’  5’
direction (termed Read 2). The data output for Read 1 contains the library, Internal Index, and
Adapter 2 of the parent strand, respectively. The Sequencing Primer for Read 1 is
complementary to the complement strand. During sequencing, fluorescence data for incorporated
bases is captured, thus the data output is of the parent strand. The data output from Read 2
contains the Internal Index, library and Adapter 1 of the complement strand, respectively. When
using Illumina Indices, the Index Read data output contains only the Illumina Index, read 5’ 
3’ of the parent strand. The Read 1 data is associated with the Index Read data via cluster
coordinates on the flow cell. Read 2 is associated with Read 1 data in the same manner.

Simulated Partitioning
To determine optimal PCR conditions for a partitioning experiment, simulated conditions using
very dilute concentrations of the m=15 DNA adapter library were PCR amplified with
CAP1/CAP2 primers. PCR reactions containing between 1 pmol and 1 fmol of library were
amplified in a gradient of cycle numbers in order to identify any nonspecific products. Following
a partitioning step, the concentration of surviving library molecules is too small to quantify via
UV absorbance and varies per experiment. Therefore, is it impossible to know how many PCR
cycles are required for sufficient amplification and if/when nonspecific products would amplify.
Primer concentration, annealing temperature, and salt concentration were also varied. It was
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found that after a certain number of amplification cycles, depending on initial concentration, the
product shifts to a larger size. Dilute concentrations of the CAP1/CAP2 PCR products were
amplified with P1/P2 under similar conditions and two different size products were also
apparent. These bands were characterized by high throughput sequencing on the Illumina MiSeq.

Two-Step amplification and characterization of dual PCR products
To simulate partitioning, a serial dilution series from 1 pmol to 1 fmol of DNA library was
amplified using CAP1 and CAP2 primers. DNA libraries were PCR amplified using Paq5000
DNA polymerase Master Mix (Agilent Technologies): 10 µl 2X Master mix, 8 µl library, 1 µl 4
µM CAP1, 1 µl 4 µM CAP2 with the following conditions.
Denature
Variable # of Cycles

Final Extension

95 ⁰C
95 ⁰C
60 ⁰C
72 ⁰C
72 ⁰C

2 min.
30 sec.
30 sec.
30 sec.
10 min.

Following the first experiment to evaluate the amplification of the m=15 DNA adapter library, it
was found that a second PCR product of greater size appears at increased cycle number, as
illustrated in Figure 4.4. The appearance is gradual, but over 4-6 cycles the product size
completely shifts from a visual 80 base-pairs to 90 base-pairs (expected is 82 base-pairs). These
bands have been termed “bottom” and “top”. In order to achieve maximum resolution of the two
bands, 4% TAE agarose gels made from 3% NuSieve GTG agarose and 1% standard high melt
agarose were implemented. NuSieve GTG Agarose (Lonza) is a high purity and low melting
agarose that finely resolves to 10 base-pairs. The product bands were excised from the gel with a
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4.0 mm by 1.0 mm disposable gel excision tip (GeneCatcher) to ensure minimal risk of crosscontamination between gel lanes. The product was extracted with the MiniElute Gel Extraction
Kit (Qiagen), eluted in 10 µl dH2O, and quantified via UV absorbance on the Synergy 2
Microplate spectrophotometer (BioTek).

The second round of amplification used Primer 1, indexed Primer 2 and 0.1 pmol of the gel
purified CAP PCR product. The 0.1 pmol concentration was determined from a dilution series of
starting concentrations that indicated 0.1 pmol as suitable for the range of desired amplification
cycles. With template concentrations above 1.0 pmol, amplification was inhibited by the large
concentration of template. The product was PCR amplified using Paq5000 DNA polymerase
Master Mix (Agilent Technologies): 10 µl 2X Master mix, 8 µl gel purified product, 1 µl 4 µM
P1, 1 µl 4 µM P2.X.
Denature
Varied # of Cycles

Final Extension

95 ⁰C
95 ⁰C
65 ⁰C
72 ⁰C
72 ⁰C

2 min.
30 sec.
30 sec.
30 sec.
10 min.

Similarly to the CAP PCR product, a second product appears with increased cycle number. The
product shifts from a visual 135 base-pairs to approximately 150 base-pairs (137 bp expected)
over the course of 4-6 cycles. Figure 4.5 illustrates the amplification of a gel purified bottom
band CAP PCR product with P1/P2 Primers. Additional experiments determined that both the
bottom and top bands from the CAP PCR products produce both the bottom and top bands in
P1/P2 PCR. These four bands have been termed “bottom-bottom” (for a bottom P1/P2 product
produced from a bottom CAP product), “bottom-top,” “top-bottom,” and “top-top,” respectfully.
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It was found that DNA and 2’-OMe RNA/DNA chimera libraries of any length variable region
produce both bands in CAP and P1/P2 PCR.

From initial experiments to test the PCR amplification of the DNA adapter libraries, it was found
that the number of cycles needed to amplify enough product to visualize varies. At 0.1 pmol of
starting product, the bottom band is visible at six cycles and the top band is visible at twelve
cycles. The shift is gradual, with both bands visible at cycles eight to ten during some 0.1 pmol
amplification experiments. Regardless of when the bottom band becomes visible (not until 24
cycles for 1 fmol, etc.), the shift always occurs gradually over a period of four to six cycles. This
is true for both the DNA and 2’-OMe RNA/DNA chimera libraries.

It was initially believed that the top band was a nonspecific product and experimental conditions
were altered in an attempt to prevent the formation of two different products. The primer
concentration for the aforementioned experiments is 0.2 µM. It was found that reducing the
primer concentration delays the formation of the top band, but does not eliminate it. Also,
altering the Mg2+ or KCl concentration in an attempt to influence amplification specificity did
not eliminate the top band, but increasing the concentrations caused the top band to be produced
faster. The length of the CAP1 and CAP2 primers was also varied in an attempt to produce a
single band. The CAP1 primer adds an additional fifteen bases to the 5’-terminus of the library
and CAP2 primer adds an additional six bases to the 3’-terminus. Shorter versions of each primer
that did not add any additional bases (completely complementary to the library adapters) were
tested in all combinations with the longer versions. Sequences can be found in Appendix 4. It
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was found that no combination of short/long CAP1 and short/long CAP2 produced a single PCR
product. In an attempt to determine the source of the second band, the fixed TBA scrambled
sequence, dGGTGGTTGTTGTGGT (termed TBAsc), with the adapter constructs was amplified
with CAP primers. Over a gradient of cycle numbers, the TBAsc product was a single band of
similar size to the bottom band. From this, it was determined that the dual PCR products were a
result of the variable library region. Also supportive of this hypothesis is the fact that the size
difference between the bottom and top bands increases with an increase in library size; for an
m=15 library the difference is approximately ten base-pairs and for an m=40 library, the
difference is larger at approximately 25 base-pairs. The annealing temperature was also varied in
an attempt to eliminate the second PCR product. A temperature gradient from 50⁰C to 72⁰C was
used with no change in product formation.

In order to characterize the difference between the bottom and top bands, melt curve analysis
was used. A 0.1 fmol starting quantity of m=15 DNA adapter library was amplified using the
SYBR Select Master Mix (Life Technologies) and CAP primers with a gradient of cycle
numbers. The 0.1 fmol starting quantity was selected from a dilution series used to determine the
optimal quantity for visualization with SYBR Select Master Mix. Samples were pulled from the
thermocycler at even cycle numbers from 2-30 cycles during the following protocol:
UDG Activation
Polymerase, UP Activation
Variable Cycle # of

50⁰C 2min.
95⁰C 2 min.
95⁰C 15 sec.
60⁰C 1 min.

The samples were replaced and melt curve data was collected over a gradient of 95°C to 50°C at
a rate of 0.5 °C per 30 seconds. The dissociation curves of the product from cycle numbers 18,
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20, 22, and 24 are shown in Figure 4.6. The samples were then analyzed on a 4% TAE agarose
gel to visualize the association between band size and melting temperature as shown in Figure
4.7. Based on the gel analysis, it can be concluded that the product in the bottom band has a
melting temperature of 82°C and the product in the top band has a melting temperature of 76°C.
The gradual shift in product size seen on the gel correlates with the gradual change in melting
temperature seen in Figure 4.6. The average melting temperature of the CAP PCR product was
calculated as 78°C under the SYBR Select reaction conditions, which does not correlate with
either band. The dissociation curves of specific products versus primer dimers are similar to
those of the top and bottom bands observed in CAP and P1/P2 PCR. However, it is unlikely that
primer-dimers are responsible for the shift in product size. Primer-dimers are typically shorter
than the desired product and are amplified in addition to the desired product. If the bottom bands
were primer-dimers, they would not disappear with increased cycle number and would not have
a higher melting temperature. Although primer-dimers compete for PCR reagents, if the bottom
band was the desired product, it would not disappear with the amplification of primer-dimers
with increased cycle number. Although primer-dimers are not responsible for the shift in band
size, identifying the cause of differing melting temperatures was important to ensure that the
correct product was sequenced. If the majority of the quantifiable product was PCR artifacts, a
lesser percentage of the desired product would be sequenced, decreasing the sequence space. A
requirement for the success of AIA is deep sequencing, so determining the nature of the dual
products was critical.

In order to determine any structural differences in the bottom and top bands, an m=15 DNA
library was prepared in a simulated partitioning for sequencing. The four band combinations
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were sequenced: bottom-bottom, bottom-top, top-bottom, and top-top. A quantity of 0.1 pmol of
adapter library was PCR amplified using CAP1 and CAP2 primers following the above protocol.
Individual PCR reactions were amplified is a gradient of cycles numbers (10, 12, 14, 16, 18, 20,
22, 24 cycles). The bottom band was gel excised for 10 cycles and the top band excised for 24
cycles. The bands were quantified via UV absorbance and 0.1 pmol was amplified using P1 and
indexed P2. Each CAP product was amplified in a gradient of cycle numbers in order to generate
both the bottom and top bands (8, 10, 12, 14, 16 cycles). In order to distinguish the four types of
bands, two sets of PCR reactions per CAP product band were made, each with a different
Illumina Index. The four combinations were indexed as followed:
Bottom-Bottom
Bottom-Top
Top-Bottom
Top-Top

Illumina Index 4
Illumina Index 3
Illumina Index 2
Illumina Index 1

The four products were sequenced using a TruSeq Single Read format and run on an Illumina
MiSeq in a 1:1:1:1 ratio as determined by qPCR. A 10 µl volume of 2 nM DNA was prepared.
The sequence data was parsed based on the assigned Illumina Indices and run statistics are
presented in Table 4.3. Good reads were identified by qualifying the length of the variable
region and first 5 bases of Adapter 2, which includes a single dA and the first four bases of the
internal index. The average percentage of good reads per total reads was approximately 85%,
indicating relatively high quality data. There is no significant variation in the percentage of good
reads for each band type, with a ratio of 1.054:1.020:1.026:1. This indicates that the sequencing
primer binding region, the last 32 bases of Adapter 1 (see Figure 4.3), is intact for each of the
four band types. From the limitations of a Single Read reagent kit, the samples were sequenced
50 bases from the end of Adapter 1 and include the entire library region (m=15), the internal
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index and a portion of Adapter 2 (26 bases). The raw data for each of the four band types
contains the correct sequence arrangement, in the expected order. Figure 4.8 shows a snapshot
of the raw data from the bottom-bottom band. Minor sequence errors are visible in the form of
deletions that shift the correct sequence. These types of errors are present in all four data files
and typically account for the sequences other than “good reads”. Although the data quality was
similar for all four bands, the quantity of data is dominated by the bottom-bottom sequences
(higher total reads). This indicates either inaccurate qPCR calculations and/or a higher
percentage of successful bridge amplification for the bottom-bottom sample. If the bottom-top,
top-bottom, and top-top samples contain some sequence anomalies that were quantified with
qPCR, but failed bridge amplification on the flow cell, it would explain the higher number of
total reads for the bottom-bottom samples.

Data from the Single Read run did not provide any explanation for the apparent difference in size
of the two bands. The 50 cycle read only provided the sequence arrangement of the library
region and a portion of Adapter 2. It was possible that a structural difference contributing to the
size and melting temperature difference was present in the Adapter 1 region or farther into
Adapter 2. For this reason, a Paired End run with reagent kit capable of sequencing the entire
137 base product was used to sequence the four bands. The sample preparation was repeated due
to low sample volume of the first set of experiments. The samples were prepared in a similar
manner, with the following associated Illumina Indices:
Bottom-Bottom
Bottom-Top
Top-Bottom
Top-Top

Illumina Index 1
Illumina Index 2
Illumina Index 3
Illumina Index 4
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The reversal of associated Illumina Index is of no consequence. The products were sequenced
using the Paired End Read format (Illumina MiSeq with a TruSeq kit) in a 1:1:1:1 ratio as
determined by qPCR. A 5 µl volume of 4 nM DNA was prepared.

The sequence dataset was parsed based on the assigned Illumina Indices and run statistics are
presented in Table 4.4. Good reads were identified by qualifying the length of the variable
region and first 5 bases of Adapter 2, which includes a single dA and the first four bases of the
internal index. For Read 1, there is no significant variation in the percentage of good reads. The
Read 1 raw data for all four bands contains the library region (m=15), internal index, entire
Adapter 2 (55 bases), and 5 bases into the oligo-T lawn for a total of 84 bases. There is no
apparent difference in sequence arrangement for each band, indicating that the quality of
reported data is equivalent. For Read 2, there is no significant variation in the percentage of good
reads. The Read 2 raw data should contain the internal index, library region (m=15), entire
Adapter 1 (58 bases), and 5 bases into the oligo-T lawn for a total of 87 bases. The Read 2 data
for all four bands contains the correct sequence arrangement, in the expected order, again
indicating that the quality of reported data is equivalent for all bands. Figure 4.9 shows a sample
of the raw data from the Read 1 and Read 2 bottom-bottom band. Minor sequence errors are
visible in the form of deletions that shift the correct sequence. These types of errors are present
in all four data files and account for the sequences other than “good reads.” Similarly to the
Single Read run data, the total reads for R1 and R2 are dominated by the bottom-bottom band
sequences. According to qPCR quantification, the four samples were sequenced in equal
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concentrations. For such a disparity between total read numbers, a 2.56:1.54:1.00:1.38 ratio, a
data quality issue that cannot be visualized by high throughput sequencing must be occurring.

Based on the Paired End sequencing data from the four bands, it was determined that the shift in
product size was a result of the formation of heteroduplex DNA. For the first few rounds of PCR,
the correct size product is amplified. After the first several rounds of PCR, primer concentration
begins to deplete. Once the primer concentration has depleted significantly, amplification is
saturated and the full length single-stranded fragments are no longer amplified to the double
stranded product. Instead, the full length single-stranded fragments simply anneal, denature and
reanneal to each other during each amplification cycle. The highly randomized nature of the
library region prevents the single-stranded fragments from finding their complements in solution
while the highly conserved adapter regions allow the fragments to improperly anneal. After a
certain threshold cycle number, the product will be composed solely of this partially doublestranded heteroduplex DNA. The heteroduplex DNA migrates slower than perfectly annealed
DNA during gel electrophoresis.[165] This was observed during gel purification of the CAP and
P1/P2 PCR products. This explanation was validated by the melt curve analysis; the top band
was determined to have a lower melting temperature than the bottom band, which is consistent
with the partially single-stranded nature of the heteroduplex DNA of the top band.

The formation of heteroduplexes is common in the amplification of highly complex mixtures of
genomic DNA.[165] However, this is not a concern when quantifying libraries via qPCR
because the method involves complete denaturation of heteroduplex DNA and amplification of
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only

perfectly

complementary

double-stranded

products

during

the

log

phase

of

amplification.[158] This also indicates that heteroduplex DNA should not affect sequencing
because the product is denatured to single-stranded DNA prior to clustering and still contains the
proper library sequence. Additionally, it has been shown that amplifying beyond the log phase
and into the plateau phase does not introduce any biases.[166] Although this behavior should not
impact the quality of qPCR or sequencing data, the quantity of total reads for the bottom-bottom
band was highest for both the Single Read and Paired End Read runs. From the data, it was
concluded that the four bands could be sequenced and the results would include the correct
sequence arrangement. Any aptamer candidates found from an AIA partitioning would likely be
at high enough counts to be identified using any of the four products bands. However,
considering the superior performance of the bottom-bottom band, controlling the amplification in
order to collect the higher quality bottom band in both CAP and P1/P2 PCR was ideal.

Preliminary experiments monitoring the amplification of a DNA or 2’-OMe RNA/DNA chimera
library in real-time indicated that it would be possible to control the formation of the top band.
The option of a single step amplification scheme using P1 and P2 was considered for this
application in order to further simplify the AIA protocol. The P1/P2 primers were used to
amplify 0.1 pmol, 0.1 fmol, and 0.1 amol of m=15 DNA adapter library using Paq5000 DNA
polymerase Master Mix (Agilent): 10µl 2X Master Mix, 8µl library, 1µl 4 µM P1, 1µl 4 µM
P2.1.
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Denature
18 Cycles of

Final Extension

95 ⁰C
95 ⁰C
65 ⁰C
72 ⁰C
72 ⁰C

2 min.
30 sec.
30 sec.
30 sec.
10 min.

Once it was determined that the adapter library was successfully amplified with P1/P2 in single
step amplification, the SYBR Select Master Mix (Applied Biosystems, Life Technologies) and a
SYBR Green One-Step qRT-PCR Kit (SuperScript III Platinum, Invitrogen, Life Technologies)
were used to monitor amplification in real time. A benefit of the two step amplification scheme
was to control the amount of template in P1/P2 PCR in order to achieve a sufficient quantity of
product for qPCR and sequencing without over-amplifying, causing the formation of
heteroduplex DNA. Following partitioning, the quantity of surviving library is unknown and too
small to quantify by UV absorbance. By monitoring the one-step amplification of the library
with P1/P2 in real time, the number of PCR cycles can be controlled on an individual reaction
basis. Amplification can be ended early to avoid the formation of heteroduplex DNA or PCR
champions, or extended if needed. The procedure was first tested with CAP1 and CAP2 primers
for simplicity and to reserve the more costly indexed P2 primers. A dilution series of the m=15
DNA adapter library from 100 fmol to 100 zmol was amplified with the SYBR Select Master
Mix using the following conditions: 10 µl 2X Master mix, 8 µl library, 1 µl 4 µM CAP1, 1 µl 4
µM CAP2.
UDG Activation
Polymerase, UP Activation
Variable Cycle # of

50 ⁰C
95⁰C
95⁰C
60⁰C
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2min.
2 min.
15 sec.
1 min.

A dilution series of the adapter library using m=15 chimeric 2’-OMe RNA/DNA covering 100
fmol to 100 zmol was amplified with the SYBR Green One-Step qRT-PCR Kit (SuperScript III
Platinum) using the following conditions: 10 µl 2X Master mix, 7.5 µl library, 1 µl 4 µM CAP1,
1 µl 4 µM CAP2, 0.5 µl enzyme.
cDNA Synthesis
Polymerase, UP Activation
Variable Cycle # of

50 ⁰C
95⁰C
95⁰C
60 ⁰C

3 min.
5 min.
15 sec.
1 min.

All samples were run in duplicate. Amplification was ended for the first of each sample when the
amplification curve had visually begun to increase and was still exponential. Amplification of the
second sample was ended once the curve had plateaued. Both samples were characterized with
melt curve analysis from 96°C to 50°C with a gradient of 0.5°C per 30 seconds. Once saturation
has been reached (curve plateaus), heteroduplex DNA has formed. By monitoring amplification
in real-time, it can be ended at a predetermined intensity, void of heteroduplex DNA.
Preliminary experiments using this method indicated that it would be possible to monitor sample
amplification on an individual basis to obtain the desired product, in this case, the bottom band
only. Samples removed when the amplification curve was still exponential produced the desired
product; samples removed once the amplification curve had plateaued produced heteroduplex
DNA. This method would be beneficial for AIA partitioning with a single step amplification
scheme because the quantity of surviving library from a partitioning step is too low to accurately
quantify and differs for each experiment. The ability to monitor amplification and end the
protocol prior to heteroduplex product formation would be useful. However, based on results
from AIA for thrombin presented in next section, the adapter libraries and the one-step
amplification were not pursued further.
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AIA for Thrombin
To gauge the functionality of adapter libraries in AIA, they were screened against thrombin
using agarose-Concanavalin-A beads. Both m=15 DNA and m=15 2’-OMe RNA/DNA chimera
libraries were screened in various ratios. Many previous attempts to PCR amplify the surviving
library molecules from bead-based partitioning required trial and error to amplify enough
product to visualize. It was found that even experimentally identical partitioning produced highly
variable quantities of surviving library. However, when an adequate amount of product could be
detected with qPCR, multiple thrombin screens were successfully prepared and sequenced on the
Illumina MiSeq.

Experimental methods
Partitioning of the m=15 DNA adapter library was performed using agarose-Concanavalin-A
beads (GE Healthcare Life Sciences) at room temperature. The Con-A beads contained in spin
columns were pre-equilibrated in partitioning buffer (20 mM Tris-HCl, 140 mM NaCl, 5 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) by three wash cycles. The following represents a 1:1
library: protein screen. A 100 pmol aliquot of glycosylated human α-thrombin (Haematologic
Technologies) in 750 µl partitioning buffer was immobilized on 100 µl of pre-equilibrated ConA beads during a 30 minute incubation with end-over-end rotation at 25 rpm. Unbound thrombin
was removed by centrifugation. A 100 pmol aliquot of m=15 DNA adapter library in 750 µl
partitioning buffer was applied to the immobilized thrombin. Following one hour incubation with
end-over-end rotation at 25 rpm, the unbound DNA was removed by centrifugation. Three wash
cycles (5 minutes, rotation at 25 rpm) with 750 µl partitioning buffer ensured thorough removal
of unbound DNA. Thrombin-DNA complexes were eluted from the Con-A beads with 200 µl
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elution buffer (α-methyl mannoside, Glycoprotein Isolation Kit, Pierce Biotechnology) during a
5 minute incubation, rotation at 25 rpm. The m=15 DNA and 2’-OMe RNA/DNA chimera
libraries were screened at ratios of 60:1, 10:1, 1:1 and 1:10 protein: library, with the library
quantity maintained at 100 pmol. Based on qPCR data, the following m=15 DNA library:
thrombin ratios were sequenced on the Illumina MiSeq: 60:1 (6 nmol thrombin: 100 pmol
library) and 1:1 (100 pmol thrombin: 100 pmol library). The following m=15 2’-OMe
RNA/DNA chimera library: thrombin ratios were sequenced on the Illumina MiSeq; 60:1 (6
nmol thrombin: 100 pmol library) and 1:1 (100 pmol protein: 100 pmol library).

Phenol extraction was used to recover the partitioned DNA and 2’-OMe RNA/DNA chimera
libraries. An equal volume of Tris-buffered, pH 8.0, 0.1mM EDTA, 50% phenol, 48%
chloroform, 2% isoamyl alcohol (Sigma Aldrich) was added and vortexed for 30 seconds. After
centrifugation at 13,000 rpm for 5 minutes the aqueous layer (top) was removed and extracted
twice with equal volumes 100% chloroform. The library was then purified by ethanol
precipitation. One tenth the volume (20 µl) of 3M sodium acetate and three times the volume
(600 µl) of cold ethanol and were added to the library and mixed briefly. Following a minimum
12 hour incubation at -20 °C, centrifugation at 13,000 rpm for 30 minutes resulted in a library
pellet. After decanting the liquid, the pellet was washed with 1 ml 70% ethanol. Centrifugation at
13,000 rpm for 10 minutes resulted in a library pellet. The pellet was air dried at room
temperature in a PCR hood, and then resuspended in dH2O.

124

The recovered library was amplified using CAP1 and CAP2 primers. DNA libraries were PCR
amplified using Paq5000 DNA polymerase Master Mix (Agilent Technologies): 10 µl 2X Master
Mix, 8 µl resuspended library, 1 µl 4µM CAP1, 1 µl 4µM CAP2.
Denature
18 Cycles of

Final Extension

95 ⁰C
95 ⁰C
60 ⁰C
72 ⁰C
72 ⁰C

2 min.
30 sec.
30 sec.
30 sec.
10 min.

It was determined that 18 cycles was sufficient for the majority of partitioning samples to
visualize a product and quantify via UV absorbance. The 2’-OMe RNA/DNA chimera libraries
were RT-PCR amplified using the One-Step RT-PCR System with Platinum Taq DNA
polymerase (SuperScript, Invitrogen): 10 µl 2X Master Mix, 7.5 µl resuspended library, 1 µl 4
µM CAP2, 0.5 µl RT/Platinum Taq HiFi Mix.
cDNA Synthesis
Pre-denaturation

50 ⁰C 15 min.
94 ⁰C 2 min.

Addition of 1 µl 4 µM CAP1.
Denature
18 Cycles of

Final Extension

94 ⁰C
94 ⁰C
60 ⁰C
68 ⁰C
72 ⁰C

30 sec.
30 sec.
30 sec.
30 sec.
30 sec.

The 82 base-pair PCR product (whether present as bottom, top, or both, depending on the
experiment) was purified by a 4% TAE agarose gel. Excision of the product band from the gel
with a 4.0 mm by 1.0 mm disposable gel excision tip (GeneCatcher) ensured minimal risk of
cross-contamination between gel lanes. The product was extracted from the gel with the
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MiniElute Gel Extraction Kit (Qiagen), eluted in 10 µl dH2O, and quantified via UV absorbance
on the Synergy 2 Microplate spectrophotometer (BioTek).

The second round of amplification used P1 and indexed P2 and 0.1 pmol of the gel purified CAP
PCR product. The product was PCR amplified using Paq5000 DNA polymerase Master Mix
(Agilent Technologies): 10 µl 2X Master Mix, 8 µl gel purified product, 1 µl 4µM P1, 1 µl 4µM
P2.X.
Denature
Variable Cycle # of

Final Extension

95 ⁰C
95 ⁰C
65 ⁰C
72 ⁰C
72 ⁰C

2 min.
30 sec.
30 sec.
30 sec.
10 min.

The 137 base-pair product (whether present as bottom, top, or both, depending on experiment)
was gel purified as described above.

During each experiment, a control reaction was used as a size marker in the event that the
experimental sample was too dilute to be visualized. A 0.1 pmol aliquot of a size appropriate
DNA library, 2’-OMe RNA/DNA chimera library, or fixed sequence was amplified under
identical conditions. With 0.1 pmol starting library or CAP PCR product, 18 cycles produced the
top band size marker, while controls amplified at six to ten cycles produced the bottom band.
These controls help identify which band is present more accurately than comparison with a DNA
ladder, as the starting library concentration for CAP PCR is typically too low to be accurately
quantified. If a fixed sequence was used (e.g. TBAsc), the bottom band was produced regardless
of cycle number.
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Results and data analysis
The results from five successfully prepared partitioning experiments were sequenced on the
Illumina MiSeq. The experiments qualified as successful based on qPCR results. At least 5 nM
(in 2 µl – 10 µl volumes) was sufficient for a MiSeq run. The first experiment was a 60:1 ratio of
6 nmol thrombin: 100 pmol DNA adapter library that was sequenced simultaneously with the
Single Read run mentioned in the previous section. The goal was to sequence the bottom and top
bands from a partitioning experiment and observe any difference in distribution of aptamer
candidates. Following 18 cycles of CAP PCR, the bottom band was gel purified and quantified.
Both the bottom and top bands from P1/P2 PCR were selected from five PCR reactions using 0.1
pmol of the CAP product each. The five PCR reactions were performed in duplicate with P2.5
and P2.6 in order to index the bottom and top bands as shown in Figure 4.10. A summary of
sequence data is presented in Table 4.5. For both bands, the highest frequency sequences are
variations of TBAsc, dGGTGGTTGTTGTGGT. This fixed sequence was used as a size marker
during the CAP PCR step and has a different Internal Index than the m=15 DNA library. The raw
data revealed that these sequences contained the Internal Index 1, ACACAGCA, the index
associated with TBAsc. The high number of bad reads associated with each sample is attributed
to this contamination. The Perl script identifies good read based on the first four bases of the
Internal Index, thus qualifying the majority of the contaminating sequences as bad reads. The
few TBAsc sequences that qualified as good reads and were counted in the nmer file had
sequence mismatches in the Internal Index, qualifying them as good reads. The desired TBA
sequence with the correct Internal Index 15, dATGCCTGG, was not found in either sample,
indicating that the partitioning of the m=15 DNA library against thrombin was not successful in
identifying TBA from the library pool. Due to contamination, the experiment was repeated but
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with an unpartitioned library in place of TBAsc as the size marker. The following experiments
were prepared without regard to the top and bottom band based results from the previous section.

The next four thrombin partitioning experiments were sequenced on a multiplexed Paired End
run, including 60:1 (6 nmol thrombin: 100 pmol library :) and 1:1 (100 pmol thrombin: 100 pmol
library) ratios for both the m=15 DNA and m=15 2’-OMe RNA/DNA chimera libraries.
Following partitioning, 18 cycles of PCR with CAP primers resulted in the bottom band for all
four experiments. Following quantification, 0.1 pmol of each was amplified using a single
indexed P1/P2 PCR reaction. The resulting products from 18 cycles were the top band for all
four experiments. Table 4.6 contains a summary of relevant sequencing statistics.

After parsing the data based on library region length and quality of the internal index, it was
apparent that an error in the 2’-OMe samples had occurred. The expected Internal Index 8 was
not found at any significant counts in the 2’-OMe samples. Instead, the expected Internal Index
of the DNA library, Index 15, was found to dominate the data. It is clear from the results that
either the m=15 2’-OMe library was synthesized with the incorrect Internal Index or the incorrect
library was used during partitioning. The library was not synthesized by IDT, but in-house by Dr.
Mark McPike on the ABI 394 synthesizer, making it possible for an error in sequence input. If it
were an issue of contamination during PCR and gel purification, it would be expected that the
Internal Index 8 would be found at some significant frequency. It would be possible to identify
the Internal Index of the library by Sanger sequencing. However, the results from the four
experiments do not necessitate any further action with the libraries. In all four experiments, the
thrombin binding aptamer was not identified from the library pool. Regardless of whether the 2’-
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OMe library contains the incorrect Internal Index or if the DNA library was actually used, the
TBA sequence is still expected for a successful partitioning.

Conclusions
Of the five adapter library for thrombin partitioning that were sequenced, none were successful
at identifying TBA from the library pool. The partitioning method was successful in identifying
TBA using the hairpin ligation libraries, both DNA and 2’-OMe. As demonstrated in chapters 2
and 3, if the TBA quadruplex structure was made available for binding by the construct of the
library, it is highly likely that the sequence would be recovered using Concanavalin-A beads as
an immobilization method. Therefore, it is likely that the adapter constructs inhibit aptamer
discovery for short libraries such as m=15. The basic structure of the adapter library is not
unusual for aptamer selection and has significant success in SELEX for both DNA and RNA
aptamers using various partitioning methods. Unlike the long libraries typically used in SELEX,
the adapter constructs of the AIA adapter libraries used in this chapter constitutes the majority of
the library size. It is hypothesized that this interferes with selection of the variable region. Even
if the adapter constructs influence aptamer selection in SELEX, multiple rounds of enrichment
and selection may allow SELEX to overcome this obstacle whereas the selection is simply not
stringent enough for a single round in AIA. It is possible that redesigning the adapter libraries
with shorter adapters, variations in adapter sequence, or with no internal indices could improve
the performance of the libraries. However, the adapter libraries were not pursued further in AIA
in favor of exploring the new library structures described in chapter 5.
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Figure 4.1 Sequence arrangement for an “adapter library.”
Library region denoted by “m.” Eight base internal index in green. The m=15 DNA library
contains Internal Index 15, sequence dATGCCTGG. The m=15 2’-OMe RNA/DNA chimera
library contains Internal Index 8, sequence dAGCTAACG. See Table 4.1 for full list of internal
Index sequences. 

Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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Figure 4.2 Adapter library amplification products
(A) Single-stranded m=15 DNA adapter library. Eight base internal index in green. (B) 82 basepair CAP1/CAP2 PCR product. Regions in blue are added by CAP1 and CAP 2 primers. (C) 137
base-pair P1/P2 PCR product. Regions in red are added by P1 and P2 primers. Six base Illumina
index is underlined. (D.) Immobilized oligos on Illumina flow cell, priming regions in purple and
orange. (E.) In orange, region of the parent strand necessary for hybridization to the flow cell
and complementary to the orange strand in D. In purple, region of the complement strand
necessary for hybridization to the flow cell and complementary to the purple stand in D. 



Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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Figure 4.3 Priming locations for Read 1, Read 2 and Index Read
Coordinating colors indicate complementarity. Arrows indicate directionality of Sequencing by
Synthesis (SBS). (A) Read 1 using Sequencing Primer. The primer sits complementary to
Adapter 1 of the complement strand. SBS proceeds across the library, Internal Index and Adapter
2 regions of the complement strand. Data output is the library, Internal index and Adapter 2
region of the parent strand, respectively. (B) Read 2 using Custom Read 2 Primer. The primer
sits complementary to the Adapter 2 of the parent strand. SBS proceeds across the Internal Index,
library and Adapter 1 of the parent strand. Data output is the Internal index, library and Adapter
1 of the complement strand, respectively. Read 2 data represents the reverse complement of the
parent strand. (C) Index Read using Custom Index Read Primer. The primer sits complementary
to Adapter 2 of the complement strand. SBS proceeds across the Illumina Index of the
complement strand. Data output is the Illumina Index of the parent strand. 



Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
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Figure 4.4 CAP1/CAP2, dual PCR products
4% TAE agarose gel. Lanes 1 and 11: 25 bp DNA ladder. Lanes 2-10: 0.1 pmol starting quantity
of template, PCR cycles 6, 8, 10, 12, 14, 16, 18, 20, and 22, respectively. (A) CAP PCR
“Bottom” band for 10 cycles, ~80 base-pairs (B) CAP PCR “Top” band for 14 cycles, ~90 basepairs.
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Figure 4.5. P1/P1, dual PCR products
4% TAE agarose gel. Lane 1: 25 bp DNA ladder. Lanes 2-10: PCR cycles 10, 12, 14, 16, 18, 20,
22, 24, 26, respectively, of 0.1 pmol gel purified bottom band, CAP PCR product (A) P1/P2 PCR
“Bottom-Bottom” band for 10 cycles, ~135 base-pairs (B) P1/P2 PCR “Bottom-Top Band” for
14 cycles, ~150 base-pairs.
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Figure 4.6 Melting temperature analysis of dual PCR products
Dissociation curves for 0.1 fmol of m=15 DNA adapter library at amplification cycles 18, 20, 22,
and 24. The melting temperature for 18 cycles is approximately 82°C. The melting temperature
for the majority of the 20 cycle product is 82°C, with a smaller portion with melting temperature
of 76 °C. The melting temperature for the majority of the 22 cycle product is 76°C, with a
smaller portion with melting temperature of 82°C. The melting temperature for 24 cycles is
approximately 76°C.
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Figure 4.7 Melting temperature and size comparison of dual PCR products
4% TAE agarose gel. Lanes 1 and 14: 25 bp DNA ladder. Lanes 2-13: Even cycle numbers 8-30,
respectively. (A) 18 cycles, bottom band. (B) 20 cycles, bottom and top band. (C.) 22 cycles, top
band. (D.) 24 cycles, top band.
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Figure 4.8 Read 1 raw data: Single Read band characterization
Snapshot of Read 1 raw data from the bottom-bottom band. Read 5’  3’ of the parent strand:
m=15 library, eight base Internal Index, 26 bases of Adapter 2. 
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Figure 4.9 Read 1 and Read 2 raw data: Paired End band characterization
Snapshot of Read 1 and Read 2 sequencing data (A) Read 1 raw data from the bottom-bottom
band. Read 5’  3’ of the parent strand: m=15 library, eight base Internal Index, 55 bases of
Adapter 2, and 5 bases into the oligo-T lawn. (B) Read 2 raw data from the bottom-bottom band.
Read 3’ 5’ of the complement strand: Internal Index, m=15 library, 58 bases of Adapter 1, and
5 bases into the oligo-T lawn.
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Figure 4.10 P1/P2, dual PCR products: AIA for thrombin, 60:1 ratio
4% TAE agarose gel. Lane 12: 25 bp DNA ladder. Lanes 1-5: Cycles 8 – 16, respectively,
P1/P2.5. Lane 6: blank. Lanes 7-11: Cycles 8-16, respectively, P1/P2.6. (A) Top band gel
extracted for qPCR. Contains Illumina Index 5. (B.) Bottom band gel extracted for qPCR.
Contains Illumina Index 6.
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Table 4.1. List of adapter library eight base internal indices
Internal Library Index
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Sequence
ACACAGCA
ACAGTGCT
ACCGTAGC
ACGTCAAC
ACGTTGCC
ACTTAGCG
AGCAACAT
AGCTAACG
AGGCATCT
AGTAGCAT
AGTCAGTC
ATAGCGAC
ATAGTTGC
ATGCACGT
ATGCCTGG
ATGTCACT

Eight base internal indices are numbered 1 through 16. Sequences were designed by Dr. Damian
Allis with minimum overlap for ease of de-multiplexing.
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Table 4.2 List of Illumina Indices and associated P2 Primers.
Illumina Index
1
2
3
4
5
6
7
8
9
10
11
12

Sequence
ATCACG
CGATGT
TTAGGC
TGACCA
ACAGTG
GCCAAT
CAGATC
ACTTGA
GATCAG
TAGCTT
GGCTAC
CTTGTA

P2 Primer
P2.1
P2.2
P2.3
P2.4
P2.5
P2.6
P2.7
P2.8
P2.9
P2.10
P2.11
P2.12

Six base Illumina indices are numbered 1 through 12. Sequences are identical to those from the
Illumina TruSeq Adapter 2 Indices. The associated P2 primers for use with the adapter library
are named in the far right column. 
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Table 4.3 Statistical sequencing data: Single Read band characterization
Sample Name
Bottom-Bottom
Bottom-Top
Top-Bottom
Top-Top

Illumina Index
4
3
2
1

Total Reads
670,553
456,005
474,495
525,605

Good Reads
586,471
386,061
404,044
436,118

% Good Reads
87.46%
84.66%
85.15%
82.97%

Read 1 results for a simulated partitioning of m=15 DNA adapter library (Illumina MiSeq with
TruSeq kit, Single Read). Total reads, good reads, and good reads as a percentage of the total
reads.
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Table 4.4 Statistical sequencing data: Paired End band characterization
Illumina R1 Total
R1 Good
Index
Reads
Reads
Bottom-Bottom
1
1,388,196 1,332,461
Sample Name

R1 %Good
Reads
95.99

R2 Total
R2 Good
Reads
Reads
1,388,522 1,300,941

R2 %Good
Reads
93.69

Bottom-Top

2

832,491

796,885

95.72

832,625

778,411

93.49

Top-Bottom

3

541,303

521,063

96.26

541,412

508,058

93.83

Top-Top

4

749,228

714,576

95.37

749,378

698057

93.15

Read 1 and Read 2 results for a simulated partitioning of m=15 DNA adapter library (Illumina
MiSeq with TruSeq kit, Paired End). Total reads, good reads, and good reads as a percentage of
total reads for Read 1 and Read 2.
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Table 4.5. Summary of statistical sequencing data: AIA for thrombin, 60:1 ratio
Sample Name
Bottom Band
Top Band

Illumina Index
6
5

R1 Total Reads
555,626
482,065

R1 Good Reads
255,388
300,865

R1 Bad Reads
265,504
130,777

MiSeq results for 60:1, thrombin: m=15 DNA adapter library (TruSeq Single End Read). The
high percentage of bad reads is due to contamination from the TBAsc sequence. TBA was not
found in either data set. The top twenty sequences for each sample can be found in Appendix 4.
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Table 4.6. Summary of statistical sequencing data: AIA for thrombin, DNA and 2’-OMe
Sample
Name

Illumina
Index

Internal
Index

DNA 60:1
DNA 1:1
2’-OMe 60:1
2’-OMe 1:1

5
7
6
8

ATGCCTGG
ATGCCTGG
AGCTAACG
AGCTAACG

R1
Total
Reads
429,493
441,140
468,343
139,269

R1 Correct
Internal
Index
412,197
415,268
55
21

R2 Total
Reads
429,617
441,223
468,448
139,289

R2 Correct
Internal
Index
401,838
401,424
189
30

MiSeq sequencing results for 60:1 and 1:1 thrombin: library experiments with m=15 DNA and
m=15 2’-OMe RNA/DNA chimera adapter libraries (TruSeq Paired End Read). The incorrect
internal index was identified for both 2’-OMe RNA/DNA chimera library samples. TBA was not
found in either the correctly indexed DNA library samples or the incorrectly indexed 2’-OMe
RNA samples.
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Chapter 5: Alternative Ligation Approaches for Amplification FreeAIA
Chapter Summary
The failure of the adapter library design in combination with the success of the hairpin loop
libraries in AIA for thrombin prompted the return to a ligation based approach for library design
and capture. It was concluded that the structure of the adapter library was interfering with the
binding of TBA to thrombin during partitioning. As demonstrated in chapters 2 and 3, if the
TBA quadruplex structure was made available for binding by the construct of the library, it is
highly likely that the sequence would be selected above background using Concanavalin-A beads
as an immobilization method. Therefore, it is likely that the adapter constructs inhibited aptamer
discovery for short libraries such as m=15. In order to investigate this hypothesis, methods to
capture un-flanked or minimally flanked libraries were explored. Minimally flanked libraries
allow substantial flexibility in secondary structure formation while un-flanked libraries allow
complete freedom in secondary structure formation. Failure of the variable length hairpin loop
DNA and 2’-OMe RNA/DNA chimera libraries in the selection against multiple Epigenetic
targets indicated that a greater freedom in secondary structure formation may be necessary if
AIA is to be successful as a universal aptamer discovery method. Compared to the length of the
short variable regions of AIA libraries, the adapter regions contributed to the bulk of the
molecule (45 of the 61 bases in an m=15 library are adapter constructs). Consider the size
comparisons illustrated in Figure 5.1.
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A second benefit to reconsidering a ligation based capture approach is the ability to eliminate the
amplification step required with the adapter libraries. Ligating full length adapters to un-flanked
or minimally flanked libraries and proceeding directly to sequencing shortens the AIA protocol
and eliminates a potential source of error. Without amplification, sequence data would accurately
represent the selected library sequences with zero amplification bias during sample preparation.
Primer-free or minimal-primer protocols have been used in SELEX.[124, 126]

However,

multiple rounds of selection require a lengthy procedure of primer ligation, PCR amplification,
and enzymatic digestion to regenerate the primer-free or minimal-primer library. This method is
suitable for long libraries where only one or a few copies exist for each sequence and enrichment
is required in order to identify aptamer candidates. However, the short libraries used in AIA,
ranging in length of m=15 to m=22, allow for thousands of copies of each possible sequence
which eliminates the cycling requirement. Using short un-flanked or minimally flanked libraries
allows for one cycle of selection and adapter ligation prior to sequencing.

This chapter outlines preliminary methods development for an un-flanked m=15 library with
various capture techniques, including randomized adapter splints and T4 DNA ligase capture,
hairpin adapters and T4 DNA ligase capture, single-stranded adapters and T4 RNA ligase/5’APP
DNA/RNA ligase capture, and chemical ligation. This chapter also outlines methods
development for minimally flanked libraries with non-complementary four base tails and their
application in AIA for thrombin.
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Ligation of Un-flanked Libraries
Utilizing randomized splints and T4 DNA Ligase capture
In this variation on ligation-based AIA, un-flanked libraries were captured with full length
adapters ligated at the 5’ and 3’-termini with randomized splints to facilitate annealing. The
experimental design is outlined in Figure 5.2A. Specific sequences have been omitted for
simplicity and can be found in Appendix 5. The Illumina TruSeq adapter sequences were used in
designing Adapter 1 (58 bases), Adapter 1 Complement (59-62 bases), Adapter 2 (64 bases), and
Adapter 2 Complement (65-68 bases) which were ordered from IDT. The six base Illumina
Index is found in Adapter 2 and Adapter 2 Complement similarly to the P1/P2 primers used for
amplification of the adapter libraries. During protocol development, Illumina Index 1 was used.
In order to ligate an un-flanked library, the “sticky ends” used to capture the library were
randomized as well. The length of the randomized sticky ends on the complement strands that
were tested had n=1, 2, 3 or 4. For fixed sequences, a 4 base splint would have higher ligation
efficiency due to more stable annealing of the two strands. However, combinatorial
considerations must be made for libraries. When n=4, there are 48 (65,536) possible sequence
combinations. As “n” is decreased, the number of possible sequences decreases. When n=3 there
are 46 (4,096), when n=2 there are 44 (256) and when n=1 there are 42 (16) possible sequence
combinations. If a library pool becomes significantly skewed towards a specific family of
sequences following a partitioning (i.e. G/T rich sequences for thrombin aptamers), the ratio of
available complementary adapters changes. For a skewed library, the percentage of
complementary adapter sequences decreases when the length of the complementary region
increases. Whether or not a balance between hybridization efficiency and the percentage of
complementary adapters can be found for this experiment is unknown, as the current partitioning
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methods skew the library in an unpredictable fashion. It does not appear that the skewness of an
AIA partitioned library is substantial enough to be a limiting factor in library capture based on
TBA and TBA variant frequencies presented in chapters 2 and 3. Although the quantity of library
recovered following a partitioning step varies, the adapters are used in enough excess to likely
overcome any combinatorial limitations for n=1, 2, 3 or 4.

After a successfully ligated library is agarose gel purified, the sample would be quantified with
qPCR.

Although the ligated product is not completely double-stranded, qPCR and high

throughput sequencing are still possible. Both the parent and complement strands are not needed
at the start of either protocol. During the first cycle of qPCR, the complement strand is generated
and data output is adjusted to compensate for the single-stranded template. During cluster
amplification on the Illumina flow cell, clusters would be generated from annealing of the parent
strand alone. The complement strand required for Read 1 and the Index Read would be generated
during bridge amplification. The Adapter 1 Complement containing the P5 region is capable of
hybridizing to the Illumina flow cell, however, the entire sequence length would not be generated
and bridge amplification would fail. Nevertheless, it may interfere with cluster generation of the
desired product by occupying sites on the oligo lawn. A second design scheme using a shorter
Adapter 1 Complement (shortened from 62 to 37 bases when n=4) lacking the region
complementary to the flow cell oligo lawn is shown in Figure 5.2.B.

Preliminary experiments to ligate an m=15 un-flanked library were successful to some measure.
The experimental design included a conventional one step ligation approach using the four full
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length adapters (complement length varied: n=1, 2, 3, 4) and m=15 insert. A 10 pmol quantity of
m=15 library, TBA (dGGTTGGTGTGGTTGG) and TBAsc (dGGTGGTTGTTGTGGT), (IDT)
as well as a no insert control were ligated to adapters in a 1:1 ratio. The oligonucleotide mixture
was denatured at 95°C for 3 minutes. After cooling to room temperature, 7 µl of 10X ligation
buffer (300 mM Tris-HCl, 100 mM MgCl2, 100 mM Dithiothreitol, 10 mM ATP, pH 7.8),
(Promega), 1 µl T4 DNA ligase (50% glycerol stock, 3 u/µl), (Promega) and dH2O to 20 µl were
added. Following an overnight incubation at 16°C, the products were visualized on a 4% TAE
agarose gel. The ligation products of the m=15 library, TBA and TBAsc with full length adapters
with n=1, n=2, n=3 and n=3 are presented in Figure 5.3. The desired product length is 137 basepairs. The band at approximately 125 base-pairs is found for all three inserts and the no insert
control, indicating that it is not the desired ligation product. Excess adapters are present between
50 and 75 base-pairs.

To determine if self-ligation of the adapters was causing the 125 base product, the m=15 library
was ligated to Adapter 1/Adapter 1 Complement and Adapter 2/Adapter Complement
independently of each other. Ligations conditions, including concentrations, were maintained
from Figure 5.3 for Figure 5.4.A. When ligated independently from each other, the source of the
125 base-pair product is identified as the self-ligation of the double stranded Adapter 2/Adapter
Complement.

Figure 5.4.A shows that the m=15 insert was successfully ligated to the

Adapter1/Adapter 1 Complement complex when n=2. In an attempt to improve ligation
efficiency, the Adapter 1 ligation was repeated with samples cooled in a thermocycler at a rate of
0.5°C per second rather than simply cooling on the bench top at room temperature following heat
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denaturation. Figure 5.4.B shows that when n=1, Adapter 1 and the insert did not ligate
efficiently. For n≥2, a ligated product is visible, indicating that controlled cooling aids in
annealing of the splints when n≥2. To resolve the problem of self-ligation of Adapter 2/Adapter
2 Complement, the use of a 3’-blocking group was implemented. An amino modifier replaced
the free hydroxyl group at the 3’-end of Adapter 2 Complement (Ordered from IDT). Figure
5.5.A illustrates how the self-ligated product forms, while Figure 25.B illustrates the location of
the 3’-amine.

Ligation of the m=15 library, TBA, and TBA in the hairpin loop format to Adapter 1/Adapter 1
Complement and Adapter 2/Adapter 2 Complement (3’-amine) independently was performed
under identical conditions to Figure 5.4.B with controlled cooling following denaturation. TBA
in the hairpin loop format was chosen as a control against the un-flanked molecules. Results
from the ligation with Adapter 2 and Adapter 2 Complement (3’-amine) indicate that the 3’terminal amine successfully prevents self-ligation of the Adapter 2/Adapter 2 Complement
complex, as shown in Figure 5.6. By eliminating the self-ligation product, a greater quantity of
the Adapter 2/Adapter 2 Complement complex is available to ligate the library or control
sequence. Although the self-ligation product was eliminated, ligation results were still poor for
both Adapter 1 and Adapter 2. The desired product is slightly visible in lanes 3 and 4, while unligated insert is clearly visible in lanes 5 and 9 at approximately 25 bp. To determine whether or
not consistency could be achieved, the temperature and reaction time were varied from the
previous 16°C for 18 hours/overnight. As temperature decreases, molecular movement slows and
the time of association increases. The melting temperature of the 1-4 base complementary region
of the adapter and library varies based on length and sequence, but it is always small (<12°C). As
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indicated by the results in Figure 5.7, as the ligation temperature is decreased and reaction time
is increased, the quantity of correctly ligated product increases. However, additional experiments
at 4°C with complementary regions of varied length (n=1, 2, 3, or 4) for m=15, TBA and TBAsc
illustrated a lack of consistency. For this reason, additional methods of capturing the un-flanked
library were explored.

Hairpin adapters and T4 DNA Ligase capture
A hairpin adapter structure was explored in an attempt to stabilize the Adapter/Adapter
Complement complex. Although the full length adapters are highly specific, it was hypothesized
that the hairpin format may improve accuracy of the Adapter/Adapter Complement
hybridization, which would ensure the correct overhang (n=1, etc.). The corresponding Adapter/
Adapter Complement pairs were designed as single-stranded molecules, with the two fragments
joined by a 5 base loop (dT-dT-rU-dT-dT). The loop allows the Adapter/Adapter Complements
to anneal in a hairpin to form the correct adapter constructs for the 5’ and 3’-ligations. Adapter 2
contains a 3’-terminal amine to prevent self-ligation as discussed in the previous section. The
ligation scheme is illustrated in Figure 5.8.A. Following ligation, the “bottom” complement
strands of the hairpins would need to be removed to eliminate large interference with
hybridization to the Illumina flow cell. Treatment with 1M NaOH successfully cleaves the
complement strands by hydrolyzing the single RNA base as confirmed with IE-HPLC. The
remaining bases of the hairpin would not likely interfere will hybridization to the Illumina flow
cell. The cleaved Adapter 1 fragments could be separated from the ligated product via denaturing
PAGE purification to prevent competition on the flow cell oligo lawn. To test the applicability of
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the hairpin adapters, shortened adapters with n=4 splints were synthesized on the ABI 394
synthesizer (Adapter 1 = 75 bases and Adapter 2 = 59 bases). The full length adapters would
range in size from 132 – 145 bases and the synthesis would be difficult in-house. If the ligation
scheme was successful with the shortened adapters, the more costly full length adapters would
have be ordered from IDT. Several ligation experiments with varied conditions were
unsuccessful. A control experiment using the previous hairpin loop library and hairpin adapters
with corresponding fixed complementary splints was also unsuccessful. This is likely due to
insufficient purity of the adapters synthesized on the ABI 394. The method was not investigated
further following these initial experiments.

Single-stranded adapters and T4 RNA ligase I /5’APP DNA/RNA ligase capture
This capture strategy employed ligation of a single stranded Adapter 1 and Adapter 2 to the unflanked m=15 DNA library with T4 RNA ligase I and Thermostable 5’APP DNA/RNA ligase
(New England BioLabs) as illustrated in Figure 5.8.B. RNA ligase is capable of ligating ss-RNA
and/or ss-DNA by blunt end ligation. Eliminating the adapter complements eliminates any
combinatorial or hybridization limitations introduced by the 1 to 4 base complementary splint.
Although an expensive and tedious procedure, if the ligation with RNA ligase were efficient, it
would be an ideal method for capturing the partitioned un-flanked library. The two step ligation
first requires the generation of AppDNA Adapter 2 from pDNA Adapter 2 with the 5’DNA
Adenylation kit (New England BioLabs). In the first ligation step, Thermostable 5’APP
DNA/RNA ligase (New England BioLabs) joins the 5’App of Adapter 2 to the free 3’-OH of the
library. The enzyme is heat denatured to terminate the ligation. Gel purification of the single
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stranded product would be difficult and is not required due to the use of two different enzymes.
In the second ligation step, T4 RNA Ligase I joins the 5’-Phosphate of the library to the free 3’OH of Adapter 1. Excess Adapter 2 will not ligate to free Adapter 1 due to the 5’App.
Experimental details are omitted for simplicity, as the protocol did not yield the correct ligated
product. The method was not pursued further do to the costly nature of the reagents and initial
failures.

Chemical ligation
The final capture strategy employed the double-stranded adapter splints in combination with
chemical ligation, “Click” DNA ligation, at the 5’-and/or 3’-ends of the insert. Copper(II)
catalyzed azide-alkyne cycloaddition (CuAAC) is a form of click chemistry used to ligate
DNA.[167, 168] The trizole linkage that forms between labeled oligonucleotides can be read by
DNA polymerases,[167, 169] making it a viable option for applications with downstream qPCR
and high throughput sequencing. An important feature of click ligation is that the 5’-terminal
azide and 3’-terminal alkyne are not found in natural systems, eliminating issues of non-specific
or self-ligation of adapters. The click ligation could be used in combination with an enzymatic
ligation to eliminate self-ligation of the Adapter 2/Adapter 2 Complement complex and perhaps
improve ligation efficiency. For example, ligation with DNA ligase of Adapter 1 to 5’phosphorylated library and click chemistry for ligation of 3’-terminal alkyne library and 5’terminal azide Adapter 2. Figure 5.8.C shows a schematic representation of how click chemistry
was applied to the ligation of un-flanked libraries in preliminary experiments. The adapters and
libraries were synthesized using terminally labeled amidites from Glen Research. Additionally,
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the fixed m=15 TBA and TBAsc sequences were synthesized with click modifications along
with corresponding adapter complements with fixed four base complementary overhangs.
Specific synthesis information has been omitted for simplicity because the protocol was not
continued after preliminary experiments. Sequences can be found in Appendix 5.

The experimental protocol followed the method by Lumiprobe, Corp. utilizing a Cu-TBTA
complex as the reaction catalyst.[170] Several problems were encountered during preliminary
experiments. In order for the azide-modified oligos to remain soluble, DMSO is required in the
reaction buffer. While loading the ligated samples onto an agarose gel, the high concentration of
DMSO caused the solution to precipitate into the 1X TAE running buffer. Desalting columns
pre-equilibrated with 50% DMSO and ethanol precipitation were used independently to
exchange the reaction buffer to successfully prevent precipitation of the sample during loading.
The click ligation was unsuccessful for all attempts with un-flanked libraries and fixed
sequences. Several measures were taken to establish why the click ligation was not successful,
including IE-HPLC purification of the oligos (not shown) and ESI/LC Mass Spectrometry
Analysis (Novatia, LLC, Newton, PA) of the TBA with 5’-terminal azide and 3’-terminate
alkyne (Figure 5.9). It was critical to determine if the chemistry involved in synthesizing the
modified oligos was successful. From the mass spectroscopy data, it was concluded that the
chemistry was successful and that the TBA oligo contained both the 5’-terminal azide and the 3’terminal alkyne. The click ligation protocol was not investigated any further due to simultaneous
improvements mentioned next, however, a variety of protocols utilizing different reagents are
available and may be investigated in the future.
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Ligation of Minimally Flanked Libraries
Due to inconsistencies encountered with ligation of un-flanked libraries, a library flanked with a
short fixed regions on both the 5’ and 3’-termini was introduced. The library contains the same
“ACAC/CACA” tails of the hairpin loop library but without the eight base complementary stem.
The adapter design with specific sequences modeled after the Illumina TruSeq Adapters is
shown in Figure 5.10. The adapter complements capture the library via the ACAC/CACA tails
with a four base fixed sequence. Adapter 2 Complement does not require the 3’-amino modifier
to prevent self-ligation because the fixed four base overhangs are not complementary.

This “tailed” library format was first tested in a two-step approach: ligation of the m=15 insert to
Adapter 1/Adapter 1 Complement followed by agarose gel purification and subsequent ligation
of Adapter 2/Adapter 2 Complement and vice versa. The ligation was successful with either
adapter used in the first step; however, a significant amount of product was lost during the gel
purification. A two-step approach without the intermediate gel purification step of the first
product was successful, indicating that it is not necessary. This suggested that a one-step protocol
may also work efficiently. A second version of the adapter complements was also tested in an
attempt to improve the ligation efficiency and consistency. The fixed four base overhangs were
extended to a total length of eight bases with the addition of four randomized bases. The
sequences are provided in Figure 5.10. The additional n=4 overhangs were hypothesized to
improve ligation efficiency by providing additional structural integrity to the annealed products
without lengthening the fixed tails of the library. The Adapter 2 Complement contains a 3’amino modifier to prevent self-ligation because the 5’-NNNNGTGT-3’ of Adapter 1
Complement and the 5’-TGTGNNNN-3’ of Adapter 2 Complement are capable of hybridizing.
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Sequence differences between the “Fixed” and “Fixed/n=4” adapter complements are highlighted
in red in Figure 5.10.

A comparison of the efficiency the “Fixed” and “Fixed/n=4” adapter complements in a one-step
ligation is shown in Figure 5.11. A 10 pmole quantity of the m=15 tailed library as well as two
fixed control sequences in the same minimally flanked format, TBA and TBAsc, were ligated to
the four corresponding adapters at a 1µM final concentration (1:1 molar ratio). The
oligonucleotide mixtures were denatured at 95°C for 3 minutes and cooled in a thermocycler at a
rate of 0.5°C per second to 4°C prior to the addition of 7 µl of 10X ligation buffer (300 mM TrisHCl, 100 mM MgCl2, 100 mM Dithiothreitol, 10 mM ATP, pH 7.8), (Promega), 1 µl T4 DNA
ligase (50% glycerol stock, 3 u/µl), (Promega) and dH2O to 20 µl. Following a 24 hour
incubation at 4°C, the products were analyzed on a 4% TAE agarose gel as shown in Figure
5.11. The correct 145 bp product is seen for m=15, TBA and TBAsc with the Fixed/n=4
complement and for m15 and TBA with the Fixed complement. The intensity of the ligated
m=15 library is significantly greater for the Fixed/n=4 complement structure. This indicates that
the Fixed/n=4 complement format is superior and the structural integrity introduced by the
additional four base randomized overhang increases ligation efficiency.

The high efficiency of the Fixed/n=4 complement format is particularly important during AIA
because the quantity of recovered library is much less than the 10 pmoles used in the control
experiments. To demonstrate whether or not this ligation scheme can successfully capture much
smaller quantities of library, a dilution series of the m=15 library was ligated with the Fixed/n=4
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complement format in a one-step protocol. The oligonucleotide mixtures were denatured at 95°C
for 3 minutes and cooled in a thermocycler at a rate of 0.5°C per second to 4°C prior to the
addition 7 µl of 10X ligation buffer (300 mM Tris-HCl, 100 mM MgCl2, 100 mM Dithiothreitol,
10 mM ATP, pH 7.8), (Promega), 1 µl T4 DNA ligase (50% glycerol stock, 3 u/µl), (Promega)
and dH2O to 20 µl. Following a 24 hour incubation at 4°C, the products were visualized on a 4%
TAE agarose gel as shown in Figure 5.12. The correct 145 bp product is clearly visible for 10
pmoles and 1 pmole of library. A faint band is present for 0.1 pmoles and no product is seen for
0.01 pmoles. As the concentration of insert decreases, the presence of single-ligation products
diminishes prior to the correct double-ligation product. This indicates that a partitioned library
with concentration too low to be visualized would be ligated correctly. The visible and nonvisible products were excised from the gel and purified with the MiniElute Gel Extraction Kit
(Qiagen). The purified products were quantified in triplicate by qPCR with the KAPA Library
Quantification kit. The purpose of this was twofold: to determine the average recovery and to
also confirm that the ligated product is in fact amplifiable with the Illumina platform. The
average recovery values for the four dilutions (10, 1.0, 0.1 and 0.01 pmoles) were calculated as
8.47nM, 0.37nM, 0.36nM and 0.11nM, respectively. This correlates to recovery values of 0.08
pmoles, 0.0037 pmoles, 0.0036 pmoles and 0.001 pmoles. The lower than expected calculated
recovery is due in part to incomplete excision of the product from the gel. A 4.0 mm by 1.0 mm
disposable gel excision tip (GeneCatcher) is used to excise the band and only excises the core of
the band. Also, the Qiagen MiniElute Gel Extraction Kit has a relatively short shelf life and
product may have been lost due to this. It is impossible to calculate a percent recovery without
also knowing the quantity of library that was successfully ligated, however, the quantity of
product recovered follows the decreasing trend of the dilution series. Additional ligated samples
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used in the optimization of the ligation scheme (including those from Figure 5.12) were also
quantified by qPCR and confirm that the gel purified product can be successfully quantified with
the Illumina platform via the KAPA Library Quantification kit.

In order to apply the new library design to AIA, multiple indexed adapters were needed. By
multiplexing samples on a single Illumina flow cell lane (for the MiSeq, a single run), a higher
rate of sample/data output can be achieved. For the initial studies, four Illumina Indices (2, 4, 6
and 12) were ordered from IDT, in addition to Illumina Index 1 used in the initial design
experiments. The selection of the four indices was based on guidelines from Illumina for
multiplexing small numbers of samples, taking into considering the level of sequence similarity.
Table 5.1 illustrates the best options for multiplexing with Illumina Indices. An additional
change was made to the Adapter 2 and Adapter 2 Complements: the Adapter design in Figure
5.10 includes a single dA base at the 5’-terminus immediately prior to the start of the Illumina
TruSeq Universal Adapter sequence. This dA was carried over during adapter design from the
adapter library from chapter 3 and is unnecessary for this format. The single base was removed
from the sequence of the four new adapter sets. This change produced an unexpected benefit in
the analysis of sequence data in experiments mentioned in the next section. The original format
with the extra dA, Index 1, was used as a size marker for gel purification of small quantities of
ligated, partitioned library that were typically too dilute to visualize. During data processing,
sequences containing Illumina Index 1 can be counted to reveal the level of contamination (if
any) from the size marker. By looking at the raw data, the additional dA helps to confirm that the
Index 1 sequence was in fact contamination from the size marker.
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Although the sequence differences were not suspected to affect the outcome of ligation, the four
indices were tested for consistency by ligating 10 pmoles of library under identical conditions.
There was no discernable difference in the ligation efficiencies of the four new adapter sets and
the original adapter set used in the experiment design. Based on the consistency at which the new
library format is ligated and the success in multiple qPCR tests, the m=15 DNA tailed library
was tested in AIA for thrombin.

Application of the Tailed m=15 DNA Library to AIA
Workflow summary
Following confirmation that the Fixed/n=4 adapter splints ligate the tailed m=15 DNA library
successfully, the library was tested in AIA for thrombin. The goal was to determine if the library
structure allowed for TBA to be selected from the over-represented library pool using
Concanavalin-A as an immobilization method. If successful, additional partitioning methods
would be explored. The m=15 DNA library was partitioned against thrombin immobilized on
agarose-Concanavilin-A beads as described in chapter 4. Phenol extraction and ethanol
precipitation resulted in a partitioned DNA library containing sequences with an affinity for
human α-thrombin. Multiplexed adapters were ligated to the partitioned library and the product
was agarose gel purified. The product was quantified via qPCR analysis in order to determine the
precise quantity required for clustering on the Illumina MiSeq Desktop Sequencer (SUNY
Microarray Core Facility, Upstate Medical University). The adapters are the full length required
for sequencing on the Illumina platform and thus require no PCR amplification. Elimination of
the amplification step prompted a more in depth analysis of the quantification data relative to the
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starting quantity of library. Sample preparation with the hairpin loop and adapter libraries
employed qPCR following amplification, so the quantity of recovered and ligated library was
unknown. In the absence of amplification, it was found that a superior level of control and
predictability in the outcome of high throughput sequencing data could be achieved. Calculations
based on the quantity of ligated library in combination with the starting quantity of library pool
and the average cluster output are capable of determining if it is possible for any sequence to
appear above background. If the quantity of recovered library is too large and/or the number of
expected clusters is too small, it may be statistically impossible for any sequence to appear above
background. As our knowledge of the Illumina sequencing platforms improved, we have been
able to predict whether or not a sample is worth sequencing based on the qPCR data and
expected cluster output. We can predict a relative maximum frequency of aptamer candidates
using these calculations. This capability is in line with the goals of AIA, which include quickly
and efficiently identifying aptamers while conserving resources.

Partitioning the DNA Library
Partitioning of the DNA library was performed using agarose-Concanavalin-A beads (GE
Healthcare Life Sciences) at room temperature The Con-A beads contained in spin columns
(ThermoScientific) were pre-equilibrated in partitioning buffer (20 mM Tris-HCl, 140 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) by three wash cycles. The following
represents a 5:1 DNA library: protein screen. A 20 pmol aliquot of glycosylated human αthrombin (Haematologic Technologies) in 200 µl partitioning buffer was immobilized on 10 µl
of pre-equilibrated Con-A beads during a 30 minute incubation with end-over-end rotation at 25
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rpm at room temperature. Unbound protein was removed by centrifugation at 1,500 rpm for 1
minute. A 100 pmol aliquot of the DNA library in 200 µl partitioning buffer was then applied to
the immobilized thrombin. Following a 1 hour incubation at room temperature with end-overend rotation at 25 rpm, the unbound DNA was removed through centrifugation. Three wash
cycles (5 minutes, rotation at 25 rpm) with 200 µl partitioning buffer ensured thorough removal
of unbound DNA. Thrombin-DNA complexes were eluted from the Con-A beads with 200 µl
1M α-methyl mannoside (Sigma Aldrich) during a 5 minute incubation, rotation at 25 rpm.

Phenol Extraction and Ethanol Precipitation
Phenol extraction was used to recover the partitioned DNA libraries. Equal volume Trisbuffered, pH 8.0, 0.1mM EDTA, 50% phenol, 48% chloroform, 2% isoamyl alcohol (Sigma
Aldrich) was added and vortexed for 30 seconds. After centrifugation at 13,000 rpm for 5
minutes the aqueous layer was removed and the library subsequently extracted twice with equal
volumes of 100% chloroform. The library was then purified by ethanol precipitation. One tenth
the volume (20 µl) of 3M sodium acetate and three times the volume (600 µl) of cold ethanol
were added to the library and mixed briefly. Following an overnight incubation at 20 °C,
centrifugation at 13,000 rpm for 30 minutes resulted in a library pellet. After decanting the
liquid, the pellet was washed with 1 ml 70% ethanol, and the pellet was dried in a SpeedVac and
resuspended in 10 µl dH2O.
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Modifying the Library for Sequencing
The libraries were ligated with full length adapters and their complements. Adapter 1, Adapter 1
Complement, Adapter 2 (indexed), and Adapter 2 Complement (indexed) at 10 µM were added
in 1 µl volumes to the recovered library. The indexed Adapter 2 was dictated by the number of
samples prepared and the number of samples desired per Illumina flow cell lane. The mixtures
were incubated at 90°C for 3 minutes and cooled in a thermocycler at a rate of 0.5°C per minute
to 4°C. At 4°C, 2 µl of 10X ligation buffer (300mM Tris-HCl (pH 7.8), 100mM MgCl2, 100mM
DTT and 10mM ATP), (Promega), 3 µl dH2O and 1 µl T4 DNA ligase (10mM Tris-HCl (pH
7.4), 50mM KCl, 1mM DTT, 0.1mM EDTA and 50% glycerol), (Promega) were added.
Incubation of the 20 µl reaction for 24 hours at 4°C completed the ligation. The ligated library
was purified by gel electrophoresis. Excision of the ~144 base-pair band from 4% TAE agarose
gel (3% NuSieve GTG Agarose, 1% high melt agarose) with a 4.0 mm by 1.0 mm disposable gel
excision tip (GeneCatcher) ensured minimal risk of cross-contamination between gel lanes. The
library was extracted from the gel with the MiniElute Gel Extraction Kit (Qiagen) and
resuspended in 10 µl of dH2O.

Control Experiments
During each experiment, a control ligation was used as a size marker in the event that the ligated
experimental sample was too low of a concentration to be visualized. A 10.0 pmol aliquot of the
m=15 DNA is ligated under identical conditions with Adapter 2/Adapter 2 Complement (Index
1). The product was gel purified alongside the experimental samples as a ~144 bp size marker
and quantified via qPCR as the positive control.
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Quantitative PCR and High Throughput Sequencing
The precise quantity of amplifiable DNA was determined with the KAPA Library Quantification
kit on the BioRad iCycler. Unlike previous methods, the concentration of the sample was not
estimated prior to qPCR analysis to reduce loss. A 1 µl quantity of each sample was required for
qPCR and was diluted to 1000 µl for analysis. All samples were quantified in triplicate to ensure
accuracy. The data is reported as pM concentration and any outliers were eliminated prior to
averaging the data points. The quantity of recovered DNA was calculated by the following
method:
Average concentration x 2 = Concentration of single-stranded product (to account for
single-stranded template)
Concentration of single-stranded product x (452/144) = Concentration of 1000 µl dilution
(Size adjustment for the KAPA control)
Concentration of 1000 µl dilution in pM x (1000/1000) = Concentration of Stock solution
in nM
Concentration of Stock solution in nM / 100 = Total pmoles recovered
Total pmoles recovered x 0.9 = pmoles available for use in sequencing (to account for 1
µl used in qPCR)
The quantity of sample still available for sequencing is important for determining whether or not
a sample should be sequenced. The MiSeq allows for a range of concentrations of
oligonucleotide to be applied to the flow cell. For this application, the maximum recommended
concentration was used due to the short length of the sequences (144 base-pairs) and resulting
small clusters as compared to commonly used genomic DNA. A 5 µl volume of 4 nM sample is
required and from this, a 20 pM denatured solution was made and loaded onto the flow cell. The
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4 nM concentration assumes that the modified libraries are double-stranded. To account for the
single-stranded nature of the modified library, an 8 nM concentration was supplied. This
indicates that 0.04 pmoles of single-stranded library is required. When multiplexing the four
indexed adapters currently in use, a maximum recovery of 0.011 pmoles of each sample is
desired. Table 5.2 demonstrates why it is desired to recover 0.011 pmoles or less of each sample
per four-plex sequencing run using a hypothetical partitioning experiment using 100 pmol m=15
DNA library with varied recovery.

Table 5.2 demonstrates that for a sample with a total recovery of 0.02 pmoles and a perfect
recovery of the 56,000 TBA molecules in the starting pool, only 28,000 of these will be loaded
on the flow cell. If 5,000,000 clusters are formed from this sample, only 23 of the original 56,000
copies of TBA will be clustered. Based on prior experiments, this is enough to select an aptamer
from the background, however, the number of expected counts for any unique sequences
becomes much lower as the quantity of library recovered increases. This indicates that the
partitioning method must be stringent in eliminating non-specific sequences to reduce
background. The ideal case for a four-plex sequencing run is to have 0.01 pmoles or less of each
sample available, with lower quantities producing the most favorable result. This means that
~0.011 pmoles or less of ligated library is the ideal for combined use in pPCR and clustering.

Data Analysis
The goal of the first set of AIA experiments was to demonstrate that TBA could be identified
from the tailed library structure. A 100 pmol aliquot of the m=15 DNA tailed library was
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selected against 20 pmol of thrombin immobilized on Con-A (1:5, thrombin: library ratio) in four
replicates to demonstrate consistency in sample preparation. Following indexed ligation, the
samples were purified on a 4% TAE agarose gel, shown in Figure 5.13. The samples were
quantified via qPCR and the quantity of library recovered and the expected number of counts of
TBA (or any unique sequence) were calculated. Calculations are provided in Table 5.3. The
results indicate that too large a quantity of library was recovered and that the frequency of any
unique sequence would not likely be found above background. The estimated number of clusters
per sample for a four-plex sequencing run (5,000,000) is optimistic. Data from previous MiSeq
runs indicates that 1,000,000 – 2,000,000 may be more appropriate, which would reduce the
counts even further. With 100% recovery of the 56,000 starting copies of TBA and 5,000,000
clusters, TBA is expected to be sequenced 11, 3, 31 or 7 times for samples 1-4 , respectively. If
only 1,000,000 clusters are sequenced, this number drops to 5, 0, 6 and 1, respectively. With
such low counts expected for the samples, they were not sequenced and modifications were
made to the partitioning method in an attempt to improve stringency.

Improving Partitioning Stringency
If it is assumed that all possible aptamer candidates exist in the pool of partitioned library, the
only manner of increasing the expected counts is to reduce the background – the number
sequences randomly carried forward with the specifically bound molecules in partitioning.
Several changes were made to the partitioning method in order to accomplish this. The first
included re-evaluating the quantity of Con-A beads. The quantity of beads required for a 1:5
ratio screen utilizing 20 pmoles of thrombin was determined by evaluating the binding capacity
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of the Con-A beads. Based on data from previous chapters demonstrating variability in the
behavior of beads, this determination would be required for each new lot of Con-A beads. A
series of volumes of the slurried beads sold by the commercial supplier (100 µl, 50 µl, 20 µl, 10
µl, 5 µl and 1µl) were pre-equilibrated in partitioning buffer by three wash cycles. A 100 pmol
aliquot of thrombin was applied to the beads in 200 µl of partitioning buffer and allowed to bind
for 30 minutes with end-over-end rotation at 25 rpm at room temperature. The beads were then
centrifuged for 1 minute at 1,500 rpm. The quantity of protein in the flow-through was
determined by absorption at 280 nm with the NanoDrop UV/Vis spectrophotometer. It was found
that no significant difference in binding capacity was seen for 20 µl or less of Con-A beads, with
an average of 80% of the 100 pmoles of thrombin binding for these volumes. According to the
manufacturer, the Con-A beads have a binding capacity of 30-67 nmoles/ml.[171] Using this
stated value, to bind 20 pmoles of thrombin at the beads’ minimum binding capacity, 0.66 µl of
Con-A beads are required. Based on the ratio of protein: beads used in the original AIA protocol,
3.3 µl of Con-A beads are required for 20 pmoles of thrombin and were used for the next two
sets of experiments (reduced from 10 µl). By decreasing the quantity of beads void of
immobilized thrombin, the probability of retaining sequences with affinity for Con-A and nonspecific binding sequences was reduced. The second modification was a wash step after the
protein has been immobilized to the Con-A beads. It is possible that unbound thrombin is still
present after the initial centrifugation. Although this step may not necessarily reduce the quantity
of library recovered, it did ensure that any thrombin present in the partitioning step is bound to
Con-A. The third modification was increasing the binding time of the library from 1 hour to
overnight (~18 hours). The fourth modification was increasing the number of wash steps from
three to six. This step was hypothesized to make the most difference in reducing the background.
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A fifth modification used in two of the four samples was the reintroduction of the negative
selection step. This step was eliminated in previous methods because the Con-A beads were
absorbing high percentages of the library prior to application to the protein. The lot of Con-A
beads used for this set of experiments was found to absorb approximately 20% of a 100 pmol
aliquot of tailed m=15 DNA library. By negatively selecting the library against these Con-A
beads, it may be possible to reduce the number of non-specific sequences recovered without
significantly reducing the number of potential aptamer candidates. Four samples were prepared
with the above modifications as described in Table 5.4. The first two samples compared the
effect of negative selection on selection stringency while the third sample compared the effect of
target: library ratio. The fourth sample (no thrombin) served as a negative control. Following
ligation, the samples were gel purified as shown in Figure 5.14. As compared to Figure 5.13,
the location of the 144 bp product band for these samples is not as intense, indicating a smaller
quantity of recovered library, which was initially promising. Following qPCR of the gel purified
samples, the quantity of library recovered and the expected number of counts of TBA (or any
unique sequence) were calculated. The specific calculations are provided in Table 5.5. The
quantity of library recovered for this sets of samples is much closer to the desired 0.01 pmoles of
each than in the first set of experiments. To compensate for the fact that sample 1 produced less
than 0.01 pmoles of library available for sequencing, the quantity of the other 3 samples in each
set was increased to reach a total of 0.04 pmoles. This has been accounted for in the data table.
The four samples were sequenced on a multiplexed TruSeq Single Read run on the MiSeq.
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Data Analysis
Following sequencing on the Illumina MiSeq, the data was parsed based on the Illumina Indices.
These data files were then parsed using a modified Perl Script that identifies the four base ACAC
head and four base CACA tail flanking the m=15 library region. The Perl script identified
sequences with perfect matches for both the head and tail as “candidate” reads and those with an
m=15 variable region were qualified as “good” reads. The Perl script was originally designed to
function optimally with the longer head and tail of the hairpin loop library. For this reason, the
Perl script must parse the data with strict qualification in order to function correctly. The counts
per unique sequences were tallied and this data is presented in Table 5.6. A brief search of the
“candidate” and “bad” reads does not indicate that the counts for the top sequences would be
altered drastically if a revision to the Perl script were made to allow for mismatches or
insertions/deletions in the head and tail. The total number of clusters, the number of clusters that
pass the instrument’s filter (PF) and the total number of reads identified in the data files are listed
in Table 5.7. The total number of reads per index and the quantity of good reads are also
summarized in Table 5.7. The counts of TBA expected (or any unique aptamer sequence) were
recalculated based on these numbers and are compared to the counts of TBA observed.

As indicated in Table 5.7, approximately 16 million original clusters were formed and
approximately 50% of the clusters did not pass filter. Of the clusters that passed filter, the data
was parsed by Illumina’s BaseSpace software into individual data files based on the Index.
During this process the software eliminates any sequence data that cannot be read properly (does
not contain the correct Index information), reducing the percentage of quality clusters further. A
total of approximately 41% of the original clusters were converted into readable data. Using this
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information and the specific number of reads identified per index, the number of expected TBA
counts (or of any unique aptamer sequence) was recalculated.

The observed counts of TBA for samples 2 and 3 are similar to what is expected. TBA was
counted 4 times in sample 2 and 24 times in sample 3, with expected counts of ~3.8 and ~2.6,
respectively. Although TBA was not identified in sample 1, it cannot be concluded whether or
not this experiment failed due to the low number of expected counts of TBA. The expected
counts of TBA assumes a 100% recovery during partitioning, ligation and gel purification. The
effect of reintroducing the negative selection step in samples 2 and 3 cannot be accurately
determined without duplicate experiments. Additional experiments are required to determine
whether or not the negative selection step is beneficial. However, this method of AIA utilizing
the tailed library and ligation of full length adapters was successful at identifying TBA from a
starting pool. The two negative controls (no thrombin) did not offer any conclusive data. The
sample was only expected to produce ~1.5 copies of any unique sequence. Any aptamer
candidates would likely not be observed for this sample. The identification of TBA above
background in combination with a decrease in the quantity of recovered library indicates that the
procedural modifications improved selection stringency.

Consistent with the hairpin loop library and adapter library data, the jump sequence is present in
the data set. In the context of the tailed library, the sequence is dCACAGATCGGAAGAG,
which is the result of skipping over the first 19 nucleotides of the library molecule
(dACACNNNNNNNNNNNNNNN). The CACA tail and the first 11 nucleotides of Adapter 2
170

compose the jump sequence. This sequence is captured by the Perl script because the next four
nucleotides of Adapter 2 are CACA, qualifying the jump sequence as a good read. It was
originally hypothesized that the jump sequence was a systematic artifact resulting from PCR
amplification. However, the jump sequence was found regardless of whether the various AIA
libraries were prepared with or without ligation or PCR amplification. This suggests that the
jump sequence is a product of bridge amplification during clustering. Although the data quality
for this sample set was moderately good, it provided proof of concept for the tailed libraries in
AIA, illustrating that the thrombin binding aptamer could be successfully identified from an
over-represented pool of the m=15 DNA tailed library.

Although bead-based partitioning was successfully used in this chapter, Con-A beads have been
historically unpredictable and often require trial and error to produce the desired result. The
frequency of TBA with respect to good reads was 0.00036% and 0.0077% for samples 2 and 3.
This is much lower than the frequencies observed in successfully AIA partitioning with hairpin
loop libraries described in chapters 2 and 3. The original 60:1 AIA experiment identified TBA at
a frequency of 2.3% and the improved AIA method identified TBA at frequencies of 0.062% and
0.18%. For targets with unknown aptamer sequences, a more reliable and reproducible
partitioning method is highly desirable. With the ability to predict counts for high affinity
sequences as described in this chapter, determining whether an AIA experiment failed due to the
partitioning method or because there were no aptamer candidates in the pool is critical. It is easy
to determine if a thrombin selection failed due to the partitioning method (assuming the library
structure has been successful previously) because the thrombin binding aptamer sequence is
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known. The next chapter discusses reversible formaldehyde crosslinking in combination with
EMSA with the intent of developing a consistent and more universal partitioning method.
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Figure 5.1 Size comparison of library designs
Visual size comparison of m=15 hairpin loop library, m=15 adapter library, m=15 un-flanked
library and m=15 tailed library.
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Figure 5.2 Randomized splints and T4 DNA Ligase capture
Sequences listed in Appendix 5. Figure not to scale. (A) Ligation scheme for un-flanked
libraries using double-stranded Adapter/Adapter Complements with randomized splints. The
randomized splint sequences, Nn, tested for annealing varies from n=1 to 4. Illumina Index
region shown in green. (B) Ligation scheme for un-flanked libraries with shortened Adapter 1
Complement to prevent annealing to the Illumina flow cell oligo lawn.
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Figure 5.3 Randomized splints and T4 DNA Ligase capture of un-flanked m=15, TBA and
TBAsc
4% TAE agarose gel. Lane 1: 25 bp DNA ladder. Ligation of full length adapters to un-flanked
m=15 library, TBA, TBAsc, and no insert control. Each set of ligation reactions in brackets
includes adapters with n=1, 2, 3, or 4, respectively. Excess adapters run between 50 and 75 bp,
ligated product at approximately 125 bp is present in all cases including the no insert control and
represents the self-ligation of Adapter 2/Adapter 2 Complement.
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Figure 5.4 Independent ligation of Adapter 1 and Adapter 2
4% TAE agarose. (A) Lane 1: 25 bp DNA ladder. Ligation of full length Adapter1/Adapter1
Complement and Adapter2/Adapter2 Complement to un-flanked m=15 library independently of
each other. Each set of ligation reactions in brackets includes adapters with n=1, 2, 3, or 4 and
n=4 with no insert, respectively. Correctly ligated product outlined in lane 3. Excess Adapters
between 50 and 75 bp. Product at approximately 125 bp is self-ligation of Adapter 2/ Adapter 2
Complement. (B) Lane 1: 25 bp DNA ladder. Repeat of Adapter1/Adapter1 Complement ligation
with n=1, 2, 3 or 4 respectively. Following heat denaturation at 95°C for 3 minutes, samples
were cooled in a thermocycler at a rate of 0.5°C per second rather than simply cooling on the
bench top at room temperature. Correctly ligated product outlined in lanes 3, 4, and 5 for n=2, 3
and 4, respectively.
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Figure 5.5 Self-ligation of Adapter 2/ Adapter 2 Complement
Sequences listed in Appendix 5. Figure not to scale. (A) Illustration of how the
Adapter2/Adapter 2 Complement complex is capable of self-ligation. Randomized splints anneal,
placing the 5’-phosphate of Adapter 2 adjacent to the 3’-hydroxyl of Adapter 2 Complement,
facilitating self-ligation of the complex. (B) 3’-terminal amine used to prevent self-ligation.
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Figure 5.6 3’-Amino modifier prevents self- ligation of Adapter 2/ Adapter 2 Complement
complex
4% TAE agarose. Lane 1: 25 bp DNA ladder. Adapter 1 Complement and Adapter 2
Complement (3’amine) have an n=4 splint. Lanes 2-5 show ligation results of Adapter 1/Adapter
1 Complement in a no insert control, to m=15 un-flanked library, to the 15-mer TBA and to TBA
in the 39 base hairpin loop stem format, respectively. Lanes 6-9 show ligation results of Adapter
2/Adapter 2 Complement (3’-amine) in a no insert control, to m=15 un-flanked library, to the 15mer TBA and to TBA in the 39 base hairpin loop format, respectively. The desired product is
slightly visible in lanes 3 and 4, while un-ligated insert (TBA in hairpin loop) is clearly visible in
lanes 5 and 9 at approximately 25 bp.
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Figure 5.7 Variable ligation conditions
4% TAE agarose. Lane 1: 50 bp DNA ladder. Ligation of Adapter 1/Adapter 1 Complement n=4
to 10 pmoles un-flanked m=15 DNA library under various conditions. Ratio of adapters to
library is 1:1. Arrow indicates correct product. No product is visible in the no template control.
The ligated product is visible in lanes 3, 4 and 5. Intensity of the ligated product increases with
decreased temperature and increased time.

App
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Figure 5.8 Various ligation methods for un-flanked libraries
Sequences listed in Appendix 5. Figure not to scale. (A) Schematic representation of the hairpin
adapter format. Each adapter is a single strand of DNA, with complementary regions joined by a
5-base loop to impose the desired hairpin structure necessary to ligate the m=15 library. The
sequence of the 5-base loop is dT-dT-rU-dT-dT. The single RNA base is cleaved via NaOH
hydrolysis to release the adapter complement strands prior to sequencing. (B) Ligation Scheme
of Adapter 1 and 5'App Adapter 2 to the un-flanked m=15 DNA library with two forms of RNA
ligase. (C) Click ligation scheme. Click Adapter 1 with 3’-terminal alkyne. Click m=15 library
with 5’-terminal azide and 3’-terminal alkyne. Click Adapter 2 with 5’-terminal azide.
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Figure 5.9 ESI/LC Mass spectrum of Click TBA
ESI/LC Mass spectrum of TBA with 5’-terminal azide and 3’-terminal alkyne. The observed
mass is 5396.2 Da, a difference of only 0.4 Da form the target mass, 5396.9 Da indicating that
the Click TBA was synthesized with the correct 5’ and 3’-modifiers.
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Figure 5.10 Ligation Scheme for tailed m=15 libraries with Fixed versus Fixed/n=4 adapter
splints
(Top) Sequences of m=15 DNA tailed library. (Middle) Sequences of Adapter 1, Adapter 1
Complement Fixed, Adapter 2 (Index 1) and Adapter 2 Complement Fixed (Index 1),
synthesized by IDT. Abbreviated structure of the ligated product shows the library in green.
Complementary overhangs of the adapters in bold. (Bottom) Sequences of Adapter 1, Adapter 1
Complement Fixed/n=4, Adapter 2 (Index 1) and Adapter 2 Complement Fixed/n=4, (Index 1),
synthesized by IDT. Abbreviated structure of the ligated product shows the library in green.
Complementary overhangs of the adapters in bold.
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Figure 5.11 Ligation comparison of Fixed versus Fixed/n=4 adapter splints
4% TAE agarose gel. Comparison of the “Fixed” and “Fixed/n=4” adapter complements.
Ligation of the no stem flanked m=15 DNA library as well as two fixed control sequences: TBA
(dACACGGTTGGTGTGGTTGGCACA) and TBAsc (dACACGGTGGTTGTTGTGGTCACA.)
The no insert control demonstrates a lack of non-specific products; Adapter 1 appears less
intense than Adapter 2 due to the partially single stranded fragment. All adapters ligate the insert
independently, resulting in the single-ligation products identified by appropriate arrows. The
correct, double-ligation product is of greater intensity for all inserts with the Fixed/n=4 splint.
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Figure 5.12 Dilution series ligation with Fixed/n=4 adapter splints
4% TAE agarose gel. Comparison of visual intensity of ligated products of a dilution series of
m=15 DNA library. As the concentration of insert decreases, the presence of single-ligation
products diminishes prior to the correct double-ligation product. This indicates that a partitioned
library with concentration too low to be visualized would be ligated correctly.
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Figure 5.13. Ligation of 1:5, thrombin: m=15 DNA tailed library
4% TAE agarose gel purification of ligated samples after partitioning. Lanes 1 and 8: 25 bp
DNA ladder. Experimental samples were loaded in alternating wells to reduce cross
contamination. The correct 144 base-pair products are indicated by the arrows. The positive
controls show the correct product as well as single ligation products. The negative controls show
no ligation products. Sample replicates 1, 2, 3 and 4 show the correctly ligated product.
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Figure 5.14. Ligation of partitioning results aimed at improving stringency
4% TAE agarose gel purification of ligated partitioned samples. Lanes 1 and 14: 25 bp DNA
ladder. Samples are loaded in alternating wells to reduce cross contamination. The correct 144
base-pair product is indicated by the arrow. The positive controls show the correct product as
well as single ligation products. The negative control shows no ligation products. The ligated
product is slightly visible for sample 4 only.
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Table 5.1 Recommended multiplexing combinations
TruSeq
Index
1
2
3
4
5
6
7
8
9
10
11
12

Index
Sequence
ATCATG
CGATGT
TTAGGC
TGACCA
ACAGTG
GCCAAT
CAGATC
ACTTGA
GATCAG
TAGCTT
GGCTAC
CTTGTA

Pool 2
samples

Pool 3
samples

Pool 6
samples

Pool 12
samples

The first 12 TruSeq Indices. A total of 27 indices exist for the Illumina TruSeq Sample prep kits.
Shaded boxes indicate which indices to select when pooling the indicated number of samples.
Custom AIA adapters with indices 2, 4, 6 and 12 were purchased from IDT with the intent of
multiplexing four or fewer samples per lane.
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Table 5.2 Sample calculations for anticipated sequence frequency
Sample

pmoles of
Library
Recovered

pmoles of
Library
Available

pmoles of
Library
Used

Percentage of
Total

Fraction of Original
56,000 TBA Copies
Used

1
2
3
4

0.05
0.04
0.03
0.02

0.045
0.036
0.027
0.018

0.01
0.01
0.01
0.01

20%
25%
30%
50%

11,200
14,000
16,800
28,000

Sample

Number of
Molecules loaded
onto flow cell

Expected
Number of
Clusters

Clusters as a
Percentage of
Molecules

Number of
Surviving TBA
molecules

1
2
3
4

6,020,000,000
6,020,000,000
6,020,000,000
6,020,000,000

5,000,000
5,000,000
5,000,000
5,000,000

0.083 %
0.083 %
0.083 %
0.083 %

9.30
11.62
13.95
23.25

Sample calculations for anticipated sequence frequency assuming 100% recovery of the starting
counts and 5,000,000 clusters per sample. “Pmoles of library recovered” is determined by qPCR.
“pmoles of library available” represents the remaining quantity of sample following qPCR
analysis. “pmoles of library used” totals 0.04 pmoles (requirement of clustering on the MiSeq).
“Percentage of total is pmoles of library used/pmoles of library recovered*100. The “fraction of
original 56,000 TBA copies used” represents the number of copies in 0.01 pmoles as a fraction
of the total amount recovered. “Expected number of clusters” is based on an ideal 20 million
clusters divided by four samples. The “clusters as a percentage of molecules” is the number of
clusters/ the number of molecules loaded on the flow cell. The “number of surviving TBA
molecules” is calculated as 0.083% of the number of TBA copies used.
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Table 5.3 Calculations for anticipated sequence frequency, 1:5 replicate partitioning
experiments
Sample

1
2
3
4

Sample

1
2
3
4

pmoles of
Library
Recovered
0.040
0.150
0.015
0.065

pmoles of
Library
Available
0.036
0.135
0.0135
0.0585

Number of
Molecules loaded
onto flow cell
6,020,000,000
6,020,000,000
6,020,000,000
6,020,000,000

pmoles of
Library Used

Percentage of
Total

0.01
0.01
0.01
0.01

25%
7%
67%
15%

Expected
Number of
Clusters
5,000,000
5,000,000
5,000,000
5,000,000

Clusters as a
Percentage of
Molecules
0.083 %
0.083 %
0.083 %
0.083 %

Fraction of Original
56,000 TBA Copies
Used
14,000
3,733
37,333
8,615

Number of Surviving
TBA molecules
11.62
3.10
31.00
7.15

Calculations for anticipated sequence frequency assuming 100% recovery of the starting counts
and 5,000,000 clusters per sample. “Pmoles of library recovered” is determined by qPCR.
“pmoles of library available” represents the remaining quantity of sample following qPCR
analysis. “pmoles of library used” totals 0.04 pmoles (requirement of clustering on the MiSeq).
“Percentage of total is pmoles of library used/pmoles of library recovered*100. The “fraction of
original 56,000 TBA copies used” represents the number of copies in 0.01 pmoles as a fraction
of the total amount recovered. “Expected number of clusters” is based on an ideal 20 million
clusters divided by four samples. The “clusters as a percentage of molecules” is the number of
clusters/ the number of molecules loaded on the flow cell. The “number of surviving TBA
molecules” is calculated as 0.083% of the number of TBA copies used.
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Table 5.4 Sample information for partitioning experiments aimed at improving stringency
Sample
1
2
3
4

Ratio
1:5
1:5
60:1
N/A

Protein
20 pmol
20 pmol
6 nmol
20 pmol

Library
100 pmol
100 pmol
100 pmol
100 pmol

Index
2
4
6
12

Negative Selection
No
Yes
Yes
No

Quantity of m=15 DNA library and protein used in partitioning as well as corresponding
Illumina Indices. Samples 1 and 2 differ by the reintroduction of the negative selection step.
Samples 2 and 3 differ by the ratio of target: library. Sample 4 serves as a negative control with
the absence of protein.
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Table 5.5 Calculations for anticipated sequence frequency, partitioning experiments aimed
at improving stringency
Sample

pmoles of
Library
Recovered

pmoles of
Library
Available

pmoles of
Library
Used

Percentage of
Total

Fraction of Original
56,000 TBA Copies
Used

1
2
3
4

0.0234
0.0279
0.0101
0.1122

0.02106
0.02511
0.00909
0.10098

0.0103
0.0103
0.0091
0.0103

44%
37%
90%
9%

24,650
20,674
50,455
5,141

Sample

1
2
3
4

Number of
Molecules
loaded onto flow
cell
6,202,000,000
6,202,000,000
5,472,000,000
6,202,000,000

Expected
Number of
Clusters

Clusters as a
Percentage of
Molecules

Number of Surviving
TBA molecules

5,000,000
5,000,000
5,000,000
5,000,000

0.083 %
0.083 %
0.0913 %
0.083 %

20.47
17.17
51.13
4.26

Calculations for anticipated sequence frequency assuming 100% recovery of the starting counts
and 5,000,000 clusters per sample. “Pmoles of library recovered” is determined by qPCR.
“pmoles of library available” represents the remaining quantity of sample following qPCR
analysis. “pmoles of library used” totals 0.04 pmoles (requirement of clustering on the MiSeq).
“Percentage of total is pmoles of library used/pmoles of library recovered*100. The “fraction of
original 56,000 TBA copies used” represents the number of copies in 0.01 pmoles as a fraction
of the total amount recovered. “Expected number of clusters” is based on an ideal 20 million
clusters divided by four samples. The “clusters as a percentage of molecules” is the number of
clusters/ the number of molecules loaded on the flow cell. The “number of surviving TBA
molecules” is calculated as 0.083% of the number of TBA copies used.
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Table 5.6. Statistical sequencing data for partitioning experiments aimed at improving
stringency
Run

Total Number Clusters

Number of Clusters PF

Total Reads in Data Files

Samples 1-4

16,317,725

8,381,792

6,777,855

20 pmol
100 pmol
56,000

1:5,
Neg. Sel.
20 pmol
100 pmol
56,000

60:1,
Neg. Sel.
20 pmol
100 pmol
56,000

Neg.
control
N/A
100 pmol
56,000

Total Reads

1,611,487

1,516,747

1,090,909

2,265,735

Total Good Reads

1,143,847

1,116,372

313,767

1,776,285

Background/Noise Threshold
Sequences Above Background

3
1

3
2

3
2

3
2

Expected Counts of TBA
Observed Counts of TBAa
Frequency of TBA per Good Readsb
Frequency of TBA per Total Readsc

4.7
N/A
N/A
N/A

3.8
2_4
0.00036 %
0.00026 %

2.6
2_24
0.0077 %
0.0022 %

0 (1.5)d
N/A
N/A
N/A

Experiment

1:5

Quantity of Protein
Quantity of Library
Starting Copies per Sequence

(Top) Total number of clusters produced per sequencing run. The number of clusters that passed
filter (PF) is approximately 51%. The total reads are approximately 43% of the original clusters.
(Bottom) Total number of reads for each sample generated by Illumina’s BaseSpace. A total of
292,720 reads had undetermined Illumina Indices and 254 reads contained Index 1 for the
positive control size marker. The number of good reads is generated by the Perl Script. The
expected number of TBA counts was calculated based on the quantity of library recovered, the
quantity of library applied to the flow cell and the number of good reads assuming a 100%
recovery of the original 56,000 copies of TBA. (a) The rank (left) and count (right) are separated
by an underscore. (b) Counts of TBA divided by the total good reads. (c) Counts of TBA
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divided by the total reads. (d) TBA is not expected for the no thrombin control, however, any
unique sequence was expected at a maximum of 1.5 counts.
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Table 5.7 Top 10 Sequences for partitioning experiments aimed at improving stringency
Sample 1: 1:5
Sequence
Count Identifier
CACAGATCGGAAGAG
51 Jump*

CAGAGACAGGTATGT
TACGTATGCGACCGT
CACATCTGCGGCACG
CGGCTATGGCGGCGC
GAGAAGAGAGTATTC
CCGATTCCGAGCAGA
ATGGACAACAGTCAA
GAGAGATACGACATC
CGTCAGACCTCGGCC

Sample 2: 1:5, Negative Selection
Sequence
Count Identifier

CACAGATCGGAAGAG
GGTTGGTGTGGTTGG
CAGAAAGAAGGTCGA
TAGAATTGGCATCGT
CTTACTGTTTGAAAT
GAGATACCCAGCAGG
TAGTAACCAAACAAT
CGCTTGCGGGCAAAG
CCAGAGCTAAACAAT
CATTAGCTTATCCGG

3
3
3
3
3
3
3
3
3

Sample 3: 60:1, Negative Selection
Sequence
Count Identifier
CACAGATCGGAAGAG
29 Jump*
TBA
GGTTGGTGTGGTTGG
24

TTATAGGCATTATAT
CTAGAATGACAGTCT
AACGATGGTATGCTT
TGCCTGAGTTAGTCC
GTCGTATAGCCGCAG
ATGGTCGTAAGGTGT
GAATTCCGACCGGCC
GAATCGCGACCTTCG

47
4
3
3
3
3
3
3
3
3

Jump*
TBA

Sample 4: No thrombin Control
Sequence
Count Identifier
CACAGATCGGAAGAG
43 Jump*

AAAGACCGGGTGGAA
CCAAGACGACATTGT
CCCCATGGATGTCAT
GCGTCGCGTCTGCAC
GAGGATACACTCGTG
ACTGGGTGAGCGCAC
GCAGGGGTTAGAATG
AGGTGCCACTCCAGT
AATCCCCGTCAGCAA

3
3
3
3
3
3
3
3

4
3
3
3
3
3
3
3
3

Top 10 sequences and corresponding counts for Samples 1-4. The thrombin binding aptamer
(TBA) was identified at counts of 4 and 24 for samples 2 and 4. The jump sequence is present in
all four sample as the highest frequency sequence. The background for all four experiments is 3.
Excluding the jump sequence, the only sequence above background for samples 1-3 is TBA. One
other sequence occurs above background in the no thrombin control.
*Jump sequence variants.
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Chapter 6: Reversible Formaldehyde Cross-linking and EMSA

Chapter Summary
To expand the applicability of AIA using the tailed libraries, a partitioning method utilizing
reversible formaldehyde cross-linking in conjunction with Electrophoretic Mobility Shift Assays
(EMSA) was investigated. Formaldehyde (HCHO) produces DNA-protein and protein-protein
cross-links when the molecules come in close contact with each other. DNA-protein cross-links
(DPCs) can be formed when the amino groups of cytosine, guanine or adenine react with HCHO
to form a Schiff base, which reacts with the amino groups of specific amino acid side chains (e.g.
Lys, Arg). [172-175] DNA-protein cross-links can also be formed when HCHO reacts with the
amino acid side chains initially as well. Imino groups, including that of thymine, are also capable
of forming cross-links.[174] Figure 6.1 illustrates the mechanism of cross-linking between two
amino groups. These covalent cross-links are stable at room temperature but are reversible at
increased temperature. At 50°C, slow degradation of the cross-links occurs and at 95°C, the
cross-links have been shown to completely degrade within 2 minutes.[173] Formaldehyde crosslinking has been used extensively to explore the association of chromosomal DNA or RNA with
nucleosomes, transcription factors and protein with Chromatin immunoprecipitation (ChIP)
assays.[172, 175, 176] Randomly fragmented DNA or RNA is equilibrated with protein in
solution and protein bound oligos are cross-linked with formaldehyde. The protein is
immunoprecipitated with antibodies, cross-links are reversed by heating, and the selected DNA
or RNA molecules are sequenced. This method was adapted to AIA with the incorporation of
EMSA following cross-linking.
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EMSA is a standard method for characterizing the affinity of nucleic acids to a protein target and
has been used as a partitioning method in SELEX.[94] For a library of DNA, high affinity
sequences remain bound to the protein while unbound sequences travel freely through the gel
and moderately bound sequences may present as a smear. The use of SDS-PAGE or a denaturing
agent in the sample buffer destroys any non-covalent interactions between the protein and
library. EMSA with denaturing conditions would allow HCHO cross-linked complexes to be
isolated from the remaining pool of free library. Additionally, HCHO cross-linking would
facilitate capture of sequences with moderate affinity that would otherwise dissociate during
EMSA alone. Using HCHO cross-linking and EMSA (or gel filtration chromatography, GFC)
may eliminate the need for protein immobilization for a wide variety of targets and could greatly
simplify aptamer selection. Immobilization can be problematic, especially for posttranslationally modified proteins and peptides isolated from serum or tissues. Some other
proteins may take considerable effort to isolate with terminal His-tags or other affinity tags, and
immobilization schemes that involve amino groups on proteins may cause conformational
changes. Other important applications that could benefit from aptamer selection via HCHO
cross-linking without immobilization could involve complex mixtures of proteins (e.g. cellular
lysates) and small molecule or other non-protein targets with amino labels.

This chapter details the development of a reversible HCHO cross-linking and EMSA protocol
that offers a fast, efficient and high throughput method for aptamer discovery. Additionally, the
library capture and sequencing methods described in chapter 5 were expanded further with the
introduction of qPCR CopyCountTM software as a means of quantifying samples prior to
sequencing. The accurate quantification of a library is crucial for maximization of data output on
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Illumina sequencing platforms. qPCR CopyCountTM ultimately reduces costs while improving
data output compared to the gold-standard KAPA Quantification kit.

Tracking cross-linked DNA with fluorescent libraries
A variety of conditions and experimental designs were explored during the development of the
HCHO cross-linking protocol. The first concern was facilitating visualization of the cross-linked
library during EMSA. As illustrated in chapter 5, a requirement of amplification-free AIA is the
recovery of low quantities of library that have been partitioned with high stringency. To this end,
the desired quantity of cross-linked library is small, on the order of 0.01 pmoles or less
(dependent on the level of over-representation of the library). In order to visualize the shifting of
such small quantities of library, a fluorescent label was introduced into the library structure.
Pyrrolo-dC is a fluorescent nucleotide capable of base pairing with dG similarly to dC and is
incorporated by DNA and RNA polymerases. The small structure of Pyrrolo-C does not interfere
with the DNA helix formation, making it suitable for use in AIA.[177] Excitation of Pyrrolo-C
occurs at 347 nm with emission at 470 nm. The fluorescence is visible under UV light, making it
an ideal marker for EMSA. Tailed libraries and fixed sequences (m=15, TBA and TBAsc) were
synthesized on the ABI 394 with Pyrrolo-dC CE phosphoramidite (Glen Research) substituted
for a single dC (see Appendix 6). The sequences were purified via DMT purification using
Glen-Pak DNA Purification Cartridges according to the manufacturer’s instructions and purified
by IE-HPLC. The TBA-PyC and TBAsc-PyC molecules were correctly identified by ESI/LC
Mass Spectrometry.

Based on the imaging results of preliminary HCHO cross-linking

experiments and a dilution series of the oligos, it was determined that the fluorescence intensity
of TBA-PyC and TBAsc-PyC was too low to be visualized for partitioning experiments. In the
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absence of any staining methods, the oligonucleotides were not visible at quantities below 10
pmol. A library with a total of four Pyrrolo-C substitutions was also synthesized; however, the
increase in fluorescence intensity was minimal. This disqualified the PyC oligos as a method to
track cross-linked versus free library in EMSA. In the absence of a fluorescent oligonucleotide,
locating the cross-linked DNA-protein complexes too dilute to be visualized was performed with
the use of a positive control size marker in adjacent lanes.

Preparative gel-shift conditions
Reversible HCHO cross-linking and preparative gel-shift conditions were optimized using
traditional staining methods, including ethidium bromide and SYBR gold. Although EMSA is
typically performed with native polyacrylamide gels, several combinations of polyacrylamide
and agarose gels in both native and denaturing conditions were tested. Agarose gels offer many
advantages, including ease of preparation, shorter running times, and simpler extraction methods.
However, polyacrylamide gels can provide greater resolution for shorter sequences and may
have advantages for some systems. Preparative gel shift conditions were optimized by crosslinking a TBA molecule flanked by ACAC/CACA tails (ordered from IDT) to thrombin. In order
to isolate the covalently cross-linked DNA-protein complexes from non-covalently linked
complexes, a denaturing agent is required. To illustrate the shifting differences between the two
types of complexes, native PAGE and native agarose were employed. The denaturing agent
(SDS) was added to the sample loading buffer if isolating the cross-linked complexes was
desired. Native tris-glycine PAGE with SDS in the sample buffer was not a suitable option; free
DNA traveled with the salt front and the denatured protein smeared. Native TAE agarose with
SDS in the sample buffer was also not an ideal option. Due to the larger pore size of agarose
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gels, both the full length protein and any degraded protein fragments traveled through the gel at
the same rate, resulting in a single band. Similarly, any protein cross-linked with DNA traveled
in that same band. Both horizontal and vertical agarose gels were tested. Vertical agarose gels
are thin (1.5 mm) and stain much quicker than horizontal slab agarose gels (~0.7 mm-10.0 mm).
The reduced thickness in combination with limited diffusion during staining resulted in a sharper
image for vertical agarose gels. However, due to the nature of the well shape, smearing of free
DNA occurred in vertical gels, which may lead to contamination while extracting cross-linked
products. Increased glycerol concentration and loading the sample while applying current did not
resolve the issue. SDS-agarose gels (SDS in gel buffer and/or running buffer) in the horizontal
and vertical orientations were also tested. Both SDS-agarose and SDS-PAGE provided distinct
separation of free DNA from cross-linked DNA. While both require the use of dialysis
membranes to extract the desired product, SDS-PAGE provides separation of full length protein
from protein fragments, ensuring that only the desired cross-linked products are collected.
Ultimately, SDS-PAGE was chosen as the preferred preparative method for separating free DNA
and cross-linked DNA. SDS-PAGE is most commonly used for protein analysis; therefore
nucleic acid staining procedures are not widely used. The preferred method for staining nucleic
acid in SDS-PAGE is washing the gel in dH2O for 10 minutes, rinsing once with dH2O, then
staining in ethidium bromide at 1 µg/ml in dH2O for 20 minutes.[178] This staining method is
superior to staining with ethidium bromide in running buffer and staining with SYBR gold, both
of which resulted in a cloudy image.
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Reversible formaldehyde cross-linking conditions
While determining the best preparative gel-shift option, the reaction conditions for HCHO crosslinking were also optimized. The detailed procedure was modeled after the technique by
Brodolin.[172]
(1) Combine DNA and thrombin with 2 µl 5X CLB buffer (0.25 M HEPES-NaOH, pH 8.0,
0.5 M NaCl, 25 mM MgCl2, 25% glycerol) to a total volume of 10 µl.
(2) Gently mix, then heat to 37°C for 30 minutes.
(3) Add 1 µl of 0.2 M formaldehyde, freshly prepared from 37% formaldehyde (SigmaAldrich).
(4) Vortex briefly and incubate for 30 minutes at 37°C.
(5) Add 11 µl of 2X SB buffer (125 mM Tris-HCl pH 6.8, 2% SDS, 10 mM DTT, and 10%
glycerol) to quench the reaction.
(6) The 22 µl final volume is used immediately for gel electrophoresis or frozen at -80°C.
(7) If desired, heat sample at 95°C for 5 minutes or 65°C for a minimum of 4 hours to
reverse cross-links.
(8) Pre-run 12% SDS-PAGE with 0.1% SDS Tri-Glycine running buffer for 1 hour at 80V at
4°C. The gel apparatus was placed in an ice bath in a 4°C chromatography refrigerator to
prevent heating which may reverse the DNA-protein cross-links.
(9) Run the gel for 1-1.5 hours under the same conditions.
(10) Rinse gel in 200 µl dH2O for 10 minutes with agitation. Rinse briefly with dH2O. Stain
gel with 1 µg/ml ethidium bromide in dH2O for 20 minutes with agitation. Visualize
under UV light.
(11) If desired, stain protein with Coomassie Blue or GelCode Blue Safe Protein Stain.
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Many of the parameters outlined above, including reaction temperature, cross-linking time, and
HCHO concentration were varied to determine the effects on cross-linking efficiency. The
quantity of cross-linked products is greater at 37°C than at 25°C and at 200 mM compared to
lower concentrations. It was also determined that at 37°C, the quantity of cross-linked product
for 100 pmol of thrombin with 100 pmol of TBA is saturated after approximately 30 minutes of
reaction time. Figure 6.2 illustrates the result of cross-linking thrombin in the presence or
absence of TBA at 37°C and the effect of heating at 95°C for 5 minutes. Following staining with
ethidium bromide in Figure 6.2.A, it was apparent that both the nucleic acid and protein could
be visualized. Vincent and Scherrer[178] noted that proteins can also be detected by ethidium
bromide and visualization of proteins can be intensified by reducing the fluorescence of the gel
itself by washing in water prior to staining. Although protein staining was used for some
preliminary experiments to confirm the location of thrombin (see Figure 6.2.B), this effect
essentially eliminates the need for protein staining. Lanes 1 through 4 show the effect of crosslinking time on thrombin in the absence of TBA. A very slight increase in size is noticed as
reaction time is increased from 30 seconds in lane 1 to 20 minutes in lane 4. In lane 5, the sample
has been heated to 95°C for 5 minutes following 20 minutes of cross-linking time. After reversal
of the cross-links, a slight shift back to the smaller product is noticed. This shift in size is likely
the result of protein-protein cross-links. Lanes 6 through 10 show the effect of cross-linking time
on thrombin in the presence of TBA. An obvious shift in size occurs with increasing intensity as
time is increased from 30 seconds in lane 6 to 20 minutes in lane 9. After reversal of the crosslinks, the larger product disappears in lane 10. Figure 6.2.B shows the same gel with coomassie
blue protein staining. The visible shift to a larger band correlates with the shifting observed in
Figure 6.2.A and only occurs in the presence of TBA. The results from this experiment indicate
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that the band that appears following the cross-linking of thrombin and TBA is a TBA-thrombin
complex and that the cross-links are visibly reversed after 5 minutes at 95°C.

Application of HCHO cross-linking to AIA
Based on sequencing data presented in chapter 5, in order for HCHO cross-linking to be an
effective method of partitioning with a 100 pmol aliquot of a tailed library and no amplification,
the quantity of recovered library must be approximately 0.011 pmoles or less. Based on
calculations from Table 5.2, if 0.01 pmoles is recovered with a 100% retention rate of a unique
sequence from a staring pool of 100 pmoles (~56,000 copies of each sequence) and optimal
cluster efficiency of a 4-plex sequencing run is achieved, that unique sequence should appear
approximately 46 times in 5,000,000 clusters. This is sufficient to distinguish aptamer hits
against a low background. However, an even smaller recovery with lower background is
favorable to accommodate less than optimal cluster density.

To test reversible HCHO cross-linking as a partitioning method, the m=15 tailed library
(pACAC-m15-CACA) was screened against thrombin in ratios of 1:1, 1:5, 1:10 and 1:50
(thrombin: library) as indicated in Table 6.1. The quantity of thrombin was held constant at 100
pmol while the library quantity was varied at 100 pmol, 500 pmol, 1 nmol and 5 nmol. The
samples were cross-linked at 37°C for 30 minutes following the aforementioned protocol and
analyzed via SDS-PAGE (Figure 6.3). Lane 1 shows the location and intensity of 100 pmol of
free m=15 library (cross-linked). Lane 2 serves as a negative control (absence of DNA) to show
the location and intensity of 100 pmol of cross-linked thrombin. Lanes 3-6 are the cross-linking
reactions in order of increasing library concentration for 100 pmol of thrombin. Due to the large
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quantity of free DNA and because thrombin is also stained by ethidium bromide, it is difficult to
estimate the quantity of DNA that is cross-linked. The gel image illustrates that as the
concentration of library increases, a greater quantity of DNA-protein cross-links are formed.
Also evident, is the formation of a second, larger cross-linked product that appears with
increasing concentration of library. This band appears clearly in lanes 4 and 5 and is likely
protein cross-linked with >1 library molecules. The bands corresponding to DNA-protein crosslinks and what is assumed to be protein cross-linked with >1 library molecules were excised for
lanes 3-6 with gel excision tips (GeneCatcher). The DNA-thrombin complexes were eluted from
the gel slices using D-Tube Dialyzers (Millipore, MW cut-off 3.5 kDa). The gel slices were
placed in pre-hydrated dialyzers with 800 µl of running buffer. The dialyzers were submerged in
running buffer in a horizontal electrophoresis unit and current was applied perpendicular to the
membrane windows at 110 V for 2 hours. The current was reversed for 1 minute to release the
protein and DNA from the membrane. The current was reapplied in the initial direction for an
additional 30 minutes followed by a final 2 minutes with reversed current. It is possible that the
HCHO cross-links were reversed during electro-elution, as warming of the buffer was not
prevented. The molecular weight cut-off of the membrane is 3.5 kDa, which is lower than the
average molecular weight of the library at ~7.0 kDa, so any free DNA would not be lost. After
pipetting up and down 5 times, the buffer was removed from the dialysis tube. An aliquot of 200
µl running buffer was used to rinse the inside of the dialysis tube and was collected in the same
manner. To ensure complete reversal of the cross-links, the combined 1,000 µl sample was
heated at 65°C overnight. Phenol extraction was used to recover the partitioned DNA libraries.
Equal volume Tris-buffered, pH 8.0, 0.1mM EDTA, 50% phenol, 48% chloroform, 2% isoamyl
alcohol (Sigma Aldrich) was added and vortexed for 30 seconds. Centrifugation at 13,000 rpm
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for 5 minutes resulted in an aqueous top layer (containing the library) and organic bottom layer.
The aqueous layer was removed and the library was subsequently extracted twice with equal
volumes 100% chloroform. The library was then purified by ethanol precipitation. One tenth the
volume of 3M sodium acetate and three times the volume of cold ethanol and were added to the
library and mixed briefly. Following an overnight incubation at -20°C, centrifugation at 13,000
rpm for 30 minutes resulted in a library pellet. After decanting the liquid, the pellet was washed
with 1 ml 70% ethanol. Centrifugation at 13,000 rpm for 20 minutes resulted in a library pellet.
The pellet was air dried in a SpeedVac, and then resuspended in 10 µl dH2O. The recovered
DNA was not quantified to reduce loss.

The libraries were modified with sequencing adapters and their complements. Adapter 1,
Adapter 1 Complement, Adapter 2 (indexed), and Adapter 2 Complement (indexed) at 10 µM
were added in 1 µl volumes to the recovered library. The mixtures were incubated at 90°C for 3
minutes and cooled in a thermocycler at a rate of 0.5°C per minute to 4°C. At 4°C, 2 µl of 10X
ligation buffer (300mM Tris-HCl (pH 7.8), 100mM MgCl2, 100mM DTT and 10mM ATP),
(Promega), 3 µl dH2O and 1 µl T4 DNA ligase (10mM Tris-HCl (pH 7.4), 50mM KCl, 1mM
DTT, 0.1mM EDTA and 50% glycerol), (Promega) were added. Following a 24 hour incubation
at 4°C, the ligated products were visualized on a 4% TAE agarose gel alongside negative and
positive controls. The gel image is shown in Figure 6.4. The ~144 bp product is identified in the
positive control lanes 3 and 8. The ligated product is visible for all four experimental samples
with increasing intensity as the starting concentration of library increases from 100 pmol to 5
nmol. This indicates that a fraction of the starting library was successfully cross-linked to
thrombin, eluted from the gel slice, and purified by phenol extraction and ethanol precipitation
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prior to ligation. From previous experiments, it is known that a visible ligation product contains
too large a quantity of DNA to be suitable for sequencing. The quantity of nonspecific sequences
in the four samples would be too high to distinguish any aptamer candidates. For this reason,
quantitative PCR was not performed. However, the results from this experiment provide
confidence that the reversible formaldehyde cross-linking procedure and the purification
methods described above will result in the correct product. This confidence is critical because the
quantity of DNA that will produce favorable sequencing data is not visible during SDS-PAGE
and agarose gel electrophoresis.

Increasing selection stringency
To determine the concentration of thrombin in a 30 minute cross-linking that would produce
fewer than 0.01 pmoles of recovered library, a dilution series of thrombin was cross-linked to the
m=15 tailed library. A 100 pmol aliquot of the library was combined with 100, 20, 10, 5, 1, 0.1,
or 0.01 pmoles of thrombin (see Table 6.2, top) and HCHO cross-linked for 30 minutes at 37°C.
The cross-linked library was separated from free library by SDS-PAGE. Figure 6.5 shows the
cross-linked products separated by SDS-PAGE. Lane 1 serves as a negative control (absence of
DNA) to indicate the location of thrombin. Lanes 2-8 are the cross-linking reactions in order of
decreasing thrombin concentration. Lane 9 is a duplicate of lane 2, containing 100 pmoles of
m=15 DNA cross-linked to 100 pmoles of thrombin, and serves as a size marker for excising the
non-visible bands across the gel. The cross-linked products from lanes 3-8 (20 – 0.01 pmol
thrombin) were excised using 4.0 mm by 1.0 mm disposable gel excision tips (GeneCatcher) to
minimize cross contamination between samples. The DNA-protein cross-links were eluted from
the gel slices using D-Tube Dialyzers, cross-links were reversed at 65°C overnight, and the
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library was phenol/chloroform extracted and ethanol precipitated as described above. The
samples were ligated with indexed adapters similarly to the previous samples and visualized on a
4% TAE agarose. Although no bands were visible, gel slices were excised at the corresponding
location as identified by a positive control size marker. The ligated library was extracted from
the gel with the MiniElute Gel Extraction Kit (Qiagen) and resuspended in 10 µl dH2O. The
precise quantity of amplifiable DNA was determined with the KAPA Library Quantification kit
on the BioRad iCycler. Table 6.2 outlines sample information and statistical data. The number of
pmoles of library recovered was calculated by qPCR and was used to determine the potential
number of TBA counts in a 4-plex sequencing run with optimal cluster efficiency. Although all
six samples were quantifiable by qPCR, the expected trend in the quantity of recovered DNA is
not seen. Because the concentration of library was too low to be visualized during ligation for
several of the samples, the ligated products were characterized by melt curve analysis to
determine whether the quantified DNA was the full length product or primer-dimers. The
samples were amplified with the SYBR Select Kit (Life Technologies). Melting curve data was
collected over a gradient of 95°C to 50°C at a rate of 0.5°C per 30 seconds. All six ligated
samples were characterized with the correct ~82.5°C melting temperature. The primer-dimer that
occurs in the negative control was characterized by a melting temperature of ~80.5°C. qPCR data
suggests that ≤20 pmoles of thrombin cross-linked for 30 minutes at 37°C will produce a low
enough quantity of library to allow high affinity binding sequences to be counted above
background.

To demonstrate consistency in sample preparation prior to a commitment to sequencing, a large
pool of samples with variations of protein and library concentration and cross-linking times were
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analyzed by EMSA on SDS-PAGE. A combination of four samples thought to provide the
greatest breadth of understanding on the dynamics of the cross-linking reaction was chosen for
sequencing. The goal was to recover a small quantity of library that contains primarily high and
moderate affinity binding sequences and low background. The m=15 tailed library was crosslinked to a dilution series of thrombin consisting of 100, 10, 1, 0.1, and 0.01 pmoles. The m=15
tailed library was used in 1 nmol quantities to ensure high copy number of approximately
560,000 in the starting pool. If 0.01 pmoles of library were recovered from a 1 nmol pool with
100% recovery of the 560,000 counts of TBA and optimal cluster efficiency of a 4-plex
sequencing run was achieved, TBA should appear approximately 460 times in 5,000,000
clusters. Each ratio was cross-linked for times of 30 seconds, 3 minutes and 30 minutes at 37°C.
The samples were analyzed on SDS-PAGE as illustrated in Figure 6.6 (only 100, 10 and 1 pmol
are shown). The thrombin-library complex is visible for 100 pmoles of thrombin at 3 minutes
and 30 minutes and for 10 pmoles of thrombin at 30 minutes. The four samples chosen for
sequencing were 100 pmoles of thrombin at 30 seconds and 1 pmole of thrombin at 30 seconds,
3 minutes and 30 minutes. This combination of samples provided a comparison of protein
concentration and cross-linking time on selection efficiency and stringency. The cross-linked
products from lanes 2, 8, 9 and 10 were excised using 4.0 mm by 1.0 mm disposable gel excision
tips (GeneCatcher) and eluted using D-Tube Dialyzers, cross-links were reversed at 65°C
overnight and the library was phenol/chloroform extracted and ethanol precipitated as described
above. The samples were ligated with indexed adapters similarly to the previous samples and
visualized on a 4% TAE agarose. Although no bands were visible, gel slices were excised at the
corresponding location as identified by a positive control size marker. The ligated library was
extracted from the gel with the MiniElute Gel Extraction Kit (Qiagen) and resuspended in 10 µl
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dH2O. The precise quantity of amplifiable DNA was determined with the KAPA Library
Quantification kit on the BioRad iCycler. Additionally, the raw amplification data was used to
calculate the quantity of amplifiable DNA using qPCR CopyCount TM software as a means of
verifying the performance of the KAPA kit to ensure maximum cluster quality.

Absolute quantification using qPCR CopyCountTM
The accurate quantification of a library is crucial for maximization of data output on Illumina
sequencing platforms. If the amount of amplifiable library is overestimated, the result is lower
than expected cluster density. If the amount of amplifiable library is underestimated, the result is
crowded clusters and poor resolution. The KAPA Library Quantification kit has been used
extensively for quantification of sequencing samples in AIA. The KAPA kit requires the use of
six DNA standards and the acquisition of a standard curve. The quantification of unknowns is
inferred based on this curve. In contrast, qPCR CopyCountTM software is capable of analyzing
the shape of any qPCR curve in the absence of standards to determine the absolute number of
amplifiable copies of DNA at cycle zero. qPCR CopyCountTM is built upon the Mass Action
Kinetic model with 2 parameters (MAK2) that account for the concentration at cycle zero and
changes in amplification efficiency by cycle to determine the relative concentration of a target in
solution[179]. pPCR CopyCountTM is three times more accurate than MAK2 and is automated
for all qPCR instrumentation. These developments led to the principle of cPCR (counting PCR),
where the fluorescence of a single copy of DNA is determined from the amplification curve to
determine the number of copies of DNA at cycle zero. The software boasts quantification with
20% absolute accuracy and 1-5% relative accuracy without calibration. The implementation of a
calibration plate (cPCR for 96-384 well plate with ~1.5 copies per well) for a given assay
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improves the absolute accuracy to less than 5% error.[180] As mentioned, the HCHO crosslinking experiments intended for sequencing were quantified using the qPCR CopyCount TM
software in addition to the KAPA Library Quantification kit. The results from both methods of
quantifications are detailed in Table 6.3. The quantity of recovered library was calculated with
the KAPA data as described in chapter 5. The raw amplification data from the KAPA data
(including amplification data for the standards) was analyzed with qPCR CopyCount TM. The
average copy number from triplicate wells was used to calculate the concentration of the reaction
in pM, which was used to calculate the pmoles of library in the stock solution.

Absolute quantification with the qPCR CopyCountTM software gave higher concentrations for all
samples. The data from both methods is in approximate agreement for samples 3 and 4. Sample 2
was estimated to be ~1.38 times higher by qPCR CopyCountTM. Sample 1 was estimated to be
~6.12 times higher by qPCR CopyCountTM. In order to provide insight into the large variation in
sample 1, the raw fluorescence data of the six KAPA standards was analyzed with qPCR
CopyCountTM. The qPCR CopyCountTM determination for the six standards was also higher than
the assumed concentrations, ranging from ~1.3 – 3.2 times higher. The discrepancies observed in
the absolute quantification of the standards explain the varied results for the unknowns. Figure
6.7 illustrates the amplification variability of the six KAPA standards as determined by qPCR
CopyCountTM for six experiments. The log of the starting concentration (pM) is plotted versus
the standard number, creating an illustration of the linear standard curve. For all six experiments,
the amplification does not fit the linear standard curve. It is overestimated by varying degrees in
all instances, with individual data points varying from approximately 1.06 – 6.6 times higher.
This variability between individual data points within a standard curve and the variability
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between standard curves of separate experiments illustrates the potential inaccuracies introduced
by the standard curve. The qPCR CopyCountTM software has been validated on over 100,000
samples and the website details digital droplet qPCR data compared to qPCR CopyCount TM data
with an R2 value of 0.99991.[180] A calibration plate for the KAPA kit assay was not successful
(unreliable due to poor Chi-squared distribution), indicating that the qPCR CopyCountTM data
should have a maximum of 20% absolute error. When compared to the KAPA determinations of
the experimental samples and standards, the qPCR CopyCountTM data varied well outside this
margin. If the qPCR CopyCountTM data is accurate within 20%, this suggests that experimental
concentrations determined from the overestimated standard curves would be underestimated.
Underestimating the quantity of amplifiable DNA results in over-loading the flow cell which can
cause over-clustering and poor resolution.

There are multiple metrics that can be used to help identify over-clustering, including the
percentage of clusters that pass filter, Q30 scores, and signal intensity per tile. If over-clustered,
clusters begin to overlap which leads to poor template generation. Especially for low diversity
libraries, distinguishing between overlapped clusters is difficult and results in poor signal purity.
This reduces the overall percentage of clusters that pass filter, ultimately reducing data output.
The same effect is observed during demultiplexing, where signal purity of low diversity indices
is compromised by over-clustering. Additionally, if a flow cell is over-clustered, the overall
fluorescence intensity of the flow cell increases, making it more difficult to analyze signal
intensity. This can lead to low Q30 scores; the Q score identifies the probability of incorrect base
calling and a score of >Q30 indicates 99.9% accuracy in base calling. The MiSeq flow cell
contains 28 tiles with both top and bottom surfaces. The average signal intensity per tile allows
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the user to identify regions of the flow cell that are over-clustered. If a tile is over-clustered,
image extraction may fail which results in an intensity of zero for that tile, rendering intensity
data for that tile unusable. The most recent sequencing run on the Illumina MiSeq was loaded
with the suggested maximum concentrations of DNA (0.04 pmoles of single-stranded library as
determined by the KAPA kit) and the number of clusters totaled ~16 million. A lower than
expected percentage of clusters passed filter (~51%), indicating poor cluster quality.
Furthermore, qualified data was reduced to 41% during demultiplexing. The percentage of
clusters with >Q30 scores was 85.5% and multiple tiles were identified with image extraction
failure. Analysis of the raw qPCR amplification data for the samples sequenced on this run with
qPCR CopyCountTM produced higher concentrations for all samples, confirming that they may
have been underestimated by the KAPA kit. For the sequencing run of the HCHO cross-linking
samples, the qPCR CopyCountTM determinations were used to prepare the sample for loading
onto the flow cell. No changes to the sequence structure were made, so if cluster quality
improved when utilizing the qPCR CopyCountTM determination for the HCHO cross-linked
samples, it would indicate a more accurate determination. Additionally, a PhiX control
(generated from the PhiX174 bacteriophage genome) was spiked at 5% during clustering. The
PhiX control introduces high diversity clusters to aid in creating cluster diversity among the low
diversity tailed libraries.

Results and Discussion
Statistical analysis of sequencing data for the four HCHO cross-linking experiments with varied
thrombin concentration and reaction times is outlined in Table 6.4. The total number of clusters
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is ~17 million with approximately 79% passed filter. Following demultiplexing, this was reduced
to ~61%. The percentage of clusters with >Q30 scores was 90.9% and there are no indications of
over-clustering based on this data. The four samples were loaded in a 1:1:1:1 ratio during
clustering according to the qPCR CopyCountTM determination. The resulting ratio of PF clusters
for samples 1-4 was 1.35:1.06:1.00:1.03.

Samples 3-4 are in approximate agreement while

sample 1 was clustered at a higher frequency. This suggests that the concentration of sample was
slightly underestimated in comparison to samples 3-4. Approximately 29% of sample 1 was
loaded onto the flow cell, however, 90% would have been required using the KAPA kit
determination which would have drastically skewed the ratio of indices to sample 1. Samples 3-4
would have been loaded with an approximate 10% increase, although the ratio remains relatively
the same. If the KAPA kit determinations had been used, the distribution of indices would have
been significantly more skewed and the flow cell may have been over-clustered. Clustering with
the qPCR CopyCountTM data produced a favorable distribution of indices and prevented overclustering.

The data was parsed with the Perl script to identify sequences with perfect matches for both the
head and tail as “candidate” reads and those with an m=15 variable region as “good” reads. The
counts per unique sequences were tallied and the top ten sequences are presented in Table 6.5.
The percentage of good reads for all four samples was lower than expected. A brief search of the
“candidate” and “bad” reads does not indicate that the counts for the top sequences would be
altered drastically if a revision to the Perl script was made to allow for mismatches or
insertions/deletions in the head and tail. The majority of the bad reads were jump sequence
variants that would not contribute to the nmer count data. Considering the improved cluster
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quality for this sequencing run, it was unclear why the percentage of good reads was low. The
expected counts of TBA (or any unique aptamer sequence) for each sample were recalculated
based on the total number of reads identified after demultiplexing and an assumed 100%
recovery of the ~560,000 starting counts.

The presence of TBA above background indicates that reversible HCHO-crosslinking in
conjunction with EMSA was a successful partitioning method. The expected counts were
determined as 85, 184, 103 and 96, respectively, while the observed counts of TBA were 123,
15, 0 and 342, respectively. As indicated in Table 6.5, the only non-TBA molecules above
background are jump sequence variants. This indicates a high level of stringency during
partitioning. The results also confirm the applicability of the tailed libraries in amplification-free
AIA and the ability to predict relative sequence frequency. The similarity of observed
counts/frequency of TBA to the expected counts/frequency confirms the selection efficiency.
Cross-linking 1 nmol of m=15 tailed library against 100 pmol of thrombin for 30 seconds
produced 123 counts of TBA, an increase of 145% over the expectation. Cross-linking for the
same duration with 1 pmol of thrombin produced 15 counts, only 8% of the expected. Increasing
the cross-linking time to 3 minutes for 1 pmol of thrombin produced 0 counts of TBA. If the
cross-linking was comparably efficient to the 30 second cross-linking time that recovered 8% of
the expected, ~8.24 counts of TBA would be expected for sample 3. Although the samples were
prepared carefully, slight variations in sample preparation are always possible, including
pipetting techniques. For example, a 10% variation in library volume would reduce the starting
counts of expected counts of TBA from 103 to 92. Variations in HCHO or protein volume are
also possibilities. Increasing the cross-linking time to 30 minutes produced 342 counts of TBA,
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an increase of 356% over the expectation. The calculations for the expected counts are based on
the assumption that the 1 nmol library pool contained ~560,000 copies of TBA. It is possible that
the concentration of the stock solution was underestimated, resulting in a larger than expected
quantity of starting pool. This would explain the higher than anticipated counts of TBA observed
for samples 1 and 4. Regardless, this data suggests that for 1 pmol of thrombin and ~1 nmol of
library, 30 seconds and 3 minutes are not sufficient to reliably select for TBA above background.
A 30 second cross-linking time is sufficient for 100 pmol of thrombin; however, cross-linking
for 30 minutes with 1 pmol of thrombin was superior. In both experiments, a single TBA variant
is also identified above background.

To confirm the results of cross-linking for various times, samples 2-4 were repeated and
sequenced on the Illumina Seq. Table 6.6 details the sample information and anticipated
sequence frequency according to qPCR data from both the KAPA kit and qPCR CopyCount TM.
The calculated recovery for each sample was below the maximum 0.01 pmoles for a 4-plex
sequencing run, therefore, the samples were loading in their entirety (90% of the recovered
library after qPCR analysis) in a 1.6:1.1:1 ratio. The overall reduced quantity of recovered
library could be attributed to variations in sample preparation, inducing efficiency of electroelution, phenol extraction, ethanol precipitation or ligation. Statistical analysis of sequencing
data for the three HCHO cross-linking experiments with varied reaction times is outlined in
Figure 6.7. The total number of clusters is ~13.5 million with approximately 79% passed filter.
Following demultiplexing, this was reduced to ~57%. A fourth, unrelated sample was also
sequenced and 88% of the readable data corresponds to the three HCHO cross-linking samples.
The percentage of clusters with >Q30 scores was 90.2% and there are no indications of over-
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clustering based on this data. The resulting ratio of PF clusters for samples 2.1-4.1 was
1.45:1.06:1, which is in approximate agreement with the ratio of recovered library as determined
by qPCR CopyCountTM. The ratio as determined by the KAPA kit is 0.42:1.25:1, indicating that
the qPCR CopyCountTM determination was more accurate.

The data was parsed with the Perl script as described above and the counts per unique sequences
were tallied and the top ten sequences are presented in Table 6.8. The percentage of good reads
for all three samples was also lower than expected and the majority of the bad reads were jump
sequence variants that would not contribute to the nmer count data. The expected counts of TBA
(or any unique aptamer sequence) for each sample were recalculated based on the total number
of reads identified after demultiplexing and an assumed 100% recovery of the ~560,000 starting
counts.

The expected counts of TBA for 30 seconds, 3 minutes, and 20 minutes of cross-linking were
determined as 400, 448 and 451, respectively. The observed counts of TBA were 28, 4, and 272,
respectively. The results correlate with the findings in the first set of samples: a 30 minute crosslinking time with 1 pmol of thrombin and 1 nmol of library is capable of selecting TBA well
above background, while 30 second and 3 minute cross-linking times are not as efficient. The 30
minute cross-linking time also selected four TBA variants above background, while one was
counted in the prior run reported in Tables 6.4 and 6.5. Although the Kd’s of these sequences are
not known, it can be assumed that they are lower affinity binders. This supports the hypothesis
that both high and moderate affinity aptamers can be selected with reversible HCHO crosslinking in conjunction with EMSA.
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A comparison of the frequency of TBA observed in these seven experiments is not
straightforward due to the low percentage of good reads and varied quantity of recovered library.
A comparison of frequency within a sequencing run may offer a different conclusion than a
comparison of frequency across sequencing runs. If a comparison is made across sequencing
runs, it could be concluded that the conditions for sample 1 (30 seconds, 100 pmol thrombin) and
sample 2.1 (30 seconds, 1 pmol thrombin) offer similar partitioning efficiencies because they
have the same frequency of 0.015%. However, a comparison of the frequencies for sample 1 and
sample 2 from the same sequencing run (0.015% and 0.039%, respectively) indicates that sample
1 offers more efficient partitioning conditions. In previous chapters, the frequency of TBA was
compared across sequencing runs as a metric for determining partitioning efficiency. However,
amplification free AIA introduces a higher level of understanding of the relationship between the
quantities of recovered library and sequence frequency. For example, the frequency of TBA for
samples 2 and 2.1 (30 seconds, 1 pmol thrombin) are 0.0039% and 0.015%, which correlates
with the quantity of recovered library of 0.0127 pmoles and 0.0065 pmoles, respectively. A
larger quantity of recovered library contains a larger percentage of nonspecific sequences which
reduces the expected frequency of any high affinity sequence.

Conclusions
The results from two MiSeq sequencing runs for reversible formaldehyde cross-linking in
conjunction with EMSA illustrate that the method was successful as a partitioning method for the
selection of the thrombin binding aptamer against thrombin in solution. The sequencing data also
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confirms the applicability of the tailed libraries in amplification-free AIA and the ability to
predict relative sequence frequency. Additionally, the sequencing data suggests that
quantification with qPCR CopyCountTM software is more accurate and produces a more
favorable distribution of indices compared to the KAPA Library Quantification kit. The accurate
quantification of libraries is crucial for maximization of data output on Illumina sequencing
platforms. Maximizing high quality data output while decreasing costs and labor demands are
consistent with the goals of AIA. Implementation of qPCR CopyCountTM eliminates the need for
standard curves, which saves both time and money. Additionally, producing higher quality
sequencing data with the desired distribution of indices eliminates costly resequencing.

For the discovery of novel aptamers to protein targets, the cross-linking conditions would need to
be determined empirically from multiple sequencing experiments. The cross-linking efficiency
for individual protein targets will differ based on the amino acid sequence and availability of
amino/imino groups as well as the relative affinity of any aptamer candidates. The cross-linking
conditions used for the m=15 DNA tailed library and thrombin may serve as a starting point for
these experiments. Figure 6.8 shows the EMSA of a preliminary reversible HCHO cross-linking
experiment of SL3 RNA with NCp7. NCp7 was also shown to cross-link with an m=40 minimal
primer library (described in the next section) and the m=15 DNA tailed library. Sequencing the
results of a reversible HCHO cross-linking partitioning of a DNA or 2’-OMe RNA/DNA
chimera library against NCp7 would illustrate the applicability of the method for other protein
targets.
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Figure 6.1 Formaldehyde cross-link formation
218

Formaldehyde crosslinking mechanism. (A) Reaction of formaldehyde with an amino group to
form a Schiff bae. (B) The Schiff base can then react with another amino group to form the
cross-link.
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Figure 6.2 EMSA of reversible HCHO cross-linking of thrombin and TBA-thrombin
(A) 12% SDS-PAGE stained with ethidium bromide. Lanes 1-5: 10 pmol of thrombin. Lanes 14: HCHO cross-linked for 30 seconds, 5 minutes, 10 minutes and 20 minutes respectively. Lane
5: HCHO cross-linked for 20 minutes and reversed with heat. A slight shift in band size is
observed with increased cross-linking time. Lanes 6-10: 10 pmol of thrombin and 100 pmol of
TBA. Lanes 6-9: HCHO cross-linked for 30 seconds, 5 minutes, 10 minutes and 20 minutes,
respectively. Lane 10: HCHO cross-linked for 20 minutes and reversed with heat. The thrombinTBA complex is visible after 5 minutes of cross-linking time. Thrombin-TBA cross-links are
visibly reversed after heating. (B) Same gel stained with Coomasie Blue protein stain. The
visible shift to a larger band correlates with the shifting observed in (A) and only occurs in the
presence of TBA.
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Figure 6.3 EMSA of reversible HCHO cross-linking of m=15 DNA tailed library to
thrombin
12% SDS-PAGE stained with ethidium bromide. Lane 1: 100 pmol of cross-linked m=15 DNA
library. Lane 2: 100 pmol of cross-linked thrombin. Lanes 3-6: 100 pmol thrombin cross-linked
with m=15 DNA library in 100 pmol, 500 pmol, 1 nmol and 5 nmol quantities, respectively.
Thrombin-library complexes are visible for all samples in lanes 3-6, with an increase in intensity
as the concentration of library is increased. A second, larger band appears with increased library
concentration as the result of crosslinking >1 library molecule.
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Figure 6.4. Ligation of library recovered by HCHO cross-linking and EMSA
Lane 1: 25 bp ladder. Lane 2: No template control. Lanes 3 and 8: positive controls, 10 pmol of
m=15 DNA tailed library ligated to adapters. Lanes 4-7: ligated samples #1-4 (as named in
Table 6.1). Correct double ligation product is seen for all four samples with increasing intensity
as the concentration of library used in cross-linking increases.
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Figure 6.5 EMSA of reversible HCHO cross-linking of the m=15 DNA tailed library to a
dilution series of thrombin
12% SDS-PAGE stained with ethidium bromide. 100 pmol of m=15 DNA tailed library HCHO
cross-linked to a dilution series of thrombin for 30 minutes at 37°C. Lane 1 is a no DNA control.
Lanes 2-8: 100, 20, 10, 5, 1, 0.1 and 0.01 pmoles thrombin, respectively. Lane 9 is a duplicate of
Lane 2 to serve as a size marker. The thrombin-m=15 library complex is visualized for 100, 20
and 10 pmoles of thrombin.
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Figure 6.6 EMSA of reversible HCHO cross-linking the m=15 DNA tailed library to a
dilution series of thrombin for 30 seconds, 3 minutes and 30 minutes
12% SDS-PAGE stained with ethidium bromide. 1 nmol of m=15 DNA tailed library HCHO
cross-linked to a dilution series of thrombin for 37°C. Lane 1 is contains sample buffer only.
Lanes 2-4: 100 pmoles of thrombin cross-linked at 30 seconds, 3 minutes and 30 minutes,
respectively. The m=55-thrombin complex is visualized for 3 minutes and 30 minutes. Lanes 57: 10 pmoles of thrombin cross-linked at 30 seconds, 3 minutes and 30 minutes, respectively.
The m=15-thrombin complex is visualized for 30 minutes. Lanes 8-10: 1 pmole of thrombin
cross-linked at 30 seconds, 3 minutes and 30 minutes, respectively. The m=15- thrombin
complex is not visible.
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Figure 6.7 Comparison of KAPA Standard Curve versus qPCR CopyCountTM
determination
The log of the starting concentration (pM) is plotted versus the standard number, creating an
illustration of the linear standard curve of the KAPA Library Quantification kit. “Standard
Curve” represents the six DNA standards with assumed concentrations of 20, 2, 0.2, 0.02, 0.002
and 0.0002 pM. The qPCR CopyCountTM determination for the six standards was determined for
six experiments and is plotted versus standard number. The amplification data does not fit the
linear standard curve and is overestimated by varying degrees in all instances, with individual
data points varying from approximately 1.06 – 6.6 times higher.
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Figure 6.8 EMSA of reversible HCHO cross-linking NCp7 and SL3-NCP7
12% SDS-PAGE stained with ethidium bromide. Lanes 1-2: 10 pmol of NCp7 cross-linked for
20 minutes. Lane 2: reversed with heat. Lanes 3-7: 10 pmol of NCp7 and 100 pmol of SL3
RNA. Lanes 3-6:

cross-linked for 30 seconds, 5 minutes, 10 minutes and 20 minutes,

respectively. Lane 7: HCHO cross-linked for 20 minutes and reversed with heat. The SL3-NCp7
complex is visible after 30 seconds and cross-links are visibly reversed after heating.
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Table 6.1 Reversible HCHO cross-linking sample information
Sample
1
2
3
4

Ratio (protein: library)
1:1
1:5
1:10
1:50

Protein
100 pmol
100 pmol
100 pmol
100 pmol

Library
100 pmol
500 pmol
1 nmol
5 nmol

Index
2
4
6
12

Sample information for four HCHO cross-linking experiments used to confirm the preparative
methods.
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Table 6.2 Sample information and anticipated sequence frequency for HCHO cross-linking
the m=15 DNA tailed library to a dilution series of thrombin
Sample
3
4
5
6
7
8

Ratio (protein: library)
1:5
1:10
1:20
1:100
1:1,000
1:10,000

Protein
20 pmol
10 pmol
5 pmol
1 pmol
0.1 pmol
0.01 pmol

Library
100 pmol
100 pmol
100 pmol
100 pmol
100 pmol
100 pmol

Index
6
12
2
4
6
12

Sample

pmoles of
Library
Recovered

pmoles of
Library
Available

Number of
Molecules

Expected
Number of
Clusters

Clusters as a
Percentage
of Molecules

3
4
5
6
7
8

0.00118
0.00026
0.00040
0.00073
0.00103
0.00070

0.00106
0.00024
0.00036
0.00066
0.00093
0.00063

6,380,000,000
1,440,000,000
2,170,000,000
3,970,000,000
5,600,000,000
3,790,000,000

5,000,000
5,000,000
5,000,000
5,000,000
5,000,000
5,000,000

0.78 %
3.47 %
2.30 %
1.25 %
0.89 %
1.32 %

Number of
Surviving
TBA
molecules
436
1943
1288
700
498
739

(Top) Sample information for six HCHO cross-linking experiments of m=15 DNA tailed library
cross-linked to thrombin. Sample name corresponds to the lanes in Figure 6.5. (Bottom)
“pmoles of Library Recovered” was determined by qPCR analysis. “pmoles of Library
Available” is the quantity of remaining sample after preparing the qPCR samples. “Number of
molecules” is the number of molecules loaded onto the flow cell for a four-plex MiSeq run.
“Expected number of clusters” is based on 20 million clusters for a four-plex MiSeq run.
“Clusters as a percentage of molecules” is 5,000,000 as a percentage of the total molecules per
sample. “Number of surviving TBA molecules” is the maximum number of TBA counts
expected to be seen at 5,000,000 clusters with 100% recovery of the initial 56,000 copies of TBA
in the 100 pmol pool of library.
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Table 6.3 Sample information and anticipated sequence frequency for HCHO cross-linking
the m=15 DNA tailed library with varied thrombin concentration and reaction times
Protein
100 pmol
1 pmol
1 pmol
1 pmol

Library
1 nmol
1 nmol
1 nmol
1 nmol

Index
2
4
6
12

Cross-linking time
30 sec.
30 sec.
3 min.
30 min.

Sample

pmoles of
Library
Recovered

pmoles
of
Library
Used

Percentage
of Total

Number of
Molecules
Used

Expected
Number of
Clusters

Clusters
as a % of
Molecules

Number of
Surviving
TBA
molecules

KAPA

Ratio (protein: library)
1:10
1:1000
1:1000
1:1000

1
2
3
4

0.0057
0.0092
0.0220
0.0213

0.0051
0.0082
0.0125
0.0125

90%
90%
57%
59%

3,074,775,200
4,965,898,000
7,525,000,000
7,525,000,000

2,000,000
2,000,000
2,000,000
2,000,000

0.07%
0.04%
0.03%
0.03%

328
203
84
87

qPCR
CopyCountTM

Sample
1
2
3
4

1
2
3
4

0.0349
0.0127
0.0212
0.0235

0.0100
0.0100
0.0100
0.0100

29%
79%
47%
43%

6,020,000,000
6,020,000,000
6,020,000,000
6,020,000,000

2,000,000
2,000,000
2,000,000
2,000,000

0.03%
0.03%
0.03%
0.03%

53
147
88
79

(Top) Sample information for four HCHO cross-linking experiments of m=15 DNA tailed
library cross-linked to thrombin at varied protein concentration and cross-linking times.
(Bottom) “pmoles of Library Recovered” was determined by qPCR analysis with the KAPA kit
and QPCR CopyCountTM software. “pmoles of Library used” is the quantity of sample required
to equal a total of 0.04 pmoles for clustering. “Percentage of total” is pmoles of library used as a
fraction of pmoles of library recovered. “Number of molecules” is the number of molecules
loaded onto the flow cell for a four-plex MiSeq run. “Expected number of clusters” is based on
cluster quality from previous data for a four-plex MiSeq run. “Clusters as a percentage of
molecules” is 2,000,000 as a percentage of the total molecules per sample. “Number of surviving
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TBA molecules” is the maximum number of TBA counts expected to be seen at 2,000,000
clusters with 100% recovery of the initial 560,000 copies of TBA in the 1 nmol pool of library.
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Table 6.4. Statistical analysis of sequencing data for HCHO cross-linking of the m=15 DNA
tailed library with varied thrombin concentration and reaction times
Run

Total Number Clusters

Number of Clusters PF

Total Reads in Data Files

Samples 1-4

17,076,298

13,446,773

10,462,729

100 pmol thb
30 sec.
100 pmol
1 nmol
560,000

1 pmol thb
30 sec.
1 pmol
1 nmol
560,000

1 pmol thb
3 min.
1 pmol
1 nmol
560,000

1 pmol thb
30 min.
1 pmol
1 nmol
560,000

Total Reads
Total Good Reads

3,182,769

813,673

2,504,860
387,470

2,354,637
188,277

2,420,463
480,985

Background/Noise Threshold
Sequences Above Background

3
4

3
3

3
2

3
4

Expected Counts of TBA
Observed Counts of TBAa
Frequency of TBA per Good Readsb
Frequency of TBA per Total Readsc

85
1_123
0.015%
0.0039%

184
2_15
0.0039%
0.00060 %

103
0
0
0

96
1_342
0.07%
0.0040%

Experiment
Quantity of Protein
Quantity of Library
Starting Copies per Sequence

(Top) Total number of clusters produced per sequencing run. The number of clusters that passed
filter (PF) is approximately 79%. After demultiplexing, the total reads are approximately 61% of
the original clusters. (Bottom) Total number of reads for each sample generated by Illumina’s
BaseSpace. A total of 7,827 reads contained Index 1 of the positive control size marker. The
number of good reads was generated by the Perl Script. The expected number of TBA counts
was calculated from the quantity of library recovered, the quantity of library applied to the flow
cell and the number of good reads assuming a 100% recovery of the original 56,000 copies of
TBA. (a) The rank (left) and count (right) are separated by an underscore. (b) Counts of TBA
divided by the total good reads. (c) Counts of TBA divided by the total reads.
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Table 6.5. Top 10 Sequences for HCHO cross-linking the m=15 DNA tailed library with
varied thrombin concentration and reaction times

Sample 1: 100 pmol thb, 30 sec.
Sequence
Count Identifier
TBA
GGTTGGTGTGGTTGG
123
Jump*
CACAGATCGGAAGAG
71
Jump*
GTCTGATCGGAAGAG
8
Ia
GGTTGGTGTTGTTGG
5
TGCGTGGGCCGGCGC
GTGTTATCGAATCCT
TAGATAGCCAACTTA
GTAAACCCAACTGCG
TATATGAACCCGGAA
CTGGGAAGGCGCAGC

Sample 2: 1 pmol thb, 30 sec.
Sequence
Count Identifier
CACAGATCGGAAGAG
GGTTGGTGTGGTTGG
GTCTGATCGGAAGAG
TGAGGCGAGTGAACG
ATCATGAACGTCAGT
AATGTTGTGCAGAAC
GATCTGATGTAACCC
CTCAACCTGTTTGCG
CCCGCTTCTAAATTG
GTAACCCGGGGCCGA

3
3
3
3
3
3

Sample 3: 1 pmol thb, 3 min.
Sequence
Count Identifier
Jump*
CACAGATCGGAAGAG
11
Jump*
GTCTGATCGGAAGAG
7
CCCACACGGGTATTT
CAGCCAGAAACTACC
CAGGAATACGTATCC
ATAAGTCCTGATACC
TTAAAGATATGCTGA
GATATATCGGCTTAT
ATCACACCCCTACCC
CAGGCTTACTTCGCG

28
15
14
3
3
3
3
3
3
3

Jump*
TBA
Jump*

Sample 4: 1 pmol thb, 30 min
Sequence
Count Identifier
TBA
GGTTGGTGTGGTTGG
342
Jump*
CACAGATCGGAAGAG
30
Jump*
GTCTGATCGGAAGAG
11
Ia
GGTTGTTGTGGTTGG
5

3
3
3
3
3
3
3
3

CGATGTACGCCATGA
TACCGCGCTGACTCC
CCAAACAAGATAAGG
ATACCACGTCGGGCG
CCCCTTGACCCGAGT
ACCAGCTTAAACTTA

3
3
3
3
3
3

Top 10 sequences and corresponding counts for Samples 1-4. The thrombin binding aptamer
(TBA) was identified at counts of 123, 15, 0, and 342, respectively. Jump sequence variants are
present in all four samples and account for the only non-TBA variants above background. The
background for all four experiments is 3. Variants of TBA occur in samples 1 and 4 as the 4th
ranked sequences.
*Jump sequence variants.
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Table 6.6 Sample information and anticipated sequence frequency for repeat of HCHO
cross-linking the m=15 DNA tailed library to thrombin with varied reaction times
Sample
2.1
3.1
4.1

KAPA

Sample

2.1
3.1

qPCR
CopyCountTM

4.1
2.1
3.1
4.1

Ratio (protein: library)
1:1000
1:1000
1:1000

Protein
1 pmol
1 pmol
1 pmol

Library
1 nmol
1 nmol
1 nmol

Index
2
6
12

Cross-linking time
30 sec.
3 min.
30 min.

Number of
Molecules Used

Expected
Number of
Clusters

Clusters
as a % of
Molecules

Number
of
Surviving
TBA
molecules

90%
90%
90%

1,619,982,000
4,827,438,000
3,906,378,000

2,000,000
2,000,000
2,000,000

0.12%
0.04%
0.05%

622
209
258

90%
90%
90%

3,543,372,000
2,308,068,000
2,172,618,000

2,000,000
2,000,000
2,000,000

0.06%
0.09%
0.09%

284
437
464

pmoles of
Library
Recovered

pmoles
of
Library
Used

Percentage
of Total

0.0030
0.0089
0.0072

0.0026
0.0080
0.0064

0.0065
0.0043
0.0040

0.0059
0.0038
0.0036

(Top) Sample information for three HCHO cross-linking experiments of m=15 DNA tailed
library cross-linked to thrombin with varied cross-linking times. (Bottom) “pmoles of Library
Recovered” was determined by qPCR analysis with the KAPA kit and QPCR CopyCountTM
software. “pmoles of Library used” is the quantity of library required to equal a total 0.04 pmoles
for clustering. “Percentage of total” is pmoles of library used as a fraction of pmoles of library
recovered. “Number of molecules” is the number of molecules loaded onto the flow cell for a
four-plex MiSeq run. “Expected number of clusters” is based on cluster quality for previous data
from a four-plex MiSeq run. “Clusters as a percentage of molecules” is 2,000,000 as a
percentage of the total molecules per sample. “Number of surviving TBA molecules” is the
maximum number of TBA counts expected to be seen at 2,000,000 clusters with 100% recovery
of the initial 560,000 copies of TBA in the 1 nmol pool of library.
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Table 6.7. Statistical analysis of sequencing data for repeat of HCHO cross-linking the
m=15 DNA tailed library to thrombin with varied reaction times
Run

Total Number Clusters

Number of Clusters PF

Total Reads in Data Files

Samples 2.1-4.1

13,525,058

10,738,484

7,712,596

Quantity of Protein
Quantity of Library
Starting Copies per Sequence

1 pmol thb
30 sec.
1 pmol
1 nmol
560,000

1 pmol thb
3 min.
1 pmol
1 nmol
560,000

1 pmol thb
30 min.
1 pmol
1 nmol
560,000

Total Reads
Total Good Reads

2,815,007
186,221

2,053,062
391,049

1,944,873
382,900

Background/Noise Threshold
Sequences Above Background

3
4

3
4

3
8

Expected Counts of TBA
Observed Counts of TBAa
Frequency of TBA per Good Readsb
Frequency of TBA per Total Readsc

400
1_28
0.015%
0.00099%

448
3_4
0.0010%
0.00019%

451
1_272
0.071%
0.014%

Experiment

(Top) Total number of clusters produced per sequencing run. The number of clusters that passed
filter (PF) is approximately 79%. After demultiplexing, the total reads are approximately 57% of
the original clusters. (Bottom) Total number of reads for each sample generated by Illumina’s
BaseSpace. A total of 6,382 reads contained Index 1 of the positive control size marker. The
number of good reads was generated by the Perl Script. The expected number of TBA counts
was calculated based on the quantity of library recovered, the quantity of library applied to the
flow cell and the number of good reads assuming a 100% recovery of the original 560,000 copies
of TBA. (a) The rank (left) and count (right) are separated by an underscore. (b) Counts of TBA
divided by the total good reads. (c) Counts of TBA divided by the total reads.
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Table 6.8 Top 10 sequences for repeat of HCHO cross- linking the m=15 DNA tailed
library to thrombin with varied reaction times
Sample 2.1: 1 pmol thb, 30 sec.
Sequence
Count Identifier
TBA
GGTTGGTGTGGTTGG
28
Jump*
CACAGATCGGAAGAG
17
TBAsc
GGTGGTTGTTGTGGT
7
Jump*
GTCTGATCGGAAGAG
7
GTGTGCAGTCGAGTT
GTAGCATCTGGTCGA
TTCTATTGGTCATAT
TTAAGAGTCACGCTC
ATTATAATTAGGTTC
GAGCTAATTAGATAA

Sample 3.1: 1 pmol thb, 3 min.
Sequence
Count Identifier
CACAGATCGGAAGAG
GTCTGATCGGAAGAG
GGTTGGTGTGGTTGG
TTTGTGCGTACTGTA
TCTATGCACAAATCT
GTATCGGAGCTCTAG
ATCCCGGGGAGTCTG
ATAACGCTGATTAGC
ACCGCGCTTGGAAGA
TCAGCAAATCGGCGA

3
3
3
3
3
3

36
24
4
4
3
3
3
3
3
3

Jump*
Jump*
TBA

Sample 4.1: 1 pmol thb, 30 min.
Sequence
Count Identifier
TBA
GGTTGGTGTGGTTGG
272
Jump*
CACAGATCGGAAGAG
24
Jump*
GTCTGATCGGAAGAG
11
Ia
GGTTGGTGTTGTTGG
6
Ia
GGTTGGTGTGGTTTG
6
Ia
GGTTGGTTTGGTTGG
6
Ia
GGTTGTTGTGGTTGG
5
ATGAGGATTAGCGGT
ACATAAGTAGGGGAC
TGGGGTGCGATACAC

4
3
3

Top 10 sequences and corresponding counts for Samples 2.1-4.1. The thrombin binding aptamer
(TBA) was identified at counts of 28, 4 and 272, respectively. Jump sequence variants are
present in all three samples and account for the majority of non-TBA variants above background.
The background for all four experiments is 3. Variants of TBA occur in sample 4.1 as the 4th-7th
ranked sequences. The TBAsc sequence is found in sample 1 as the 4rd ranked sequence. It is
possible that this is the result on contamination during sample preparation.
*Jump sequence variants.
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Chapter 7: Discussion and Conclusions

The purpose of the work described in this thesis was to expand upon the capabilities of AIA to
develop a fast, consistent, high throughput and universal aptamer discovery approach. In its
infancy, AIA offered a simple and fast method for aptamer discovery that circumvented the
cycling bottleneck of SELEX by employing over-represented libraries and high throughput
sequencing.

The hairpin loop library structure allowed for the isolation of the canonical

thrombin binding aptamer as well as several lower affinity binding sequences in one round of
selection. An AIA experiment could be completed in 3-6 days, including high throughput
sequencing and data analysis, a marked improvement from the weeks to months required for a
single SELEX experiment. During preliminary attempts to replicate the results of the original,
published AIA results and explore the effects of target to library ratio, inconsistencies in
partitioning efficiency, sample preparation and sequencing data quality were encountered. This
work successfully expanded the applicability of AIA by (1) remedying sample preparation and
sequencing data quality inconsistencies through a series of troubleshooting experiments and
procedural modifications. TBA and dozens of variants were successfully identified above
background for two variable ratio experiments that demonstrated a correlation between observed
frequency of TBA/TBA variants and the degree of over-representation of the starting pool of
library. (2) A 2’-OMe RNA/DNA chimera hairpin loop library was used to successfully identify
TBA and multiple variants above background. This demonstrated a superior method for
incorporation of 2’-OMe RNA in aptamer selection that does not require regeneration of 2’-OMe
RNA during selection or risk altering the aptamer’s functionality with post-selection
modifications. (3) Implementing indexed adapters with sequence “barcodes” that allow
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multiplexing of multiple ligated samples in a single flow cell lane which increased sample
throughput and lowered costs. (4) Development of an efficient method to capture the minimally
flanked, tailed library utilizing adapter splints with partially randomized splints and a 3’-amino
modifier to prevent self-ligation. (5) Demonstrated the ability to predict the maximum frequency
for a sequence in amplification-free AIA based on the quantity of recovered library as
determined by qPCR, the degree of over-representation of the starting pool of library, and the
number of clusters generated during high throughput sequencing. (6) Development of a novel
partitioning method utilizing reversible formaldehyde cross-linking in conjunction with EMSA.
The method was used to successfully identify TBA above background at varying frequencies for
multiple reaction conditions. This method allows for partitioning in solution without the
requirement of protein immobilization, circumventing the inconsistencies encountered with bead
based partitioning. (7) Effectively improved high throughput sequencing data and distribution of
indices during multiplexing with absolute quantification with qPCR CopyCountTM software. The
software exhibited a higher level of accuracy than the KAPA Library Quantification kit while
eliminating the requirement of a standard curve. Ultimately, this directly reduces labor demands
and cost while minimizing the potential need for costly resequencing.

Recommendations for Future Work
The sample preparation techniques that evolved over the course of this work offer superior
control and predictability in the outcome of high throughput sequencing data. This affords the
researcher great flexibility in experimentation with partitioning techniques and modified
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libraries. The following are suggestions for future work that would expand the applicability of
AIA further.

ForteBio Octet RED96 as a partitioning method
The ForteBio Octet RED96 interaction analysis system is typically used to quantify proteins and
small molecules and analyze the kinetics of molecular interactions. The Octet platform boasts
advantages such as label-free detection, real-time interaction data, accurate and reproducible
results, a non-microfluidic design and simple user interface. The Octet RED96 specifically
offers increased sensitivity, enabling the detection of low molecular weight molecules,[181]
ideal for use with the tailed libraries of approximately 7 kDa. Two types of biosensors were used
during the preliminary experiments considering the Octet RED96 as a partitioning method:
Streptavidin (SA) and Amine Reactive Second Generation (AR2G). The streptavidin (SA)
biosensors are coated at the tip with streptavidin and are designed for immobilization of biotin
labeled proteins for studying protein: protein interactions.[182] The SA biosensors were used as
the solid surface for immobilization of biotinylated thrombin for partitioning against multiple
library formats. Also, biotinylated Con-A was immobilized on the SA biosensors and used as the
solid support for partitioning experiments against native thrombin. The AR2G biosensors are
coated at the tip with a carboxy-terminated ligand. An EDC-catalyzed amide bond formation
between the carboxylic acids on the biosensor and reactive amines of the protein surface creates
a covalent linkage.[183] The protein immobilization is irreversible, allowing for freedom in
screening conditions. Preliminary experiments found that the AR2G biosensors may offer a more
reliable method of protein immobilization for partitioning over the SA biosensors due to changes
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in binding affinity of thrombin following biotinylation. The binding capacity of the AR2G
biosensors is on the order of fmoles, which is low for traditional SELEX and for some past AIA
experiments (typically tens or hundreds of pmoles of protein). However, aptamers have been
successfully identified using fmole quantities of protein in SELEX.[84] If the AR2G biosensors
are successful at identifying TBA from a library pool partitioned against immobilized thrombin,
the AIA method could see great improvements from their implementation.

In preliminary experiments, the AR2G biosensors were adapted for AIA by immobilizing native
thrombin and screening against the m=15 DNA tailed library. The AR2G biosensors were
hydrated in dH2O for 15 minutes prior to the experiment. The instrument utilizes 96-well plates
with 200 µl reagent volumes; the biosensors are “dipped” into successive wells across the plate.
Figure 7.1 illustrates the experimental plate set-up and assay steps list. Chemistry in columns 15 occurs at a plate rotation of 1,000 rpm. Chemistry in columns 6 and 7 occurs at a plate rotation
of 60 rpm. Baseline is achieved in column 1, dH2O, for 120 seconds. The sensors were activated
in a solution of 20 nM EDC (1-Ethyl-3-[3-dimethylsminopropyl] carbodiimide hydrochloride)
and 10 nM NHS (N-hydroxysulfosuccinimide) for 300 seconds in column 2. Thrombin in 10
mM acetate buffer, pH 6.0, was loaded onto the activated sensors at 0.5 µM for sensors B-H for
900 seconds in column 3, corresponding to the period marked A in Figure 7.2. The 0.5 µM
concentration of thrombin was determined from preliminary experiments with the AR2G
biosensors to be a concentration for sufficient binding. The reactive sites on the sensors were
quenched in 1M ethanolamine, pH 8.5, for 300 seconds in column 4, corresponding to the period
immediately following the large increase in mass in period A. The next two periods between the
dashed lines in Figure 7.2 correspond to equilibration in the AIA partitioning buffer (20 mM
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Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) for 120 seconds,
followed by another 120 seconds in column 6 also containing the partitioning buffer. Period B in
the figure corresponds to the association of the analyte (m=15 DNA tailed library) in partitioning
buffer for 600 seconds in column 7. The library was associated at 5.0 µM, 2.5 µM, and 0.5 µM
in duplicate. For the 200 µl used in each well, this corresponds to 1 nmol, 500 pmol and 100
pmol of library, respectfully. This translates to approximately 560,000 copies, 280,000 copies,
and 56,000 copies of any unique sequence, respectively. Dissociation in partitioning buffer,
column 8, for 600 seconds washed off any unbound sequences in period C. The association of
thrombin in period A produces a large increase in signal due to the large molar mass of thrombin
(36.7 kDa). Little to no association is visualized in period B; this is thought to be a result of the
small size of the library in comparison to thrombin. Typical experiments performed on this
instrument employ analytes much larger in size than the immobilized target, where an
association curve would be apparent. The sensors were retrieved from the instrument and
resuspended in 10 µl dH2O. There was no discernible difference in the quantity of recovered
library between phenol/chloroform extracted samples and those ligated directly off of the
biosensors. The libraries were ligated with sequencing adapters directly off of the biosensors,
agarose gel purified and quantified with the KAPA Library Quantification kit and qPCR
CopyCountTM as described in chapter 6. A single sample from this experiment, sensor B, was
sequenced on the Illumina MiSeq and loaded according to the qPCR CopyCount TM
determination. Based on the recovered quantity of library, 100% recovery of the ~560,000 copies
of TBA in the starting pool and the number of clusters generated, the relative maximum
frequency of TBA was expected to be 1,329. TBA was not found in the data set and the only
sequences to occur above background were jump sequence variants. The Octet RED96 was also
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used to partition the m=15 DNA and m=15 2’-OMe RNA/DNA chimera adapter libraries
previous to this experiment and TBA was not isolated in these experiments.

Only a small number of experiments were performed with the Octet RED96 as a partitioning
method and there are a number of conditions that would require optimization before it could be
disqualified as a partitioning method. Most importantly is optimal loading of the protein target to
avoid over-crowding the biosensor while maintaining sufficient target to capture aptamers. One
benefit of the Octet RED96 is the consistency in the quantity of recovered library. With a
binding capacity on the order of fmoles, the quantity of recovered library ranged from 0.0002 –
0.002 pmoles for numerous experiments. This is well below the desired 0.01 pmoles of a 4-plex
sequencing run. If an aptamer sequence was efficiently selected using this method, it would
appear well above background. Additionally, this would allow for multiplexed sequencing runs
with >4 indices, increasing sample throughput.

The Minimal Primer (MP) method
The tailed libraries described in chapters 5 and 6 are flanked by four fixed bases on each side,
reducing the interaction between the randomized library region and the fixed regions necessary
for primer annealing. It may be advantageous to apply the concept of minimal fixed regions of
over-represented libraries used in AIA to the longer, under-represented libraries traditionally
used in SELEX. For under-represented libraries with copy numbers <1,000, it is necessary to
perform multiple rounds of partitioning. To accomplish this while retaining minimal fixed
regions, restriction enzyme digestion can be used to regenerate the library. The Minimal Primer
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(MP) method, as discussed in chapter 1, reduces the length of the fixed regions to 2 nucleotides
on each side of the library.[124] The proposed MP protocol was adapted with the AIA ligation
scheme and is outlined in Figure 7.3. The protocol utilizes advancements in the ligation scheme
including a four base randomized overhang that improves capture and a 3’-NH2 on the Adapter 2
complement to prevent self-ligation of the Adapter 2/Adapter 2 Complement complex.

A preliminary experiment illustrates the ligation efficiency of the MP library design using a 40mer “library” containing the 15-mer TBA sequence within the randomized region, flanked by
two nucleotide non-complementary tails. A 50 pmol aliquot of the 44-mer was ligated to
Adapters MP1a, 1b, 2a, and 2b at 20% excess concentration with conditions as described in
chapter 6. Results following incubation of the 20 µl reaction for 24 and 48 hours at 4°C are
shown in Figure 7.4 After 24 hours, both a single (~50 bp) and double (~80 bp) ligated product
are visible, with an estimated 70-80% capture of the double ligated product. After 48 hours, the
intensity of the double ligated product increases to an estimated >90% capture, while the
intensity of the single ligated product decreases. The overall intensity of free adapters decreases
after 48 hours compared to 24 hours. It was found that a 24 hour ligation yields a visibly
equivalent percentage of ligated products when additional adapters, buffer and enzyme are added
after the initial 12 hour incubation. This would reduce the time commitment of a 48 hour
incubation.

After ligation, PCR primers are used to amplify the ligated library. Restriction enzyme digestion
would regenerate the next generation MP library. This method would allow for the cycling
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required by under-represented libraries while maintaining the minimally flanked structure of the
tailed libraries used in AIA. The library could be prepared for sequencing in two manners:
ligation of the full length Illumina adapters in place of MP adapters (this would require no
additional PCR after the final partitioning) or ligation with the MP adapters and addition of the
critical Illumina adapter sequences by PCR. In keeping with the goals of AIA, simulating the
evolution that occurs in multiple rounds of SELEX as a result of errors in PCR amplification
would shorten the aptamer discovery process, saving time and money. It is often the case that
identified aptamer sequences for under-represented libraries are not present in the initial pool,
but evolved due to amplification errors in PCR.[147] This could be accomplished with
aggressive chemical mutagenesis, which has been used at low rates in prior studies.[184, 185]
Aggressively mutating 1-50% of the library molecules would introduce sequences that were not
present in the starting pool, but are relatives of sequences selected in previous rounds. Reversible
formaldehyde cross-linking and EMSA partitioning may be ideal for the MP method because it
may be possible to observe the convergence of the library pool to high affinity binding sequences
via EMSA.

Additional suggestions
Additional experiments to be considered include the introduction of new protein targets to the
reversible HCHO cross-linking and EMSA partitioning method. Specifically, partitioning of an
m=40 (and possibly, m=60) DNA library in the MP format against E. coli cellular lysates via
HCHO cross-linking. Additionally, partitioning tailed DNA and 2’-OMe or 2’-F RNA/DNA
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chimera libraries against the four Epigenetic protein targets described in chapter 3 with HCHO
cross-linking is suggested.
A final recommendation incorporates the high throughput sequencing utilized by AIA with postsequencing, protein-binding studies. The GAIIx used for sequencing in chapter 2 and 3 would
be transitioned for protein-imaging in order to rapidly identify and eliminate aptamer leads that
cross-react with off-target proteins. This is specifically useful for libraries selected against
mixtures of proteins, including cellular lysates. After clustering and sequencing, restriction
enzyme digestion and NaOH denaturation would generate ssDNA features on the flow cell. The
flow cell would be washed with binding buffer and subsequently screened with rhodamine 6G
labelled thrombin in proof of concept experiments. Software developed at MIT for a similar
application[186] would be used to capture images of protein bound DNA and identify the
sequences with high affinity for the protein. This method may circumvent secondary screening
techniques used during the assessment of aptamer candidates by using the sequenced flow cell as
a microarray.
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Figure 7.1. Octet RED96 experimental set-up
(left) 96-well experimental plate. Rows A-H correspond to sensors while columns 1-12
correspond to assay steps. Column 1: Baseline in dH2O. Column 2: Activation in EDC and NHS.
Column 3: Loading of thrombin. Column 4: Quenching with ethanolamine. Column 5: Wash in
AIA partitioning buffer. Column 6: Baseline in partitioning Buffer and dissociation. Column 7:
Association of analyte. (right) Assay steps list.
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Figure 7.2 Binding curve graph of m=15 tailed library against immobilized thrombin
A. Period for loading of thrombin on sensors B-H: 0.5 µM, sensor A: 0.0 µM. B. Period for
association of m=15 DNA tailed library: Sensors B-C: 5.0 µM library, sensors D-E: 2.5 µM,
sensors F-G: 0.5 µM library, sensor H: 0.0 µM library. C. Period for dissociation of complex in
partitioning buffer. Baseline drift is observed in green, sensor A, 0.0 µM thrombin and 0.0 µM
m=15 DNA tailed library.
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Figure 7.3 Minimal Primer (MP) cycling
The m=40 library (red), flanked by two-nucleotide fixed sequences, is partitioned against a
protein target. Surviving sequences are captured by the adapters MP1a, 1b, 2a, and 2b. The 6
nucleotide overhangs contain a 4 nucleotide randomized region to improve annealing efficiency.
The NH2- at the 3-terminus of MP2b prevents self-ligation of adapters. After ligation, PCR
primers MP1p and MP2p are used to amplify the ligated library. Restriction enzyme NotI makes
two staggered cuts (triangles) and Nt.BstNB cuts once; enzyme recognition sequences are
underlined. The regenerated library can then be used for the next round of partitioning.
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Figure 7.4 Ligation of MP 44-mer
4% Agarose gel stained with Ethidium Bromide. Lane 1: 25 bp DNA ladder. Lane 2: 60 pmol
each of Adapters MP1a, 1b, 2a, 2b. Lane 3: 50 pmol of 44-mer library/TBA insert. Lane 4: 50
pmol of 44-mer library/TBA ligated with 60 pmol of Adapters. (A.) 24 hour ligation (B.) 48 hour
ligation.
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Appendix 2
DNA Sequences (All sequences written 5’ to 3’)

m=15 DNA library (39 bases)
Phos/ACACGCGCATGC-m15-GCATGCGCCACA

Adapter 1 (33 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCT
Adapter 1 Complement (45 bases)
GCATGCGCGTGTAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 2 (33 bases)
Phos/GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTG
Adapter 2 Complement (45 bases)
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGTGGCGCATGC

PCR Forward Primer (58 bases)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT

PCR Reverse Primer (34 bases)
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT

SL1 Primer (21 bases)
CAGTCCAGTTACGCTGGAGTC

KAPA Primer 1 (20 bases)
AATGATACGGCGACCACCGA
KAPA Primer 2 (21 bases)
CAAGCAGAAGACGCCATACGA


Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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Sequencing Primer (33 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCT

Illumina P5 Region, SR Flow Cell (20 bases)
AATGATACGGCGACCACCGA
Illumina P7 Region, SR Flow Cell (21 bases)
CAAGCAGAAGACGGCATACGA



Oligonucleotide sequences © 2007-2013 Illumina, Inc. All rights reserved. Derivative works created by Illumina customers are
authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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Table 2.6 60:1, m=19 DNA for thrombin
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
Count
CCACAGATCGGAAGAGCTC
283
GCCACAGATCGGAAGAGCT
129
GCACAGATCGGAAGAGCTC
68
GCCACAGATCGGAGAGCTC
38
GCCACAGATCGAAGAGCTC
33
GCCAAGATCGGAAGAGCTC
27
ACACAGATCGGAAGAGCTC
24
GCCACAGATCGGAAGGCTC
19
GCCCAGATCGGAAGAGCTC
17
GCCACAGATCGGAAGACTC
15
GCCACGATCGGAAGAGCTC
14
GCCACAGATCGGAAAGCTC
12
GCCACAGACGGAAGAGCTC
12
GCCACAGATCGGAAGAGTC
11
TCACAGATCGGAAGAGCTC
9
CCACAGATCGGCAGAGCTC
7
GCCACAGATCGGCAGAGCT
7
GCCACAGATCGGAAGAGCC
7
GCCACAGATCGGAAGAGAT
6
CACCAGATCGGAAGAGCTC
6

Top twenty sequences from the 60:1, thrombin: m=19 DNA partitioning. A total of 4,644,765
good reads out of a total 5,932,215 reads. A total of 4,640,900 unique sequences occur in the file.
A total of 38 of the top 50 sequences are variations on the jump sequence, including all of the top
20. The background threshold was identified as 2 counts. 40 unique sequences occur above
background.
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Annotated Perl Script
Authored by Dr. Huitao Sheng, annotated by Dr. Damian Allis. The Perl Script is included for
readers who may wish to use it. User defined requirements in BOLD. All text has been left
justified.
#!/usr/bin/perl -w
# ---- USER DEFINED ---#my $fullhead='ACACGCGCATGC';
#my $fulltail='GCATGCGCCACA';
# NN for multiplexing
my $fullhead='ACACGCGCATGC';
my $fulltail='GCATGCGCCACA';
my $nmerlen=15; # length of nmers that we are looking for
# the location of the two multiplexing bases in head sequence
# index starting from 0
my $mp1 = 0;
my $mp2 = 0;
# query length
my $longQueryLength = 8;
my $shortQueryLength = 4;
# penalty and award
my $gapScore = -2;
my $mismatchScore = -1;
my $matchScore = 1;
# threshold: no more than 1/4 mismatches or gaps
my $minLongScore = $longQueryLength / 2;
my $minShortScore = $shortQueryLength / 2;
my $seqId = "S1_L001_R1_001";
my $readsfile = $seqId . ".fastq"; # input fasta file of reads
my $taskId = $seqId . "_"
. $longQueryLength . "_" . $nmerlen. "_" . $shortQueryLength;
my $goodReads = $taskId . "_goodReads.txt";
my $badReads = $taskId . "_badReads.txt";
my $candidateReads = $taskId . "_candidateReads.txt";
my $nmerCount = $taskId . "_nmerCount.txt";
my $locSta = $taskId . "_locationStatistics.txt";
# ---------------------# relative location
$mp1 -= length($fullhead) - $longQueryLength;
$mp2 -= length($fullhead) - $longQueryLength;
open(GOOD, ">$goodReads");
open(BAD, ">$badReads");
open(CAND, ">$candidateReads");
open(CUNT, ">$nmerCount");
open(LST, ">$locSta");
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open(FILE,$readsfile) or die("Cannot open!");
# looking for {junk}{long head}{N15}{short tail}
my $longHead = substr($fullhead,
length($fullhead) - $longQueryLength, $longQueryLength);
my @longh = split(//, $longHead);
my $shortTail = substr($fulltail, 0, $shortQueryLength);
my @shortt = split(//, $shortTail);
# looking for {short head}{N15}{long tail}{junk}
my $shortHead = substr($fullhead,
length($fullhead) - $shortQueryLength, $shortQueryLength);
my @shorth = split(//, $shortHead);
my $longTail = substr($fulltail, 0, $longQueryLength);
my @longt = split(//, $longTail);
my %mers=();
my $BASE_A = 0;
my $BASE_C = 1;
my $BASE_T = 2;
my $BASE_G = 3;
my $BASE_N = 4;
my $DEL = 5;
my $INS = 6;
my @headBaseCnt = ();
for(my $bIdx = 0; $bIdx < length($longHead); $bIdx++) {
for(my $cIdx = 0; $cIdx < 7; $cIdx++) {
$headBaseCnt[$cIdx][$bIdx] = 0;
}
}
my @tailBaseCnt = ();
for(my $bIdx = 0; $bIdx < length($shortTail); $bIdx++) {
for(my $cIdx = 0; $cIdx < 7; $cIdx++) {
$tailBaseCnt[$cIdx][$bIdx] = 0;
}
}
while (<FILE>) {
chomp;next if(/[^ACTGNactgn]/);
next if(/AAAA/);
my $read = $_;
my $matchLongHead = substr($read,
0, (length($read) - $shortQueryLength - $nmerlen));
my @mlh = split(//, $matchLongHead);
my @lhIdx = ();
my @mlhIdx = ();
my $mlhAlg = "";
my $longHeadScore = &DP_ALIGN(\@longh, \@mlh,
\@lhIdx, \@mlhIdx, \$mlhAlg);
my $lhst = "";
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my $lhstScore = $gapScore * length($read);
if($longHeadScore > $minLongScore) {
my $headMatchIdx = $#lhIdx;
my $readHeadIdx = $lhIdx[$headMatchIdx];
while(($readHeadIdx == -1) &&($headMatchIdx >= 0)) {
$headMatchIdx--;
$readHeadIdx = $lhIdx[$headMatchIdx];
}
if($headMatchIdx >= 0) {
my $matchShortTail = substr($read,
($readHeadIdx + $nmerlen - 1));
my @mst = split(//, $matchShortTail);
my @stIdx = ();
my @mstIdx = ();
my $mstAlg = "";
my $shortTailScore = &DP_ALIGN(\@shortt, \@mst,
\@stIdx, \@mstIdx, \$mstAlg);
if($shortTailScore > $minShortScore) {
my $tailMatchIdx = 0;
my $readTailIdx = $stIdx[$tailMatchIdx];
while(($readTailIdx == -1)
&& ($tailMatchIdx <= $#stIdx)) {
$tailMatchIdx++;
$readTailIdx = $stIdx[$tailMatchIdx];
}
if($tailMatchIdx <= $#stIdx) {
$lhstScore =
$longHeadScore + $shortTailScore;
$lhst = substr($read,
($readHeadIdx + 1),
($readTailIdx +$nmerlen - 2));
if(length($lhst) == $nmerlen) {
my $headMatchNum = 0;
my $headMisNum = 0;
my $headDelNum = 0;
my $headInsNum = 0;
for(my $bIdx = 0; $bIdx < length($longHead); $bIdx++) {
if($lhIdx[$bIdx] == -1) {
$headBaseCnt[$DEL][$bIdx]++;
}
elsif($mlh[$lhIdx[$bIdx]] eq "A") {
$headBaseCnt[$BASE_A][$bIdx]++;}
elsif($mlh[$lhIdx[$bIdx]] eq "C") {
$headBaseCnt[$BASE_C][$bIdx]++;
}
elsif($mlh[$lhIdx[$bIdx]] eq "T") {
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$headBaseCnt[$BASE_T][$bIdx]++;
}
elsif($mlh[$lhIdx[$bIdx]] eq "G") {
$headBaseCnt[$BASE_G][$bIdx]++;
}
elsif($mlh[$lhIdx[$bIdx]] eq "N") {
$headBaseCnt[$BASE_N][$bIdx]++;
}
# an insertion happened before this location
if(($bIdx > 0) && (($lhIdx[$bIdx] - $lhIdx[$bIdx - 1]) > 1) && ($lhIdx[$bIdx - 1] != -1)) {
$headBaseCnt[$INS][$bIdx]++;
$headInsNum++;
}
if($lhIdx[$bIdx] == -1) {
$headDelNum++;
}
elsif(($mlh[$lhIdx[$bIdx]] eq $longh[$bIdx])
|| ($mlh[$lhIdx[$bIdx]] eq "N")
|| ($longh[$bIdx] eq "N")) {
$headMatchNum++;
}
else {
$headMisNum++;
}
}
my $tailMatchNum = 0;
my $tailMisNum = 0;
my $tailDelNum = 0;
my $tailInsNum = 0;
for(my $bIdx = 0; $bIdx < length($shortTail); $bIdx++) {
if($stIdx[$bIdx] == -1) {
$tailBaseCnt[$DEL][$bIdx]++;
}
elsif($mst[$stIdx[$bIdx]] eq "A") {
$tailBaseCnt[$BASE_A][$bIdx]++;
}
elsif($mst[$stIdx[$bIdx]] eq "C") {
$tailBaseCnt[$BASE_C][$bIdx]++;
}
elsif($mst[$stIdx[$bIdx]] eq "T") {
$tailBaseCnt[$BASE_T][$bIdx]++;
}
elsif($mst[$stIdx[$bIdx]] eq "G") {
$tailBaseCnt[$BASE_G][$bIdx]++;
}
elsif($mst[$stIdx[$bIdx]] eq "N") {
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$tailBaseCnt[$BASE_N][$bIdx]++;
}
# an insertion happened before this location
if(($bIdx > 0) && (($stIdx[$bIdx] - $stIdx[$bIdx - 1]) > 1) && ($stIdx[$bIdx - 1] != -1)) {
$tailBaseCnt[$INS][$bIdx]++;
$tailInsNum++;
}
if($stIdx[$bIdx] == -1) {
$tailDelNum++;
}
elsif(($mst[$stIdx[$bIdx]] eq $shortt[$bIdx])
|| ($mst[$stIdx[$bIdx]] eq "N")
|| ($shortt[$bIdx] eq "N")) {
$tailMatchNum++;
}
else {
$tailMisNum++;
}
}
print GOOD $read;
print GOOD "\t";
&PRNMATCH(GOOD, \@lhIdx, \@mlh);
print GOOD "\t";
print GOOD $headMatchNum;
print GOOD "\t";
print GOOD $headMisNum;
print GOOD "\t";
print GOOD $headDelNum;
print GOOD "\t";
print GOOD $headInsNum;
print GOOD "\t";
print GOOD $lhst;
print GOOD "\t";
print GOOD length($lhst);
print GOOD "\t";
&PRNMATCH(GOOD, \@stIdx, \@mst);
print GOOD "\t";
print GOOD $tailMatchNum;
print GOOD "\t";
print GOOD $tailMisNum;
print GOOD "\t";
print GOOD $tailDelNum;
print GOOD "\t";
print GOOD $tailInsNum;
print GOOD "\t";
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print GOOD "\t"
. "$mlh[$lhIdx[$mp1]]"
. "$mlh[$lhIdx[$mp2]]"
. "\n";
if(defined($mers{$lhst})) {
$mers{$lhst}++;
}
else {
$mers{$lhst} = 1;
}
}
else {
print CAND $read;
print CAND "\t";
&PRNMATCH(CAND, \@lhIdx, \@mlh);
print CAND "\t";
print CAND $lhst;
print CAND "\t";
print CAND length($lhst);
print CAND "\t";
&PRNMATCH(CAND, \@stIdx, \@mst);
print CAND "\n";
}
next;
}
}
}
}
my $matchLongTail = substr($read, ($shortQueryLength + $nmerlen));
my @mlt = split(//, $matchLongTail);
my @ltIdx = ();
my @mltIdx = ();
my $mltAlg = "";
my $longTailScore = &DP_ALIGN(\@longt, \@mlt,
\@ltIdx, \@mltIdx, \$mltAlg);
my $shlt = "";
my $shltScore = $gapScore * length($read);
if($longTailScore > $minLongScore) {
my $tailMatchIdx = 0;
my $readTailIdx = $ltIdx[$tailMatchIdx];
while(($readTailIdx == -1) && ($tailMatchIdx <= $#ltIdx)) {
$tailMatchIdx++;
$readTailIdx = $ltIdx[$tailMatchIdx];
}
if($tailMatchIdx <= $#ltIdx) {
my $matchShortHead = substr($read,
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0, ($shortQueryLength + $readTailIdx + 2));
my @msh = split(//, $matchShortHead);
my @shIdx = ();
my @mshIdx = ();
my $mshAlg = "";
my $shortHeadScore = &DP_ALIGN(\@shorth, \@msh,
\@shIdx, \@mshIdx, \$mshAlg);
if($shortHeadScore > $minShortScore) {
my $headMatchIdx = $#shIdx;
my $readHeadIdx = $shIdx[$headMatchIdx];
while(($readHeadIdx == -1)
&& ($headMatchIdx >= 0)) {
$headMatchIdx--;
$readHeadIdx = $shIdx[$headMatchIdx];
}
if($headMatchIdx >= 0) {
$shltScore =
$shortHeadScore + $longTailScore;
$shlt = substr($read,
($readHeadIdx + 1),
($shortQueryLength + $nmerlen + $readTailIdx - $readHeadIdx - 1));
print CAND $read;
print CAND "\t";
&PRNMATCH(CAND, \@shIdx, \@msh);
print CAND "\t";
print CAND $shlt;
print CAND "\t";
print CAND length($shlt);
print CAND "\t";
&PRNMATCH(CAND, \@ltIdx, \@mlt);
print CAND "\n";
next;
}
}
}
}
print BAD "$read\n";
}
foreach $key (sort {$mers{$b} <=> $mers{$a}} keys %mers) {
print CUNT "$key\t$mers{$key}\n";
}
for(my $bIdx = 0; $bIdx <= $#longh; $bIdx++) {
print LST "\t$longh[$bIdx]";
}
print LST "\n";
for(my $cIdx = 0; $cIdx < 7; $cIdx++) {
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if($cIdx == $BASE_A) {
print LST "A";
}
elsif($cIdx == $BASE_C) {
print LST "C";
}
elsif($cIdx == $BASE_T) {
print LST "T";
}
elsif($cIdx == $BASE_G) {
print LST "G";
}
elsif($cIdx == $BASE_N) {
print LST "N";
}
elsif($cIdx == $DEL) {
print LST "DEL";
}
elsif($cIdx == $INS) {
print LST "INS(b4)";
}
for(my $bIdx = 0; $bIdx <= $#longh; $bIdx++) {
print LST "\t$headBaseCnt[$cIdx][$bIdx]"
}
print LST "\n";
}
print LST "\n";
for(my $bIdx = 0; $bIdx <= $#shortt; $bIdx++) {
print LST "\t$shortt[$bIdx]";
}
print LST "\n";
for(my $cIdx = 0; $cIdx < 7; $cIdx++) {
if($cIdx == $BASE_A) {
print LST "A";
}
elsif($cIdx == $BASE_C) {
print LST "C";
}
elsif($cIdx == $BASE_T) {
print LST "T";
}
elsif($cIdx == $BASE_G) {
print LST "G";
}
elsif($cIdx == $BASE_N) {
print LST "N";
259

}
elsif($cIdx == $DEL) {
print LST "DEL";
}
elsif($cIdx == $INS) {
print LST "INS(b4)";
}
for(my $bIdx = 0; $bIdx <= $#shortt; $bIdx++) {
print LST "\t$tailBaseCnt[$cIdx][$bIdx]"
}
print LST "\n";
}
close(GOOD);
close(BAD);
close(CAND);
close(FILE);
close(CUNT);
close(LST);
# dynamic programming sequence alignment
sub DP_ALIGN {
# input: the two sequences to be aligned
# array references
my $s1Ref = shift;
my $s2Ref = shift;
my $len1 = $#$s1Ref + 1;
my $len2 = $#$s2Ref + 1;
# output: the index of aligned bases for each input sequence
# array references
my $a1Ref = shift;
my $a2Ref = shift;
# -1 in index means a gap
my $gapIdx = -1;
for(my $sIdx = 0; $sIdx < $len1; $sIdx++) {
$$a1Ref[$sIdx] = $gapIdx;
}
for(my $sIdx = 0; $sIdx < $len2; $sIdx++) {
$$a2Ref[$sIdx] = $gapIdx;
}
my $alignRef = shift;
#
# penalty and award
#
my $gapScore = -2;
#
my $mismatchScore = -1;
#
my $matchScore = 1;
# initialize score talbe
my @scoreTable = ();
for(my $row = 0; $row <= $len1; $row++) {
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for(my $col = 0; $col <= $len2; $col++) {
$scoreTable[$row][$col]= 0; # ignore leading gaps
}
}
# trace direction
my $fromNowhere = 0;
my $fromLeft = 1;
my $fromAbove = 2;
my $fromAboveLeft = 3;
# initialize trace table
my @traceTable = ();
$traceTable[0][0] = $fromNowhere;
for(my $col = 1; $col <= $len2; $col++) {
$traceTable[0][$col] = $fromLeft;
}
for(my $row = 1; $row <= $len1; $row++) {
$traceTable[$row][0] = $fromAbove;
for(my $col = 1; $col <= $len2; $col++) {
$traceTable[$row][$col] = $fromNowhere;
}
}
#fill out score table and traceback table
for(my $row = 1; $row <= $len1; $row++) {
for(my $col = 1; $col <= $len2; $col++) {
my $aboveScore =
$scoreTable[$row - 1][$col] + $gapScore;
my $leftScore = $scoreTable[$row][$col - 1] + $gapScore;
my $aboveLeftScore = $scoreTable[$row - 1][$col - 1];
if(&SAME_BASE($$s1Ref[$row - 1],
$$s2Ref[$col - 1]) == 1) {
$aboveLeftScore += $matchScore;
}
else {
$aboveLeftScore += $mismatchScore;
}
$scoreTable[$row][$col] = $aboveLeftScore;
$traceTable[$row][$col] = $fromAboveLeft;
if($aboveScore > $scoreTable[$row][$col]) {
$scoreTable[$row][$col] = $aboveScore;
$traceTable[$row][$col] = $fromAbove;
}
if($leftScore > $scoreTable[$row][$col]) {
$scoreTable[$row][$col] = $leftScore;
$traceTable[$row][$col] = $fromLeft;
}
}
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}
# ignore tailing gaps
my $maxCol = $scoreTable[0][$len2];
my $maxRowIdx = 0;
for(my $row = 1; $row <= $len1; $row++) {
if($scoreTable[$row][$len2] > $maxCol) {
$maxCol = $scoreTable[$row][$len2];
$maxRowIdx =$row;
}
}
my $maxRow = $scoreTable[$len1][0];
my $maxColIdx = 0;
for(my $col = 1; $col <= $len2; $col++) {
if($scoreTable[$len1][$col] > $maxRow) {
$maxRow = $scoreTable[$len1][$col];
$maxColIdx = $col;
}
}
if($maxRow > $maxCol) {
for(my $col = $len2; $col > $maxColIdx; $col--) {
$traceTable[$len1][$col] = $fromLeft;
}
$scoreTable[$len1][$len2] = $maxRow;
}
else {
for(my $row = $len1; $row > $maxRowIdx; $row--) {
$traceTable[$row][$len2] = $fromAbove;
}
$scoreTable[$len1][$len2] = $maxCol;
}
# get output
my $row = $len1;
my $col = $len2;
my $as1 = "";
my $as2 = "";
while($traceTable[$row][$col] != $fromNowhere) {
if($traceTable[$row][$col] == $fromAboveLeft) {
$$a1Ref[$row - 1] = ($col - 1);
$$a2Ref[$col - 1] = ($row - 1);
$as1 = $$s1Ref[$row - 1] . $as1;
$as2 = $$s2Ref[$col - 1] . $as2;
$row--;
$col--;
}
elsif($traceTable[$row][$col] == $fromAbove) {
$$a1Ref[$row - 1] = -1;
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$as1 = $$s1Ref[$row - 1] . $as1;
$as2 = '-' . $as2;
$row--;
}
elsif($traceTable[$row][$col] == $fromLeft) {
$$a2Ref[$col - 1] = -1;
$as1 = '-' . $as1;
$as2 = $$s2Ref[$col - 1] . $as2;
$col--;
}
}
# test output
#
print "Score table:\n";
#
for(my $row = 0; $row <= $len1; $row++) {
#
for(my $col = 0; $col <= $len2; $col++) {
#
print "\t$scoreTable[$row][$col]";
#
}
#
print "\n";
#
}
#
#
print "Trace table:\n";
#
for(my $row = 0; $row <= $len1; $row++) {
#
for(my $col = 0; $col <= $len2; $col++) {
#
print "\t$traceTable[$row][$col]";
#
}
#
print "\n";
#
}
$$alignRef = $as1 . "\n" . $as2 . "\n";
return $scoreTable[$len1][$len2];
}
# dynamic programming sequence alignment
sub DP_ALIGN_4H {
# input: the two sequences to be aligned
# array references
my $s1Ref = shift;
my $s2Ref = shift;
my $len1 = $#$s1Ref + 1;
my $len2 = $#$s2Ref + 1;
# output: the index of aligned bases for each input sequence
# array references
my $a1Ref = shift;
my $a2Ref = shift;
# -1 in index means a gap
my $gapIdx = -1;
for(my $sIdx = 0; $sIdx < $len1; $sIdx++) {
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$$a1Ref[$sIdx] = $gapIdx;
}
for(my $sIdx = 0; $sIdx < $len2; $sIdx++) {
$$a2Ref[$sIdx] = $gapIdx;
}
my $alignRef = shift;
#
# penalty and award
#
my $gapScore = -2;
#
my $mismatchScore = -1;
#
my $matchScore = 1;
# initialize score talbe
my @scoreTable = ();
for(my $row = 0; $row <= $len1; $row++) {
for(my $col = 0; $col <= $len2; $col++) {
$scoreTable[$row][$col]= 0; # ignore leading gaps
}
}
# trace direction
my $fromNowhere = 0;
my $fromLeft = 1;
my $fromAbove = 2;
my $fromAboveLeft = 3;
# initialize trace table
my @traceTable = ();
$traceTable[0][0] = $fromNowhere;
for(my $col = 1; $col <= $len2; $col++) {
$traceTable[0][$col] = $fromLeft;
}
for(my $row = 1; $row <= $len1; $row++) {
$traceTable[$row][0] = $fromAbove;
for(my $col = 1; $col <= $len2; $col++) {
$traceTable[$row][$col] = $fromNowhere;
}
}
#fill out score table and traceback table
for(my $row = 1; $row <= $len1; $row++) {
for(my $col = 1; $col <= $len2; $col++) {
my $aboveScore =
$scoreTable[$row - 1][$col] + $gapScore;
my $leftScore = $scoreTable[$row][$col - 1] + $gapScore;
my $aboveLeftScore = $scoreTable[$row - 1][$col - 1];
if(&SAME_BASE($$s1Ref[$row - 1],
$$s2Ref[$col - 1]) == 1) {
$aboveLeftScore += $matchScore;
}
else {
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$aboveLeftScore += $mismatchScore;
}
$scoreTable[$row][$col] = $aboveLeftScore;
$traceTable[$row][$col] = $fromAboveLeft;
if($aboveScore > $scoreTable[$row][$col]) {
$scoreTable[$row][$col] = $aboveScore;
$traceTable[$row][$col] = $fromAbove;
}
if($leftScore > $scoreTable[$row][$col]) {
$scoreTable[$row][$col] = $leftScore;
$traceTable[$row][$col] = $fromLeft;
}
}
}
# ignore tailing gaps
#my $maxCol = $scoreTable[0][$len2];
#my $maxRowIdx = 0;
#for(my $row = 1; $row <= $len1; $row++) {
#
if($scoreTable[$row][$len2] > $maxCol) {
#
$maxCol = $scoreTable[$row][$len2];
#
$maxRowIdx =$row;
#
}
#}
my $maxRow = $scoreTable[$len1][0];
my $maxColIdx = 0;
for(my $col = 1; $col <= $len2; $col++) {
if($scoreTable[$len1][$col] > $maxRow) {
$maxRow = $scoreTable[$len1][$col];
$maxColIdx = $col;
}
}
#if($maxRow > $maxCol) {
for(my $col = $len2; $col > $maxColIdx; $col--) {
$traceTable[$len1][$col] = $fromLeft;
}
$scoreTable[$len1][$len2] = $maxRow;
#}
#else {
#
for(my $row = $len1; $row > $maxRowIdx; $row--) {
#
$traceTable[$row][$len2] = $fromAbove;
#
}
#
$scoreTable[$len1][$len2] = $maxCol;
#}
# get output
my $row = $len1;
my $col = $len2;
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my $as1 = "";
my $as2 = "";
while($traceTable[$row][$col] != $fromNowhere) {
if($traceTable[$row][$col] == $fromAboveLeft) {
$$a1Ref[$row - 1] = ($col - 1);
$$a2Ref[$col - 1] = ($row - 1);
$as1 = $$s1Ref[$row - 1] . $as1;
$as2 = $$s2Ref[$col - 1] . $as2;
$row--;
$col--;
}
elsif($traceTable[$row][$col] == $fromAbove) {
$$a1Ref[$row - 1] = -1;
$as1 = $$s1Ref[$row - 1] . $as1;
as2 = '-' . $as2;
$row--;
}
elsif($traceTable[$row][$col] == $fromLeft) {
$$a2Ref[$col - 1] = -1;
$as1 = '-' . $as1;
$as2 = $$s2Ref[$col - 1] . $as2;
$col--;
}
}
# test output
#
print "Score table:\n";
#
for(my $row = 0; $row <= $len1; $row++) {
#
for(my $col = 0; $col <= $len2; $col++) {
#
print "\t$scoreTable[$row][$col]";
#
}
#
print "\n";
#
}
#
#
print "Trace table:\n";
#
for(my $row = 0; $row <= $len1; $row++) {
#
for(my $col = 0; $col <= $len2; $col++) {
#
print "\t$traceTable[$row][$col]";
#
}
#
print "\n";
#
}
$$alignRef = $as1 . "\n" . $as2 . "\n";
return $scoreTable[$len1][$len2];
}
# dynamic programming sequence alignment
sub DP_ALIGN_4T {
# input: the two sequences to be aligned
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# array references
my $s1Ref = shift;
my $s2Ref = shift;
my $len1 = $#$s1Ref + 1;
my $len2 = $#$s2Ref + 1;
# output: the index of aligned bases for each input sequence
# array references
my $a1Ref = shift;
my $a2Ref = shift;
# -1 in index means a gap
my $gapIdx = -1;
for(my $sIdx = 0; $sIdx < $len1; $sIdx++) {
$$a1Ref[$sIdx] = $gapIdx;
}
for(my $sIdx = 0; $sIdx < $len2; $sIdx++) {
$$a2Ref[$sIdx] = $gapIdx;
}
my $alignRef = shift;
#
# penalty and award
#
my $gapScore = -2;
#
my $mismatchScore = -1;
#
my $matchScore = 1;
# initialize score talbe
my @scoreTable = ();
for(my $row = 0; $row <= $len1; $row++) {
for(my $col = 0; $col <= $len2; $col++) {
#$scoreTable[$row][$col]= 0; # ignore leading gaps
$scoreTable[$row][$col]= $gapScore * $row; # ignore leading gaps
}
}
# trace direction
my $fromNowhere = 0;
my $fromLeft = 1;
my $fromAbove = 2;
my $fromAboveLeft = 3;
# initialize trace table
my @traceTable = ();
$traceTable[0][0] = $fromNowhere;
for(my $col = 1; $col <= $len2; $col++) {
$traceTable[0][$col] = $fromLeft;
}
for(my $row = 1; $row <= $len1; $row++) {
$traceTable[$row][0] = $fromAbove;
for(my $col = 1; $col <= $len2; $col++) {
$traceTable[$row][$col] = $fromNowhere;
}
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}
#fill out score table and traceback table
for(my $row = 1; $row <= $len1; $row++) {
for(my $col = 1; $col <= $len2; $col++) {
my $aboveScore =
$scoreTable[$row - 1][$col] + $gapScore;
my $leftScore = $scoreTable[$row][$col - 1] + $gapScore;
my $aboveLeftScore = $scoreTable[$row - 1][$col - 1];
if(&SAME_BASE($$s1Ref[$row - 1],
$$s2Ref[$col - 1]) == 1) {
$aboveLeftScore += $matchScore;
}
else {
$aboveLeftScore += $mismatchScore;
}
$scoreTable[$row][$col] = $aboveLeftScore;
$traceTable[$row][$col] = $fromAboveLeft;
if($aboveScore > $scoreTable[$row][$col]) {
$scoreTable[$row][$col] = $aboveScore;
$traceTable[$row][$col] = $fromAbove;
}
if($leftScore > $scoreTable[$row][$col]) {
$scoreTable[$row][$col] = $leftScore;
$traceTable[$row][$col] = $fromLeft;
}
}
}
# ignore tailing gaps
my $maxCol = $scoreTable[0][$len2];
my $maxRowIdx = 0;
for(my $row = 1; $row <= $len1; $row++) {
if($scoreTable[$row][$len2] > $maxCol) {
$maxCol = $scoreTable[$row][$len2];
$maxRowIdx =$row;
}
}
my $maxRow = $scoreTable[$len1][0];
my $maxColIdx = 0;
for(my $col = 1; $col <= $len2; $col++) {
if($scoreTable[$len1][$col] > $maxRow) {
$maxRow = $scoreTable[$len1][$col];
$maxColIdx = $col;
}
}
if($maxRow > $maxCol) {
for(my $col = $len2; $col > $maxColIdx; $col--) {
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$traceTable[$len1][$col] = $fromLeft;
}
$scoreTable[$len1][$len2] = $maxRow;
}
else {
for(my $row = $len1; $row > $maxRowIdx; $row--) {
$traceTable[$row][$len2] = $fromAbove;
}
$scoreTable[$len1][$len2] = $maxCol;
}
# get output
my $row = $len1;
my $col = $len2;
my $as1 = "";
my $as2 = "";
while($traceTable[$row][$col] != $fromNowhere) {
if($traceTable[$row][$col] == $fromAboveLeft) {
$$a1Ref[$row - 1] = ($col - 1);
$$a2Ref[$col - 1] = ($row - 1);
$as1 = $$s1Ref[$row - 1] . $as1;
$as2 = $$s2Ref[$col - 1] . $as2;
$row--;
$col--;
}
elsif($traceTable[$row][$col] == $fromAbove) {
$$a1Ref[$row - 1] = -1;
$as1 = $$s1Ref[$row - 1] . $as1;
$as2 = '-' . $as2;
$row--;
}
elsif($traceTable[$row][$col] == $fromLeft) {
$$a2Ref[$col - 1] = -1;
$as1 = '-' . $as1;
$as2 = $$s2Ref[$col - 1] . $as2;
$col--;
}
}
# test output
#
print "Score table:\n";
#
for(my $row = 0; $row <= $len1; $row++) {
#
for(my $col = 0; $col <= $len2; $col++) {
#
print "\t$scoreTable[$row][$col]";
#
}
#
print "\n";
#
}
#
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#
print "Trace table:\n";
#
for(my $row = 0; $row <= $len1; $row++) {
#
for(my $col = 0; $col <= $len2; $col++) {
#
print "\t$traceTable[$row][$col]";
#
}
#
print "\n";
#
}
$$alignRef = $as1 . "\n" . $as2 . "\n";
return $scoreTable[$len1][$len2];
}
sub SAME_BASE {
my $base1 = shift;
my $base2 = shift;
$base1 =~ s/$base1/\U$base1\E/;
$base2 =~ s/$base2/\U$base2\E/;
if($base1 eq $base2) {
return 1;
}
if($base1 eq 'N') {
return 1;
}
if($base2 eq 'N') {
return 1;
}
return 0;
}
sub PRNMATCH {
my $FH = shift;
my $hIdx = shift;
my $rh = shift;
for(my $mIdx = 0; $mIdx <= $#{$hIdx}; $mIdx++) {
my $rIdx = ${$hIdx}[$mIdx];
if($rIdx == -1) {
print $FH "-";
}
else {
print $FH "${$rh}[$rIdx]";
}
}
}
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Appendix 3
DNA Sequences (All sequences written 5’  3’). Indexes are underlined. 

Indexed Adapter 1/ Adapter 1 Complement (Indices 1-8 of 16 were synthesized and listed below)
Adapter 1 (Index 1), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTATCGTA
Adapter 1 Complement (Index 1), (51 bases)
GCATGCGCGTGTTACGATAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 2), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTGATAGC
Adapter 1 Complement (Index 2), (51 bases)
GCATGCGCGTGTGCTATCAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 3), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGATCT
Adapter 1 Complement (Index 3), (51 bases)
GCATGCGCGTGTAGATCGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 4), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTTCGCTA
Adapter 1 Complement (Index 4), (51 bases)
GCATGCGCGTGTTAGCGAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 5), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTTACGTC
Adapter 1 Complement (Index 5), (51 bases)
GCATGCGCGTGTGACGTAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 6), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTAGTAGT
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Adapter 1 Complement (Index 6), (51 bases)
GCATGCGCGTGTACTACTAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 7), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTGCATGA
Adapter 1 Complement (Index 7), (51 bases)
GCATGCGCGTGTTCATGCAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 (Index 8), (39 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTGCTG
Adapter 1 Complement (Index 8), (51 bases)
GCATGCGCGTGTCAGCAGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Modified Adapter 2 (33bases)
Phos/GACAGAGGTCAGTCGTATGCCGTCTTCTGCTTG
Adapter 2 Complement (45 bases)
CAAGCAGAAGACGGCATACGACTGACCTCTGTCTGTGGCGCATGC
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Appendix 4
DNA Sequences (All sequences written 5’  3’). Indexes are underlined.
Oligonucleotide sequences for TruSeqTM RNA and DNA Sample Prep Kits:
TruSeq Universal Adapter (58 bases)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT

TruSeq Adapter Index 1 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 2 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGATGTATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 3 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTTAGGCATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 4 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 5 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACACAGTGATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 6 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGCCAATATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 7 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGATCATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 8 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACACTTGAATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 9 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGATCAGATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 10 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTAGCTTATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 11 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGGCTACATCTCGTATGCCGTCTTCTGCTTG

TruSeq Adapter, Index 12 (63 bases)
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTTGTAATCTCGTATGCCGTCTTCTGCTTG
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m=15 Adapter Library (61 bases)
Phos/ACGACGCTCTTCCGATCT –m15- AATGCCTGGGAGCACACGTCTGAACTCC

CAP1 Primer (20 bases)
ACACGACGCTCTTCCGATCT
CAP2 Primer (25 bases)
GTGACTGGAGTTCAGACGTGTGCTA
CAP1 Short (18 bases)
ACGACGCTCTTCCGATCT
CAP2 Short (17 bases)
AGACGGCATACGAGCTC

P1 Forward Primer (57 bases)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT

P2.1 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTC

P2.2 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGTGCTC

P2.3 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTC AGACGTGTGCTC

P2.4 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTC AGACGTGTGCTC

P2.5 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTC AGACGTGTGCTC

P2.6 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTC AGACGTGTGCTC

P2.7 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTC AGACGTGTGCTC

P2.8 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTC AGACGTGTGCTC
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P2.9 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGTTC AGACGTGTGCTC

P2.10 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACTGGAGTTC AGACGTGTGCTC

P2.11 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATGTAGCCGTGACTGGAGTTC AGACGTGTGCTC

P2.12 Reverse Primer (55 bases)
CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTC AGACGTGTGCTC

Read 1 Primer (33 bases)
ACACTCTTTCCCTACACGACGCTCTTCCGATCT
Custom Read 2 Primer (25 bases)
GTGACTGGAGTTCAGACGTGTGCTC
Custom Index Read Primer (25 bases)
GAGCACACGTCTGAACTCCAGTCAC

Illumina TruSeq Flow Cell Oligo (P5), (39 bases)
TTTTTTTTTTAATGATACGGCGACCACCGAGAUCTACAC
Illumina TruSeq Flow Cell Oligo (P7), (34 bases)
TTTTTTTTTTCAAGCAGAAGACGGCATACGAGAT
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Top 20 Sequences, 60:1, m=15 adapter library bottom-bottom band
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
GGTGGTTGTTGTGGT
GGTGGTTGTTGTGAT
GGTGGTTATTGTGGT
AGTGGTTGTTGTGGT
GGTGGTTGTTATGGT
GGTGGTTGTTGAGGT
GCGCAGTGCCACATC
CGATGACTGACGCGT
GGTGGTTGTTGTGCT
GATGGTTGTTGTGGT
TGTGGTTGTTGTGGT
GGTGGTTGTCGTGGT
NGTGGTTGTTGTGGT
GGTGGTTGTTCTGGT
GTGCGACCGCACCCC
CGCCTCTTCTGATGC
ACACGGCCCGCCCGG
CGACCTCCGTCCAGC
CGCGCCCAGTCCTCC
CTGCTTCGCTCAGGC
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Count
927
7
6
6
5
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2

Identifier
TBAsc
TBAsc
TBAsc
TBAsc
TBAsc
TBAsc

TBAsc
TBAsc
TBAsc
TBAsc
TBAsc
TBAsc

Top 20 Sequences, 60:1, m=15 adapter library bottom-top band
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Sequence
GGTGGTTGTTGTGGT
GGTGATTGTTGTGGT
GGTAGTTGTTGTGGT
GGTGGTTGTTGTAGT
GGTGGTTGTTATGGT
TTACGATGTCCGACT
AGTGGTTGTTGTGGT
CGGTTCGCGATGGAC
GATGGTTGTTGTGGT
GCGCCCGATCGTGAT
GGTGGTTGTTGCGGT
GGTGGCTGTTGTGGT
GCACCAGCCGTTACC
CTTGATTGCTTGGTG
TCTGCCGGGCCCAAC
GGCCAGGCCCACTGC
GGCGTGACACGGTCG
CCACTGCTTGTTATC
GCGATGCTTACTCGC
ATTTCTCCATGGGTC
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Count
534
6
6
6
5
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2

Identifier
TBAsc
TBAsc
TBAsc
TBAsc
TBAsc

TBAsc
TBAsc

Appendix 5
DNA Sequences (All sequences written 5’  3’). Indexes are underlined.
Adapters for ligating un-flanked libraries:
Adapter 1 (58 bases)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT

Adapter 1 Complement, Full Length (64 bases)
AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATT

Adapter 1 Complement, Short, n=1 (34 bases)
NAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 Complement, Short, n=2 (35 bases)
NNAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 Complement, Short, n=3 (36 bases)
NNNAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 Complement, Short, n=4 (37 bases)
NNNNAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT

Adapter 2, Index 1 (64 bases)
Phos/GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG

Adapter 2 Complement, Index 1, n=1 (3’-Amine), (65 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCN/3AmMO/

Adapter 2 Complement, Index 1, n=1 (3’-Amine), (66 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCNN

Adapter 2 Complement, Index 1, n=1 (3’-Amine), (67 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCNNN

Adapter 2 Complement, Index 1, n=1 (3’-Amine), (68 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCNNNN
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Click ligation adapters and libraries
m=15 DNA Click Library (5’-azide, 3’-alkyne)
TNNNNNNNNNNNNNNNC
Click TBA (5’-azide, 3’-alkyne)
TGGTTGGTGTGGTTGGC

Adapter 1(3’-alkyne) (59 bases)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTC

Adapter 1 Complement, A/ n=3 splint (38 bases)
5NNNAGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 Complement, Fixed splint (38 bases)
5ACCAGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT

Adapter 2, Index 1 (5’-azide)
/GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG

Adapter 2 Complement, G/n=3 splint (68 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCAGNN
N

Adapter 2 Complement, Fixed splint (68 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCAGCC
A
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Adapters for ligating tailed libraries:
Adapter 1 (58 bases)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT

Adapter 1 Complement, Short, Fixed splint (47 bases)
GTGTAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
Adapter 1 Complement, Short, Fixed/n=14 splint (41 bases)
NNNNGTGTAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT

Adapter 2, Index 1 (64 bases)
Phos/GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG

Adapter 2 Complement, Index , Fixed splint (3’-Amine), (68 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGTG/3AmMO/

Adapter 2 Complement, Index 1, Fixed/n=4 splint (3’-Amine), (72 bases)
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGTGNNNN/3Am
MO/
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Appendix 6
DNA Sequences (All sequences written 5’  3’).
Pyrrolo-C oligos, underlined base indicates Pyrrolo-C C substitution:
m=15 tailed library, external Py-C (24 bases)
pACACNNNNNNNNNNNNNNNCACA

m=15 tailed library, internal PyC (24 bases)
pACACNNNNNNNCNNNNNNNCACA

Tailed TBA-PyC (24 bases)
pACACGGTTGGTGTGGTTGGCACA

Tailed TBAsc-PyC (24 bases)
pACACGGTGGTTGTTGTGGTCACA

44-mer library/TBA (44 bases)
pCANNNNN(CN)4GGTTGGTGTGGTTGG(N)12GC
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